<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25146427</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1755-5949</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>CNS neuroscience &amp; therapeutics</Title>
                <ISOAbbreviation>CNS Neurosci Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Glucocorticoid-Induced Leucine Zipper (GILZ) Controls Inflammation and Tissue Damage after Spinal Cord Injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/cns.12315</ELocationID>
            <Abstract>
                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Spinal cord injury (SCI) occurs following damage to the spinal column. Following trauma, tissue damage is further exacerbated by a secondary damage due to a SCI-activated inflammatory process. Control of leukocytes activity is essential to therapeutic inhibition of the spinal cord damage to ameliorate the patient's conditions. The mechanisms that regulate neuroinflammation following SCI, including T-cell infiltration, have not been completely clarified. Glucocorticoids (GC) are antiinflammatory drugs widely used in therapy, including treatment of SCI. GC efficacy may be linked to many molecular mechanisms that are involved in regulation of leukocytes migration, activation, and differentiation. We have previously shown that the antiinflammatory activity of GC is in part mediated by glucocorticoid-induced leucine zipper (GILZ). Here, we investigated the role of GILZ in inflammation and spinal cord tissue damage following a spinal trauma.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We address the role of GILZ in SCI-induced inflammation and tissue damage using a model of SCI in gilz knockout (gilz KO) and wild-type (WT) mice.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We found that GILZ deficiency is associated with a strong reduction of SCI-induced inflammation and a significantly reduced lesion area following SCI.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These results demonstrate that GILZ is involved in induction of neuroinflammation and functional outcomes of spinal cord trauma.</AbstractText>
                <CopyrightInformation>?? 2014 John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mazzon</LastName>
                    <ForeName>Emanuela</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>IRCCS Centro Neurolesi &quot;Bonino-Pulejo&quot;, Via Provinciale Palermo, Messina, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bruscoli</LastName>
                    <ForeName>Stefano</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Galuppo</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Biagioli</LastName>
                    <ForeName>Michele</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Sorcini</LastName>
                    <ForeName>Daniele</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Bereshchenko</LastName>
                    <ForeName>Oxana</ForeName>
                    <Initials>O</Initials>
                </Author>
                <Author>
                    <LastName>Fiorucci</LastName>
                    <ForeName>Chiara</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Migliorati</LastName>
                    <ForeName>Graziella</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Bramanti</LastName>
                    <ForeName>Placido</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Riccardi</LastName>
                    <ForeName>Carlo</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>CNS Neurosci Ther</MedlineTA>
            <NlmUniqueID>101473265</NlmUniqueID>
            <ISSNLinking>1755-5930</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Glucocorticoid-induced leucine zipper</Keyword>
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Spinal cord injuries</Keyword>
            <Keyword MajorTopicYN="N">T lymphocytes</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cns.12315</ArticleId>
            <ArticleId IdType="pubmed">25146427</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25146423</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2047-2927</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Andrology</Title>
                <ISOAbbreviation>Andrology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effect of tetrabromobisphenol A on protamine content and DNA integrity in mouse spermatozoa.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/j.2047-2927.2014.00257.x</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Tetrabromobisphenol A (TBBPA) is a widely used brominated flame retardant of increasing concern to human health because of its action as an endocrine disruptor. We have previously demonstrated that TBBPA is able to increase apoptosis of testicular cells and other changes in the first and second generations of mice exposed to TBBPA. However, the potential effects of TBBPA on mouse epididymal spermatozoa have not yet been investigated. Therefore, we initiated this study to determine whether TBBPA exposure could also result in increased DNA fragmentation in epididymal spermatozoa and whether it had an effect on the protamines as the major nuclear proteins. C57Bl/6J mouse pups (n??=??10) were exposed to TBBPA (experimental group) during the gestation, lactation, pre-pubertal and pubertal periods up to the age of 70??days as previously described and compared to control mouse pups (n??=??10) that were not exposed. The results demonstrate that TBBPA treatment results in a significantly decreased protamine 1/protamine 2 ratio (0.362 vs. 0.494; p??&lt;??0.001), increased total protamine/DNA ratio (0.517 vs. 0.324; p??&lt;??0.001) and increased number of terminal deoxynucleotidyl transferase dUTP nick end labelling positive spermatozoa (39.5% vs. 21.2%; p??&lt;??0.05) observed between TBBPA and control mice respectively. These findings indicate that TBBPA exposure, in addition to the resulting increased sperm DNA damage, also has the potential to alter the epigenetic marking of sperm chromatin through generation of an anomalous content and distribution of protamines. The possibility is now open to study whether the detected altered protamine content and DNA integrity are related to the previously observed second-generation effects upon TBBPA exposure.</AbstractText>
                <CopyrightInformation>?? 2014 American Society of Andrology and European Academy of Andrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zatecka</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Laboratory of Reproductive Biology, Institute of Biotechnology, Academy of Sciences of the Czech Republic, v. v. i., Prague, Czech Republic.</Affiliation>
                </Author>
                <Author>
                    <LastName>Castillo</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Elzeinova</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Kubatova</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Ded</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Peknicova</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Oliva</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <DataBankList>
                <DataBank>
                    <DataBankName>GENBANK</DataBankName>
                    <AccessionNumberList>
                        <AccessionNumber>NM_007393.3</AccessionNumber>
                        <AccessionNumber>NM_013637.4</AccessionNumber>
                        <AccessionNumber>NM_008933.1</AccessionNumber>
                        <AccessionNumber>NM_009407.2</AccessionNumber>
                        <AccessionNumber>NM_013694.4</AccessionNumber>
                    </AccessionNumberList>
                </DataBank>
            </DataBankList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Andrology</MedlineTA>
            <NlmUniqueID>101585129</NlmUniqueID>
            <ISSNLinking>2047-2919</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">TUNEL assay</Keyword>
            <Keyword MajorTopicYN="N">protamines</Keyword>
            <Keyword MajorTopicYN="N">spermatozoa</Keyword>
            <Keyword MajorTopicYN="N">tetrabromobisphenol A</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.2047-2927.2014.00257.x</ArticleId>
            <ArticleId IdType="pubmed">25146423</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25146417</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Measuring Respiratory Function in Mice Using Unrestrained Whole-body Plethysmography.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51755</ELocationID>
            <Abstract>
                <AbstractText>Respiratory dysfunction is one of the leading causes of morbidity and mortality in the world and the rates of mortality continue to rise. Quantitative assessment of lung function in rodent models is an important tool in the development of future therapies. Commonly used techniques for assessing respiratory function including invasive plethysmography and forced oscillation. While these techniques provide valuable information, data collection can be fraught with artefacts and experimental variability due to the need for anesthesia and/or invasive instrumentation of the animal. In contrast, unrestrained whole-body plethysmography (UWBP) offers a precise, non-invasive, quantitative way by which to analyze respiratory parameters. This technique avoids the use of anesthesia and restraints, which is common to traditional plethysmography techniques. This video will demonstrate the UWBP procedure including the equipment set up, calibration and lung function recording. It will explain how to analyze the collected data, as well as identify experimental outliers and artefacts that results from animal movement. The respiratory parameters obtained using this technique include tidal volume, minute volume, inspiratory duty cycle, inspiratory flow rate and the ratio of inspiration time to expiration time. UWBP does not rely on specialized skills and is inexpensive to perform. A key feature of UWBP, and most appealing to potential users, is the ability to perform repeated measures of lung function on the same animal.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lim</LastName>
                    <ForeName>Rebecca</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research; Department of Obstetrics and Gynaecology, Monash Medical Centre; rebecca.lim@monash.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zavou</LastName>
                    <ForeName>Marcus J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milton</LastName>
                    <ForeName>Phillipa-Louise</ForeName>
                    <Initials>PL</Initials>
                    <Affiliation>Animal Resource Centre, Perth, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chan</LastName>
                    <ForeName>Siow Teng</ForeName>
                    <Initials>ST</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>Jean L</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dickinson</LastName>
                    <ForeName>Hayley</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research; Department of Obstetrics and Gynaecology, Monash Medical Centre.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murphy</LastName>
                    <ForeName>Sean V</ForeName>
                    <Initials>SV</Initials>
                    <Affiliation>Wake Forest Institute for Regenerative Medicine.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jenkin</LastName>
                    <ForeName>Graham</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research; Department of Obstetrics and Gynaecology, Monash Medical Centre.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wallace</LastName>
                    <ForeName>Euan M</ForeName>
                    <Initials>EM</Initials>
                    <Affiliation>The Ritchie Centre, Monash Institute of Medical Research; Department of Obstetrics and Gynaecology, Monash Medical Centre.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51755</ArticleId>
            <ArticleId IdType="pubmed">25146417</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25146373</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-2199</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cerebral cortex (New York, N.Y. : 1991)</Title>
                <ISOAbbreviation>Cereb. Cortex</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Kalirin-9 and Kalirin-12 Play Essential Roles in Dendritic Outgrowth and Branching.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">bhu182</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Proteins derived from the Kalrn gene, encoding 2 Rho guanine nucleotide exchange factor (GEF) domains, affect dendritic and axonal morphogenesis. The roles of endogenous Kalirin-9 (Kal9) and Kalirin-12 (Kal12), the Kalrn isoforms expressed before synaptogenesis, have not been studied in neurite growth and maturation during early development. The Caenorhabditis elegans and Drosophila melanogaster orthologues of Kalrn encode proteins equivalent to Kal9 but, lacking a kinase domain, neither organism expresses a protein equivalent to Kal12. Both in vivo and in vitro analyses of cortical neurons from total Kalrn knockout mice, lacking all major Kalirin isoforms, revealed a simplified dendritic arbor and reduced neurite length. Using isoform-specific shRNAs to reduce Kal9 or Kal12 expression in hippocampal cultures resulted in stunted dendritic outgrowth and branching in vitro, without affecting axonal polarity. Exposing hippocampal cultures to inhibitors of the first GEF domain of Kalirin (ITX3, Z62954982) blunted neurite outgrowth and branching, confirming its essential role, without altering the morphology of neurons not expressing Kalrn. In addition, exogenous expression of the active kinase domain unique to Kal12 increased neurite number and length, whereas that of the inactive kinase domain decreased neurite growth. Our results demonstrate that both endogenous Kal9 and endogenous Kal12 contribute to dendritic maturation in early development.</AbstractText>
                <CopyrightInformation>?? The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yan</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Neuroscience, UConn Health, Farmington, CT 06030, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Eipper</LastName>
                    <ForeName>Betty A</ForeName>
                    <Initials>BA</Initials>
                    <Affiliation>Department of Neuroscience, UConn Health, Farmington, CT 06030, USA Molecular Biology and Biophysics, UConn Health, Farmington, CT 06030, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mains</LastName>
                    <ForeName>Richard E</ForeName>
                    <Initials>RE</Initials>
                    <Affiliation>Department of Neuroscience, UConn Health, Farmington, CT 06030, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cereb Cortex</MedlineTA>
            <NlmUniqueID>9110718</NlmUniqueID>
            <ISSNLinking>1047-3211</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Kalirin knockout mouse</Keyword>
            <Keyword MajorTopicYN="N">Rho GEF</Keyword>
            <Keyword MajorTopicYN="N">kinase</Keyword>
            <Keyword MajorTopicYN="N">neurite</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">bhu182</ArticleId>
            <ArticleId IdType="doi">10.1093/cercor/bhu182</ArticleId>
            <ArticleId IdType="pubmed">25146373</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25146369</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-2199</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cerebral cortex (New York, N.Y. : 1991)</Title>
                <ISOAbbreviation>Cereb. Cortex</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Novel Striatal GABAergic Interneuron Populations Labeled in the 5HT3aEGFP Mouse.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">bhu179</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Histological and morphological studies indicate that approximately 5% of striatal neurons are cholinergic or ??-aminobutyric acidergic (GABAergic) interneurons (gINs). However, the number of striatal neurons expressing known interneuron markers is too small to account for the entire interneuron population. We therefore studied the serotonin (5HT) receptor 3a-enhanced green fluorescent protein (5HT3a(EGFP)) mouse, in which we found that a large number of striatal gINs are labeled. Roughly 20% of 5HT3a(EGFP)-positive cells co-express parvalbumin and exhibit fast-spiking (FS) electrophysiological properties. However, the majority of labeled neurons do not overlap with known molecular interneuron markers. Intrinsic electrical properties reveal at least 2 distinct novel subtypes: a late-spiking (LS) neuropeptide-Y (NPY)-negative neurogliaform (NGF) interneuron, and a large heterogeneous population with several features resembling low-threshold-spiking (LTS) interneurons that do not express somatostatin, NPY, or neuronal nitric oxide synthase. Although the 5HT3a(EGFP) NGF and LTS-like interneurons have electrophysiological properties similar to previously described populations, they are pharmacologically distinct. In direct contrast to previously described NPY(+) LTS and NGF cells, LTS-like 5HT3a(EGFP) cells show robust responses to nicotine administration, while the 5HT3a(EGFP) NGF cell type shows little or no response. By constructing a molecular map of the overlap between these novel populations and existing interneuron populations, we are able to reconcile the morphological and molecular estimates of striatal interneuron numbers.</AbstractText>
                <CopyrightInformation>?? The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mu??oz-Manchado</LastName>
                    <ForeName>A B</ForeName>
                    <Initials>AB</Initials>
                    <Affiliation>Department of Medical Biochemistry and Biophysics.</Affiliation>
                </Author>
                <Author>
                    <LastName>Foldi</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Medical Biochemistry and Biophysics.</Affiliation>
                </Author>
                <Author>
                    <LastName>Szydlowski</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sjulson</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Psychiatry Department of Neuroscience and Physiology, NYU Neuroscience Institute, NYU Langone Medical Center, New York, NY, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Farries</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Biology, University of Texas at San Antonio, San Antonio, TX, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wilson</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Biology, University of Texas at San Antonio, San Antonio, TX, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Silberberg</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hjerling-Leffler</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Medical Biochemistry and Biophysics.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cereb Cortex</MedlineTA>
            <NlmUniqueID>9110718</NlmUniqueID>
            <ISSNLinking>1047-3211</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">5HT3a</Keyword>
            <Keyword MajorTopicYN="N">interneuron</Keyword>
            <Keyword MajorTopicYN="N">nicotine</Keyword>
            <Keyword MajorTopicYN="N">striatum</Keyword>
            <Keyword MajorTopicYN="N">subtype</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">bhu179</ArticleId>
            <ArticleId IdType="doi">10.1093/cercor/bhu179</ArticleId>
            <ArticleId IdType="pubmed">25146369</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25146336</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1572-8773</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine</Title>
                <ISOAbbreviation>Biometals</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Oral zinc aspartate treats experimental autoimmune encephalomyelitis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The essential trace element zinc plays a critical role in the regulation of immune homeostasis. Zinc deficiency or excess can cause severe impairment of the immune response, which points to the importance of the physiological and dietary control of zinc levels for a functioning immune system. We previously reported that injection of zinc aspartate suppresses experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS), as well as effector T cell functions in vitro. Among the preferred characteristics of novel therapeutics for the treatment of autoimmune diseases such as MS are oral availability and a tolerable effective dose to minimize side effects. In this study, we investigated whether oral administration of zinc aspartate, an approved drug to treat zinc deficiency in humans, is effective in controlling EAE at clinically approved doses. We show that oral administration of 6????g/day [0.3??mg/kg body weight (BW)] or 12????g/day [0.6??mg/kg BW] of zinc aspartate reduces clinical and histopathological signs during the relapsing remitting phase of the disease in SJL mice. The clinical effect in mice was accompanied by suppression of IFN-??, TNF-??, GM-CSF and IL-5 production in stimulated human T cells and mouse splenocytes in a dose-dependent manner. Furthermore, a large array of proinflammatory cytokines was modulated by zinc aspartate exposure in vitro. These data suggest that administration of oral zinc aspartate may have beneficial effects on autoimmune diseases like MS.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Schubert</LastName>
                    <ForeName>Claudia</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guttek</LastName>
                    <ForeName>Karina</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Gr??ngreiff</LastName>
                    <ForeName>Kurt</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Thielitz</LastName>
                    <ForeName>Anja</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>B??hling</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Reinhold</LastName>
                    <ForeName>Annegret</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Brocke</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Reinhold</LastName>
                    <ForeName>Dirk</ForeName>
                    <Initials>D</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biometals</MedlineTA>
            <NlmUniqueID>9208478</NlmUniqueID>
            <ISSNLinking>0966-0844</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10534-014-9786-8</ArticleId>
            <ArticleId IdType="pubmed">25146336</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25146308</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1863-2661</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Brain structure &amp; function</Title>
                <ISOAbbreviation>Brain Struct Funct</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Triangulating the sexually dimorphic brain through high-resolution neuroimaging of murine sex chromosome aneuploidies.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Murine sex chromosome aneuploidies (SCAs) provide powerful models for charting sex chromosome influences on mammalian brain development. Here, building on prior work in X-monosomic (XO) mice, we use spatially non-biased high-resolution imaging to compare and contrast neuroanatomical alterations in XXY and XO mice relative to their wild-type XX and XY littermates. First, we show that carriage of a supernumerary X chromosome in XXY males (1) does not prevent normative volumetric masculinization of the bed nucleus of the stria terminalis (BNST) and medial amygdala, but (2) causes distributed anatomical alterations relative to XY males, which show a statistically unexpected tendency to be co-localized with and reciprocal to XO-XX differences in anatomy. These overlaps identify the lateral septum, BNST, ventral group thalamic nuclei and periaqueductal gray matter as regions with replicable sensitivity to X chromosome dose across two SCAs. We then harness anatomical variation across all four karyotype groups in our study-XO, XX, XY and XXY-to create an agnostic data-driven segmentation of the mouse brain into five distributed clusters which (1) recover fundamental properties of brain organization with high spatial precision, (2) define two previously uncharacterized systems of relative volume excess in females vs. males (&quot;forebrain cholinergic&quot; and &quot;cerebelo-pontine-thalamo-cortical&quot;), and (3) adopt stereotyped spatial motifs which delineate ordered gradients of sex chromosome and gonadal influences on volumetric brain development. Taken together, these data provide a new framework for the study of sexually dimorphic influences on brain development in health and disrupted brain development in SCA.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Raznahan</LastName>
                    <ForeName>Armin</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Child Psychiatry Branch, National Institute of Mental Health, National Institutes of Health, Rm 4C108, Building 20, 10 Center Drive, Bethesda, MD, 20815, USA, raznahana@mail.nih.gov.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lue</LastName>
                    <ForeName>YanHe</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Probst</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Greenstein</LastName>
                    <ForeName>Deanna</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Giedd</LastName>
                    <ForeName>Jay</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Lerch</LastName>
                    <ForeName>Jason</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Swerdloff</LastName>
                    <ForeName>Ronald</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Brain Struct Funct</MedlineTA>
            <NlmUniqueID>101282001</NlmUniqueID>
            <ISSNLinking>1863-2653</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00429-014-0875-9</ArticleId>
            <ArticleId IdType="pubmed">25146308</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Process">
        <PMID Version="1">25146292</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1095-9203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>345</Volume>
                    <Issue>6199</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Science (New York, N.Y.)</Title>
                <ISOAbbreviation>Science</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Riboswitches. Sequestration of a two-component response regulator by a riboswitch-regulated noncoding RNA.</ArticleTitle>
            <Pagination>
                <MedlinePgn>940-3</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1126/science.1255083</ELocationID>
            <Abstract>
                <AbstractText>Riboswitches are ligand-binding elements contained within the 5' untranslated regions of bacterial transcripts, which generally regulate expression of downstream open reading frames. Here, we show that in Listeria monocytogenes, a riboswitch that binds vitamin B12 controls expression of a noncoding regulatory RNA, Rli55. Rli55, in turn, controls expression of the eut genes, whose products enable ethanolamine utilization and require B12 as a cofactor. Defects in ethanolamine utilization, or in its regulation by Rli55, significantly attenuate Listeria virulence in mice. Rli55 functions by sequestering the two-component response regulator EutV by means of a EutV-binding site contained within the RNA. Thus, Rli55 is a riboswitch-regulated member of the small group of regulatory RNAs that function by sequestering a protein and reveals a distinctive mechanism of signal integration in bacterial gene regulation.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Association for the Advancement of Science.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mellin</LastName>
                    <ForeName>J R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Unit?? des Interactions Bact??ries-Cellules, Institut Pasteur, F-75015 Paris, France. INSERM, U604, Paris, F-75015 France. INRA, USC2020, F-75015 Paris, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koutero</LastName>
                    <ForeName>Mikael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Unit?? des Interactions Bact??ries-Cellules, Institut Pasteur, F-75015 Paris, France. INSERM, U604, Paris, F-75015 France. INRA, USC2020, F-75015 Paris, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dar</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nahori</LastName>
                    <ForeName>Marie-Anne</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Unit?? des Interactions Bact??ries-Cellules, Institut Pasteur, F-75015 Paris, France. INSERM, U604, Paris, F-75015 France. INRA, USC2020, F-75015 Paris, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sorek</LastName>
                    <ForeName>Rotem</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cossart</LastName>
                    <ForeName>Pascale</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Unit?? des Interactions Bact??ries-Cellules, Institut Pasteur, F-75015 Paris, France. INSERM, U604, Paris, F-75015 France. INRA, USC2020, F-75015 Paris, France. pcossart@pasteur.fr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <Agency>Howard Hughes Medical Institute</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
                <PublicationType>Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Science</MedlineTA>
            <NlmUniqueID>0404511</NlmUniqueID>
            <ISSNLinking>0036-8075</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <CommentsCorrectionsList>
            <CommentsCorrections RefType="CommentIn">
                <RefSource>Science. 2014 Aug 22;345(6199):876-7</RefSource>
                <PMID Version="1">25146272</PMID>
            </CommentsCorrections>
        </CommentsCorrectionsList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">345/6199/940</ArticleId>
            <ArticleId IdType="doi">10.1126/science.1255083</ArticleId>
            <ArticleId IdType="pubmed">25146292</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25146130</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>89</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Laser nanosurgery of cerebellar axons in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51371</ELocationID>
            <Abstract>
                <AbstractText>Only a few neuronal populations in the central nervous system (CNS) of adult mammals show local regrowth upon dissection of their axon. In order to understand the mechanism that promotes neuronal regeneration, an in-depth analysis of the neuronal types that can remodel after injury is needed. Several studies showed that damaged climbing fibers are capable of regrowing also in adult animals(1,2). The investigation of the time-lapse dynamics of degeneration and regeneration of these axons within their complex environment can be performed by time-lapse two-photon fluorescence (TPF) imaging in vivo(3,4). This technique is here combined with laser surgery, which proved to be a highly selective tool to disrupt fluorescent structures in the intact mouse cortex(5-9). This protocol describes how to perform TPF time-lapse imaging and laser nanosurgery of single axonal branches in the cerebellum in vivo. Olivocerebellar neurons are labeled by anterograde tracing with a dextran-conjugated dye and then monitored by TPF imaging through a cranial window. The terminal portion of their axons are then dissected by irradiation with a Ti:Sapphire laser at high power. The degeneration and potential regrowth of the damaged neuron are monitored by TPF in vivo imaging during the days following the injury.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Allegra Mascaro</LastName>
                    <ForeName>Anna L</ForeName>
                    <Initials>AL</Initials>
                    <Affiliation>European Laboratory for Non-Linear Spectroscopy, University of Florence; allegra@lens.unifi.it.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sacconi</LastName>
                    <ForeName>Leonardo</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>European Laboratory for Non-Linear Spectroscopy, University of Florence; National Institute of Optics, National Research Council.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pavone</LastName>
                    <ForeName>Francesco Saverio</ForeName>
                    <Initials>FS</Initials>
                    <Affiliation>European Laboratory for Non-Linear Spectroscopy, University of Florence; National Institute of Optics, National Research Council; Department of Physics and Astronomy, University of Florence; International Center for Computational Neurophotonics (ICON Foundation).</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>28</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51371</ArticleId>
            <ArticleId IdType="pubmed">25146130</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25146101</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2045-2322</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>4</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Scientific reports</Title>
                <ISOAbbreviation>Sci Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Gadolinium chloride improves the course of TNBS and DSS-induced colitis through protecting against colonic mucosal inflammation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6096</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/srep06096</ELocationID>
            <Abstract>
                <AbstractText>Inflammatory macrophages in colonic mucosa are the leading drivers of the pathology associated with inflammatory bowel disease (IBD). Here we examined whether gadolinium chloride (GdCl3), a macrophage selective inhibitor, would improve the course of 2,4,6-trinitro benzene sulfonic acid (TNBS) and dextran sodium sulfate (DSS)-induced colitis in mice and the potential mechanisms were investigated. By giving GdCl3 to colitis mice through intravenous or intrarectal route, we found that GdCl3 markedly ameliorated the colitis severity, including less weight loss, decreased disease activity index scores, and improved mucosal damage. To investigate the potential mechanisms, flow-cytometric analysis was performed to detect the proportion of mucosal macrophages in colon. The results showed that GdCl3 had no macrophage depletion effect in colonic mucosa, but significantly suppressed TNBS and DSS-induced TNF??, IL-1?? and IL-6 secretions. Also, Western blotting analysis indicated that NF-??B p65 expression was significantly attenuated in the mucosa in colitis mice with GdCl3 treatment. Then, the anti-inflammatory activity of GdCl3 was confirmed in LPS-stimulated RAW 264.7 cells that GdCl3 might down-regulate the production of proinflammatory cytokines by macrophages through inhibition of the NF-??B signaling pathway. Therefore, intervention with mucosal inflammatory macrophages may be a promising therapeutic target in IBD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Du</LastName>
                    <ForeName>Chao</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>1] Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China [2] Department of Gastroenterology, Linyi People's Hospital, Linyi, Shandong, 276000, PR China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Peng</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>Yanbo</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Feixue</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Yanqing</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Gastroenterology, Qilu Hospital, Shandong University, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Sci Rep</MedlineTA>
            <NlmUniqueID>101563288</NlmUniqueID>
            <ISSNLinking>2045-2322</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">srep06096</ArticleId>
            <ArticleId IdType="doi">10.1038/srep06096</ArticleId>
            <ArticleId IdType="pubmed">25146101</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25146022</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3554</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>40</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of endodontics</Title>
                <ISOAbbreviation>J Endod</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Down-regulation of Inflammatory Mediator Synthesis and Infiltration of Inflammatory Cells by MMP-3 in Experimentally Induced Rat Pulpitis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1404-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joen.2014.04.001</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0099-2399(14)00339-2</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Matrix metalloproteinase (MMP)-3 is a member of the MMP family that degrades the extracellular matrix. Application of MMP-3 to injured pulp tissue induces angiogenesis and wound healing, but its anti-inflammatory effects are still unclear. Here, we evaluated the anti-inflammatory functions of MMP-3 in??vitro and in??vivo.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Nitric oxide and inflammatory mediator synthesis in macrophages activated by lipopolysaccharide (LPS) was measured in the presence or absence of MMP-3. The mouse Mmp3 (mMmp3) expression vector containing full length cDNA sequence of mMmp3 or cDNA sequence of mMmp3 missing the signal peptide and pro-peptide regions was transfected to RAW264, a mouse macrophage cell line, and NO synthesis and inflammatory mediator expression were evaluated. Pulpal inflammation was histologically and immunohistochemically evaluated in a rat model of incisor pulpitis induced by the application of LPS for 9??hours in the presence or absence of MMP-3.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">NO and pro-inflammatory mediator synthesis promoted by LPS was significantly down-regulated by MMP-3 in??vitro. The full length of mMmp3 down-regulated the LPS-induced NO synthesis and chemical mediator mRNA expression, however the mMmp3 missing the signal peptide failed to block the NO synthesis induced by LPS. The numbers of major histocompatibility complex class II+ and CD68+??cells, which infiltrated into the rat incisor pulp tissues in response to the topical application of LPS, were significantly decreased by the application of MMP-3 in??vivo.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results indicate that MMP-3 possesses anti-inflammatory functions, suggesting its potential utility as an anti-inflammatory agent for pulpal inflammation.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Takimoto</LastName>
                    <ForeName>Koyo</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kawashima</LastName>
                    <ForeName>Nobuyuki</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Electronic address: kawashima.n.endo@tmd.ac.jp.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suzuki</LastName>
                    <ForeName>Noriyuki</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Koizumi</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamamoto</LastName>
                    <ForeName>Mioko</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakashima</LastName>
                    <ForeName>Misako</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Dental Regenerative Medicine, Center of Advanced Medicine for Dental and Oral Diseases, National Center for Geriatrics and Gerontology, Research Institute, Aichi, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suda</LastName>
                    <ForeName>Hideaki</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>04</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Endod</MedlineTA>
            <NlmUniqueID>7511484</NlmUniqueID>
            <ISSNLinking>0099-2399</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>D</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cytokine(s)</Keyword>
            <Keyword MajorTopicYN="N">inflammation</Keyword>
            <Keyword MajorTopicYN="N">matrix metalloproteinase-3</Keyword>
            <Keyword MajorTopicYN="N">pulp biology</Keyword>
            <Keyword MajorTopicYN="N">pulpitis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0099-2399(14)00339-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.joen.2014.04.001</ArticleId>
            <ArticleId IdType="pubmed">25146022</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25146015</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3554</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>40</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of endodontics</Title>
                <ISOAbbreviation>J Endod</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effect of Conditioned Medium from Preameloblasts on??Regenerative Cellular Differentiation of the Immature Teeth with Necrotic Pulp and Apical Periodontitis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1355-61</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.joen.2014.02.009</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0099-2399(14)00185-X</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The purpose of this study was to investigate the effect of conditioned medium (CM) from murine preameloblasts on the cellular differentiation of mesenchymal stem cells (MSCs) in immature teeth with necrotic pulp and apical periodontitis.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Pulp necrosis and apical periodontitis were induced in 30 immature permanent double-rooted premolars of 3??beagles and were randomly assigned to the following treatment groups: group CM (n??=??10), revascularization treatment was performed using CM from preameloblasts of C57BL/6 mice apical bud cells; group CR (n??=??10), conventional revascularization treatment was performed; positive control group (n??=??5), left infected; and negative control group (n??=??5), untreated. The dogs were followed up for 12??weeks and assessed for treatment outcomes with radiographic and histologic analyses. The effect of the CM on sequential Runx2 and osterix messenger RNA gene expression during the differentiation of MG63 osteoblastlike cells was analyzed with real-time polymerase chain reaction.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The overall treatment outcomes were not significantly different between the 2 treatment groups. However, the teeth in the CM group showed significantly more mature apices and a higher degree of hard tissue formation with projections intercalating into the pre-existing root dentin (P??&lt;??.05). In CM-treated teeth, regenerated pulplike tissue was more frequently observed (P??&lt;??.05). During differentiation, the CM induced early peak expression of Runx2 followed by sustained osterix overexpression.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">CM from preameloblasts rendered a favorable effect in providing a physiologic microenvironment for the differentiation of MSCs after revascularization treatment.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Yoo</LastName>
                    <ForeName>Yeon-Jee</ForeName>
                    <Initials>YJ</Initials>
                    <Affiliation>Department of Conservative Dentistry, Seoul National University Dental Hospital, School of Dentistry, Dental Research Institute, Seoul National University, Jongro-Gu, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>WooCheol</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Conservative Dentistry, Seoul National University Dental Hospital, School of Dentistry, Dental Research Institute, Seoul National University, Jongro-Gu, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cho</LastName>
                    <ForeName>Young-Ah</ForeName>
                    <Initials>YA</Initials>
                    <Affiliation>Department of Maxillofacial Tissue Regeneration, School of Dentistry, Kyung Hee University, Hoegi-dong, Dongdaemun-gu, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Joo-Cheol</ForeName>
                    <Initials>JC</Initials>
                    <Affiliation>Department of Oral Histology-Developmental Biology and Dental Research Institute, School of Dentistry, Seoul National University, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shon</LastName>
                    <ForeName>Won-Jun</ForeName>
                    <Initials>WJ</Initials>
                    <Affiliation>Department of Conservative Dentistry, Seoul National University Dental Hospital, School of Dentistry, Dental Research Institute, Seoul National University, Jongro-Gu, Seoul, Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baek</LastName>
                    <ForeName>Seung-Ho</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Department of Conservative Dentistry, Seoul National University Dental Hospital, School of Dentistry, Dental Research Institute, Seoul National University, Jongro-Gu, Seoul, Korea. Electronic address: shbaek@snu.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>04</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Endod</MedlineTA>
            <NlmUniqueID>7511484</NlmUniqueID>
            <ISSNLinking>0099-2399</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>D</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cellular differentiation</Keyword>
            <Keyword MajorTopicYN="N">Runx2</Keyword>
            <Keyword MajorTopicYN="N">conditioned medium</Keyword>
            <Keyword MajorTopicYN="N">osterix</Keyword>
            <Keyword MajorTopicYN="N">preameloblast</Keyword>
            <Keyword MajorTopicYN="N">revascularization</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0099-2399(14)00185-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.joen.2014.02.009</ArticleId>
            <ArticleId IdType="pubmed">25146015</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145996</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Preparation of rat serum suitable for Mammalian whole embryo culture.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51969</ELocationID>
            <Abstract>
                <AbstractText>Mammalian whole embryo culture (WEC) is a widely used technique for examining pharmacological toxicity in developing mouse and rat embryos and for investigating the mechanisms of developmental processes. Immediately centrifuged (IC) rat serum is commonly used for WEC and is essential for the growth and development of cultured mouse and rat embryos ex vivo. For the culture of midgestation embryos (i.e., E8.0-12.5 for the mouse, and E10.0-14.5 for the rat), 100% rat serum is the best media for supporting the growth of the embryo ex vivo. To prepare rat serum suitable for WEC, the collected blood should be centrifuged immediately to separate the blood cells from the plasma fraction. After centrifugation, the fibrin clot forms in the upper layer; this clot should be squeezed gently using a pair of sterile forceps and subsequently centrifuged to completely separate the blood cells from the serum. In this video article, we demonstrate our standard protocol for the preparation of optimal IC rat serum, including blood collection from the abdominal aorta of male rats and extraction of the serum by centrifugation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Takahashi</LastName>
                    <ForeName>Masanori</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Graduate School of Medicine, Jichi Medical University; Division of Biology, Center for Molecular Medicine, Jichi Medical University.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Makino</LastName>
                    <ForeName>Sayaka</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University School of Medicine.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kikkawa</LastName>
                    <ForeName>Takako</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University School of Medicine.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Osumi</LastName>
                    <ForeName>Noriko</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Developmental Neuroscience, United Center for Advanced Research and Translational Medicine (ART), Tohoku University School of Medicine; osumi@med.tohoku.ac.jp.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>03</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51969</ArticleId>
            <ArticleId IdType="pubmed">25145996</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145988</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-8022</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomaterials applications</Title>
                <ISOAbbreviation>J Biomater Appl</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Hybrid vitronectin-mimicking polycaprolactone scaffolds for human retinal progenitor cell differentiation and transplantation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">0885328214547751</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Many advances have been made in an attempt to treat retinal degenerative diseases, such as age-related macular degeneration and retinitis pigmentosa. The irreversible loss of photoreceptors is common to both, and currently no restorative clinical treatment exists. It has been shown that retinal progenitor and photoreceptor precursor cell transplantation can rescue the retinal structure and function. Importantly, retinal progenitor cells can be collected from the developing neural retina with further expansion and additional modification in??vitro, and the delivery into the degenerative host can be performed as a single-cell suspension injection or as a complex graft transplantation. Previously, we have described several polymer scaffolds for culture and transplantation of retinal progenitor cells of both mouse and human origin. This tissue engineering strategy increases donor cell survival and integration. We have also shown that biodegradable poly(??-caprolactone) induces mature photoreceptor differentiation from human retinal progenitor cells. However, poor adhesive properties limit its use, and therefore it requires additional surface modification. The aim of this work was to study vitronectin-mimicking oligopeptides (Synthemax II-SC) poly(??-caprolactone) films and their effects on human retinal progenitor cell adhesion, proliferation, and differentiation. Here, we show that the incorporation of vitronectin-mimicking oligopeptide into poly(??-caprolactone) leads to dose-dependent increases in cell adhesion; the optimum dose identified as 30?????g/ml. Inhibition of human retinal progenitor cells proliferation was seen on poly(??-caprolactone) and was maintained with the hybrid scaffold. This has been shown to be beneficial for driving cell differentiation. Additionally, we observed equal expression of Nrl, rhodopsin, recoverin, and rod outer membrane 1 after differentiation on the hybrid scaffold as compared to the standard fibronectin coating of poly(??-caprolactone). After transplantation into rd1 retina degenerative mice, human retinal progenitor cells were able to migrate to the outer nuclear layer and survive for three weeks. We conclude that Synthemax II-SC can be incorporated into poly(??-caprolactone) to create a hybrid chemically defined scaffold for clinical application.</AbstractText>
                <CopyrightInformation>?? The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lawley</LastName>
                    <ForeName>Elodie</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Schepens Eye Research Institute, Massachusetts Eye and Ear, Boston, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Baranov</LastName>
                    <ForeName>Petr</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Schepens Eye Research Institute, Massachusetts Eye and Ear, Boston, USA petr_baranov@meei.harvard.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Young</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Schepens Eye Research Institute, Massachusetts Eye and Ear, Boston, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Biomater Appl</MedlineTA>
            <NlmUniqueID>8813912</NlmUniqueID>
            <ISSNLinking>0885-3282</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Tissue engineering</Keyword>
            <Keyword MajorTopicYN="N">photoreceptors</Keyword>
            <Keyword MajorTopicYN="N">polycaprolactone</Keyword>
            <Keyword MajorTopicYN="N">retinal progenitor cells</Keyword>
            <Keyword MajorTopicYN="N">vitronectin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0885328214547751</ArticleId>
            <ArticleId IdType="doi">10.1177/0885328214547751</ArticleId>
            <ArticleId IdType="pubmed">25145988</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145969</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>89</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Reconstruction of 3-dimensional histology volume and its application to study mouse mammary glands.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51325</ELocationID>
            <Abstract>
                <AbstractText>Histology volume reconstruction facilitates the study of 3D shape and volume change of an organ at the level of macrostructures made up of cells. It can also be used to investigate and validate novel techniques and algorithms in volumetric medical imaging and therapies. Creating 3D high-resolution atlases of different organs(1,2,3) is another application of histology volume reconstruction. This provides a resource for investigating tissue structures and the spatial relationship between various cellular features. We present an image registration approach for histology volume reconstruction, which uses a set of optical blockface images. The reconstructed histology volume represents a reliable shape of the processed specimen with no propagated post-processing registration error. The Hematoxylin and Eosin (H&amp;E) stained sections of two mouse mammary glands were registered to their corresponding blockface images using boundary points extracted from the edges of the specimen in histology and blockface images. The accuracy of the registration was visually evaluated. The alignment of the macrostructures of the mammary glands was also visually assessed at high resolution. This study delineates the different steps of this image registration pipeline, ranging from excision of the mammary gland through to 3D histology volume reconstruction. While 2D histology images reveal the structural differences between pairs of sections, 3D histology volume provides the ability to visualize the differences in shape and volume of the mammary glands.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Shojaii</LastName>
                    <ForeName>Rushin</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Medical Biophysics, University of Toronto; rushin.shojaii@sri.utoronto.ca.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bacopulos</LastName>
                    <ForeName>Stephanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Platform Biological Sciences, Sunnybrook Research Institute; Department of Laboratory Medicine and Pathobiology, University of Toronto.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yang</LastName>
                    <ForeName>Wenyi</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Platform Biological Sciences, Sunnybrook Research Institute; Department of Laboratory Medicine and Pathobiology, University of Toronto.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karavardanyan</LastName>
                    <ForeName>Tigran</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Physical Sciences, Sunnybrook Research Institute.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spyropoulos</LastName>
                    <ForeName>Demetri</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Pathology and Laboratory Medicine, Medical University of South Carolina.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Raouf</LastName>
                    <ForeName>Afshin</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Manitoba Institute of Cell Biology, University of Manitoba.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martel</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Medical Biophysics, University of Toronto; Physical Sciences, Sunnybrook Research Institute.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Seth</LastName>
                    <ForeName>Arun</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Platform Biological Sciences, Sunnybrook Research Institute; Department of Laboratory Medicine and Pathobiology, University of Toronto.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>26</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51325</ArticleId>
            <ArticleId IdType="pubmed">25145969</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145965</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1860-2002</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</Title>
                <ISOAbbreviation>Mol Imaging Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Human Brain Imaging of ??7 nAChR with [(18)F]ASEM: a New PET Radiotracer for Neuropsychiatry and Determination of Drug Occupancy.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Using the ??7-nAChR radiotracer, [(18)F]ASEM, we present the first successful human positron emission tomography (PET) studies. Rodent occupancy with three clinically employed ??7-nAChR drugs confirms the specificity of the radiotracer.</AbstractText>
                <AbstractText Label="PROCEDURES" NlmCategory="METHODS">Five healthy male subjects were imaged for 90 min following IV [(18)F]ASEM. Two subjects were scanned for the second time (test/retest; TRV). Mouse biodistribution of [(18)F]ASEM was carried out in CD1 mice injected with using human equivalent doses of DMXB-A, EVP-6124, and varenicline to block specific binding.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">[(18)F]ASEM readily entered the brain and peaked at 15 min post-injection with reversible kinetics and a peak %SUV of about 400 %. The regional human brain distribution of [(18)F]ASEM matched previous in vitro data and baboon PET results. The precuneus, parietal, occipital, cingulate cortexes, putamen, and thalamus showed high values of distribution volume (&gt;20 ml/ml) and binding potentials &gt;1 with TRV averaged 10.8????????5.1 %. In mouse distribution studies, there was significant dose-dependent blockade in the mouse brain with DMXB-A as well as the other two ??7-nAChR drugs.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The characteristics of [(18)F]ASEM are consistent with the ability to quantify ??7-nAChR in the human brain. [(18)F]ASEM is suitable for imaging neuropsychiatric disorders and target engagement (receptor occupancy) of potential ??7-nAChR drugs.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wong</LastName>
                    <ForeName>Dean F</ForeName>
                    <Initials>DF</Initials>
                    <Affiliation>Department of Radiology, School of Medicine, The Johns Hopkins University, Baltimore, MD, USA, dfwong@jhmi.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kuwabara</LastName>
                    <ForeName>Hiroto</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Pomper</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Holt</LastName>
                    <ForeName>Daniel P</ForeName>
                    <Initials>DP</Initials>
                </Author>
                <Author>
                    <LastName>Brasic</LastName>
                    <ForeName>James R</ForeName>
                    <Initials>JR</Initials>
                </Author>
                <Author>
                    <LastName>George</LastName>
                    <ForeName>Noble</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Frolov</LastName>
                    <ForeName>Boris</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Willis</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <LastName>Gao</LastName>
                    <ForeName>Yongjun</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Valentine</LastName>
                    <ForeName>Heather</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Nandi</LastName>
                    <ForeName>Ayon</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Gapasin</LastName>
                    <ForeName>Lorena</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Dannals</LastName>
                    <ForeName>Robert F</ForeName>
                    <Initials>RF</Initials>
                </Author>
                <Author>
                    <LastName>Horti</LastName>
                    <ForeName>Andrew G</ForeName>
                    <Initials>AG</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Imaging Biol</MedlineTA>
            <NlmUniqueID>101125610</NlmUniqueID>
            <ISSNLinking>1536-1632</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11307-014-0779-3</ArticleId>
            <ArticleId IdType="pubmed">25145965</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145937</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Platelets in Early Antibody-Mediated Rejection of Renal Transplants.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2013121289</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Antibody-mediated rejection is a major complication in renal transplantation. The pathologic manifestations of acute antibody-mediated rejection that has progressed to functional impairment of a renal transplant have been defined in clinical biopsy specimens. However, the initial stages of the process are difficult to resolve with the unavoidable variables of clinical studies. We devised a model of renal transplantation to elucidate the initial stages of humoral rejection. Kidneys were orthotopically allografted to immunodeficient mice. After perioperative inflammation subsided, donor-specific alloantibodies were passively transferred to the recipient. Within 1 hour after a single transfer of antibodies, C4d was deposited diffusely on capillaries, and von Willebrand factor released from endothelial cells coated intravascular platelet aggregates. Platelet-transported inflammatory mediators platelet factor 4 and serotonin accumulated in the graft at 100- to 1000-fold higher concentrations compared with other platelet-transported chemokines. Activated platelets that expressed P-selectin attached to vascular endothelium and macrophages. These intragraft inflammatory changes were accompanied by evidence of acute endothelial injury. Repeated transfers of alloantibodies over 1 week sustained high levels of platelet factor 4 and serotonin. Platelet depletion decreased platelet mediators and altered the accumulation of macrophages. These data indicate that platelets augment early inflammation in response to donor-specific antibodies and that platelet-derived mediators may be markers of evolving alloantibody responses.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kuo</LastName>
                    <ForeName>Hsiao-Hsuan</ForeName>
                    <Initials>HH</Initials>
                    <Affiliation>Departments of Immunology and Department of Biological, Geological, and Environmental Sciences, Cleveland State University, Cleveland, Ohio.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fan</LastName>
                    <ForeName>Ran</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Departments of Immunology and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dvorina</LastName>
                    <ForeName>Nina</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Departments of Immunology and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chiesa-Vottero</LastName>
                    <ForeName>Andres</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Pathology, Cleveland Clinic, Cleveland, Ohio; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Baldwin</LastName>
                    <ForeName>William M</ForeName>
                    <Initials>WM</Initials>
                    <Suffix>3rd</Suffix>
                    <Affiliation>Departments of Immunology and baldwiw@ccf.org.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">acute rejection</Keyword>
            <Keyword MajorTopicYN="N">electron microscopy</Keyword>
            <Keyword MajorTopicYN="N">endothelial cells</Keyword>
            <Keyword MajorTopicYN="N">immunology and pathology</Keyword>
            <Keyword MajorTopicYN="N">platelets</Keyword>
            <Keyword MajorTopicYN="N">transplant pathology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2013121289</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2013121289</ArticleId>
            <ArticleId IdType="pubmed">25145937</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145936</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Urinary Tract Effects of HPSE2 Mutations.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2013090961</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Urofacial syndrome (UFS) is an autosomal recessive congenital disease featuring grimacing and incomplete bladder emptying. Mutations of HPSE2, encoding heparanase 2, a heparanase 1 inhibitor, occur in UFS, but knowledge about the HPSE2 mutation spectrum is limited. Here, seven UFS kindreds with HPSE2 mutations are presented, including one with deleted asparagine 254, suggesting a role for this amino acid, which is conserved in vertebrate orthologs. HPSE2 mutations were absent in 23 non-neurogenic neurogenic bladder probands and, of 439 families with nonsyndromic vesicoureteric reflux, only one carried a putative pathogenic HPSE2 variant. Homozygous Hpse2 mutant mouse bladders contained urine more often than did wild-type organs, phenocopying human UFS. Pelvic ganglia neural cell bodies contained heparanase 1, heparanase 2, and leucine-rich repeats and immunoglobulin-like domains-2 (LRIG2), which is mutated in certain UFS families. In conclusion, heparanase 2 is an autonomic neural protein implicated in bladder emptying, but HPSE2 variants are uncommon in urinary diseases resembling UFS.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Stuart</LastName>
                    <ForeName>Helen M</ForeName>
                    <Initials>HM</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Roberts</LastName>
                    <ForeName>Neil A</ForeName>
                    <Initials>NA</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Hilton</LastName>
                    <ForeName>Emma N</ForeName>
                    <Initials>EN</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>McKenzie</LastName>
                    <ForeName>Edward A</ForeName>
                    <Initials>EA</Initials>
                    <Affiliation>Faculty of Life Sciences and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Daly</LastName>
                    <ForeName>Sarah B</ForeName>
                    <Initials>SB</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Hadfield</LastName>
                    <ForeName>Kristen D</ForeName>
                    <Initials>KD</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Rahal</LastName>
                    <ForeName>Jeffery S</ForeName>
                    <Initials>JS</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Gardiner</LastName>
                    <ForeName>Natalie J</ForeName>
                    <Initials>NJ</Initials>
                    <Affiliation>Faculty of Life Sciences and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tanley</LastName>
                    <ForeName>Simon W</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>Faculty of Engineering and Physical Sciences, University of Manchester, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Lewis</LastName>
                    <ForeName>Malcolm A</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Sites</LastName>
                    <ForeName>Emily</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois;</Affiliation>
                </Author>
                <Author>
                    <LastName>Angle</LastName>
                    <ForeName>Brad</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois;</Affiliation>
                </Author>
                <Author>
                    <LastName>Alves</LastName>
                    <ForeName>Cl??udia</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Genetica Med. e Diagnostico Pre-Natal, Prof. Sergio Castedo, S.A., Porto, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Louren??o</LastName>
                    <ForeName>Teresa</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Medical Genetics, Hospital de Dona Estef??nia, Lisboa, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Rodrigues</LastName>
                    <ForeName>M??rcia</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Medical Genetics, Hospital de Dona Estef??nia, Lisboa, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Calado</LastName>
                    <ForeName>Angelina</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Pediatrics, Centro Hospitalar do Barlavento Algarvio, Portim??o, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Amado</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Pediatrics, Centro Hospitalar do Barlavento Algarvio, Portim??o, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Guerreiro</LastName>
                    <ForeName>Nancy</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Pediatrics, Centro Hospitalar do Barlavento Algarvio, Portim??o, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Serras</LastName>
                    <ForeName>In??s</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Pediatrics, Centro Hospitalar do Barlavento Algarvio, Portim??o, Portugal;</Affiliation>
                </Author>
                <Author>
                    <LastName>Beetz</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Faculty of Life Sciences and Faculty of Life Sciences and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Varga</LastName>
                    <ForeName>Rita-Eva</ForeName>
                    <Initials>RE</Initials>
                    <Affiliation>Faculty of Life Sciences and Faculty of Life Sciences and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Silay</LastName>
                    <ForeName>Mesrur Selcuk</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>Department of Urology, Faculty of Medicine, Bezmialem Vakif University, Istanbul, Turkey;</Affiliation>
                </Author>
                <Author>
                    <LastName>Darlow</LastName>
                    <ForeName>John M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>National Centre for Medical Genetics and National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland;</Affiliation>
                </Author>
                <Author>
                    <LastName>Dobson</LastName>
                    <ForeName>Mark G</ForeName>
                    <Initials>MG</Initials>
                    <Affiliation>National Centre for Medical Genetics and National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland;</Affiliation>
                </Author>
                <Author>
                    <LastName>Barton</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <Affiliation>National Centre for Medical Genetics and School of Medicine and Medical Sciences and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hunziker</LastName>
                    <ForeName>Manuela</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland;</Affiliation>
                </Author>
                <Author>
                    <LastName>Puri</LastName>
                    <ForeName>Prem</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>National Children's Research Centre, Our Lady's Children's Hospital, Dublin, Ireland; School of Medicine and Medical Sciences and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland;</Affiliation>
                </Author>
                <Author>
                    <LastName>Feather</LastName>
                    <ForeName>Sally A</ForeName>
                    <Initials>SA</Initials>
                    <Affiliation>Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Goodship</LastName>
                    <ForeName>Judith A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Goodship</LastName>
                    <ForeName>Timothy H J</ForeName>
                    <Initials>TH</Initials>
                    <Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Lambert</LastName>
                    <ForeName>Heather J</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Cordell</LastName>
                    <ForeName>Heather J</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <CollectiveName>the UK VUR Study Group</CollectiveName>
                </Author>
                <Author>
                    <LastName>Saggar</LastName>
                    <ForeName>Anand</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Clinical Genetics, St George's, University of London, London, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kinali</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Paediatric Neurology, Chelsea and Westminster Hospital and Imperial College London, and Bupa Cromwell Hospital, London, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <CollectiveName>the 4C Study Group</CollectiveName>
                </Author>
                <Author>
                    <LastName>Lorenz</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Pediatric Surgery and Urology, Klinikum Bremen-Mitte, Bremen, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Moeller</LastName>
                    <ForeName>Kristina</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Pediatrics, Klinikum Links der Weser, Bremen, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Schaefer</LastName>
                    <ForeName>Franz</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Division of Paediatric Nephrology, Centre for Paediatric and Adolescent Medicine, University Hospital of Heidelberg, Im Neuenheimer Feld, Heidelberg, Germany;</Affiliation>
                </Author>
                <Author>
                    <LastName>Bayazit</LastName>
                    <ForeName>Aysun K</ForeName>
                    <Initials>AK</Initials>
                    <Affiliation>Pediatric Nephrology, Cukurova University School of Medicine, Adana, Turkey; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Weber</LastName>
                    <ForeName>Stefanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Pediatrics II, University Children's Hospital Essen, Essen, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Newman</LastName>
                    <ForeName>William G</ForeName>
                    <Initials>WG</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom;</Affiliation>
                </Author>
                <Author>
                    <LastName>Woolf</LastName>
                    <ForeName>Adrian S</ForeName>
                    <Initials>AS</Initials>
                    <Affiliation>Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester Academic Health Science Centre and the Royal Manchester Children's and St Mary's Hospitals, Manchester, United Kingdom; adrian.woolf@manchester.ac.uk.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">genetics and development</Keyword>
            <Keyword MajorTopicYN="N">human genetics</Keyword>
            <Keyword MajorTopicYN="N">molecular genetics</Keyword>
            <Keyword MajorTopicYN="N">pediatric nephrology</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2013090961</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2013090961</ArticleId>
            <ArticleId IdType="pubmed">25145936</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145935</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>WNK1 Activates Large-Conductance Ca2+-Activated K+ Channels through Modulation of ERK1/2 Signaling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2014020186</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">With no lysine (WNK) kinases are members of the serine/threonine kinase family. We previously showed that WNK4 inhibits renal large-conductance Ca(2+)-activated K(+) (BK) channel activity by enhancing its degradation through a lysosomal pathway. In this study, we investigated the effect of WNK1 on BK channel activity. In HEK293 cells stably expressing the ?? subunit of BK (HEK-BK?? cells), siRNA-mediated knockdown of WNK1 expression significantly inhibited both BK?? channel activity and open probability. Knockdown of WNK1 expression also significantly inhibited BK?? protein expression and increased ERK1/2 phosphorylation, whereas overexpression of WNK1 significantly enhanced BK?? expression and decreased ERK1/2 phosphorylation in a dose-dependent manner in HEK293 cells. Knockdown of ERK1/2 prevented WNK1 siRNA-mediated inhibition of BK?? expression. Similarly, pretreatment of HEK-BK?? cells with the lysosomal inhibitor bafilomycin A1 reversed the inhibitory effects of WNK1 siRNA on BK?? expression in a dose-dependent manner. Knockdown of WNK1 expression also increased the ubiquitination of BK?? channels. Notably, mice fed a high-K(+) diet for 10 days had significantly higher renal protein expression levels of BK?? and WNK1 and lower levels of ERK1/2 phosphorylation compared with mice fed a normal-K(+) diet. These data suggest that WNK1 enhances BK channel function by reducing ERK1/2 signaling-mediated lysosomal degradation of the channel.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Yingli</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Renal Division, Department of Medicine, and Department of Nephrology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine;</Affiliation>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Xiang</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Cardiology, The Fourth Affiliated Hospital, Harbin Medical University, Heilongjiang, China; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Yanling</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Renal Division, Department of Medicine, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Zhen</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Nephrology, The Second Affiliated Hospital, Wenzhou Medical University, Zhejiang, China;</Affiliation>
                </Author>
                <Author>
                    <LastName>Niu</LastName>
                    <ForeName>Weihui</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Nephrology, The Second Affiliated Hospital, Wenzhou Medical University, Zhejiang, China;</Affiliation>
                </Author>
                <Author>
                    <LastName>Feng</LastName>
                    <ForeName>Xiuyan</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Renal Division, Department of Medicine, and Renal Section, Atlanta Veterans Affairs Medical Center, Decatur, Georgia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Dingying</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Nephrology, The Second Affiliated Hospital, Wenzhou Medical University, Zhejiang, China;</Affiliation>
                </Author>
                <Author>
                    <LastName>Bao</LastName>
                    <ForeName>Hui-Fang</ForeName>
                    <Initials>HF</Initials>
                    <Affiliation>Department of Physiology, Emory University School of Medicine, Atlanta, Georgia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>He-Ping</ForeName>
                    <Initials>HP</Initials>
                    <Affiliation>Department of Physiology, Emory University School of Medicine, Atlanta, Georgia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Eaton</LastName>
                    <ForeName>Douglas C</ForeName>
                    <Initials>DC</Initials>
                    <Affiliation>Department of Physiology, Emory University School of Medicine, Atlanta, Georgia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhuang</LastName>
                    <ForeName>Jieqiu</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Nephrology, The Second Affiliated Hospital, Wenzhou Medical University, Zhejiang, China; hcai3@emory.edu jieqiuzhuang@hotmail.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cai</LastName>
                    <ForeName>Hui</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Renal Division, Department of Medicine, and Renal Section, Atlanta Veterans Affairs Medical Center, Decatur, Georgia Department of Physiology, Emory University School of Medicine, Atlanta, Georgia; hcai3@emory.edu jieqiuzhuang@hotmail.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cell and transport physiology</Keyword>
            <Keyword MajorTopicYN="N">K channels</Keyword>
            <Keyword MajorTopicYN="N">cell signaling</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2014020186</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2014020186</ArticleId>
            <ArticleId IdType="pubmed">25145935</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145934</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MicroRNA-21 in Glomerular Injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2013121274</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">TGF-??1 is a pleotropic growth factor that mediates glomerulosclerosis and podocyte apoptosis, hallmarks of glomerular diseases. The expression of microRNA-21 (miR-21) is regulated by TGF-??1, and miR-21 inhibits apoptosis in cancer cells. TGF-??1-transgenic mice exhibit accelerated podocyte loss and glomerulosclerosis. We determined that miR-21 expression increases rapidly in cultured murine podocytes after exposure to TGF-??1 and is higher in kidneys of TGF-??1-transgenic mice than wild-type mice. miR-21-deficient TGF-??1-transgenic mice showed increased proteinuria and glomerular extracellular matrix deposition and fewer podocytes per glomerular tuft compared with miR-21 wild-type TGF-??1-transgenic littermates. Similarly, miR-21 expression was increased in streptozotocin-induced diabetic mice, and loss of miR-21 in these mice was associated with increased albuminuria, podocyte depletion, and mesangial expansion. In cultured podocytes, inhibition of miR-21 was accompanied by increases in the rate of cell death, TGF-??/Smad3-signaling activity, and expression of known proapoptotic miR-21 target genes p53, Pdcd4, Smad7, Tgfbr2, and Timp3. In American-Indian patients with diabetic nephropathy (n=48), albumin-to-creatinine ratio was positively associated with miR-21 expression in glomerular fractions (r=0.6; P&lt;0.001) but not tubulointerstitial fractions (P=0.80). These findings suggest that miR-21 ameliorates TGF-??1 and hyperglycemia-induced glomerular injury through repression of proapoptotic signals, thereby inhibiting podocyte loss. This finding is in contrast to observations in murine models of tubulointerstitial kidney injury but consistent with findings in cancer models. The aggravation of glomerular disease in miR-21-deficient mice and the positive association with albumin-to-creatinine ratio in patients with diabetic nephropathy support miR-21 as a feedback inhibitor of TGF-?? signaling and functions.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lai</LastName>
                    <ForeName>Jennifer Y</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Jinghui</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan; Department of Pharmaceutical Sciences, Nanfang Hospital, Southern Medical University, Guangzhou, China;</Affiliation>
                </Author>
                <Author>
                    <LastName>O'Connor</LastName>
                    <ForeName>Christopher</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Jing</LastName>
                    <ForeName>Xiaohong</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Medicine, Albert Einstein College of Medicine, Bronx, New York;</Affiliation>
                </Author>
                <Author>
                    <LastName>Nair</LastName>
                    <ForeName>Viji</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Ju</LastName>
                    <ForeName>Wenjun</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Randolph</LastName>
                    <ForeName>Ann</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Ben-Dov</LastName>
                    <ForeName>Iddo Z</ForeName>
                    <Initials>IZ</Initials>
                    <Affiliation>Howard Hughes Medical Institute, The Rockefeller University, New York, New York;</Affiliation>
                </Author>
                <Author>
                    <LastName>Matar</LastName>
                    <ForeName>Regina N</ForeName>
                    <Initials>RN</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Briskin</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Howard Hughes Medical Institute, The Rockefeller University, New York, New York;</Affiliation>
                </Author>
                <Author>
                    <LastName>Zavadil</LastName>
                    <ForeName>Jiri</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Pathology and NYU Center for Health Informatics and Bioinformatics, New York University School of Medicine, New York; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nelson</LastName>
                    <ForeName>Robert G</ForeName>
                    <Initials>RG</Initials>
                    <Affiliation>National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tuschl</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Howard Hughes Medical Institute, The Rockefeller University, New York, New York;</Affiliation>
                </Author>
                <Author>
                    <LastName>Brosius</LastName>
                    <ForeName>Frank C</ForeName>
                    <Initials>FC</Initials>
                    <Suffix>3rd</Suffix>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kretzler</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan;</Affiliation>
                </Author>
                <Author>
                    <LastName>Bitzer</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Internal Medicine, University of Michigan, Ann Arbor, Michigan; Department of Medicine, Albert Einstein College of Medicine, Bronx, New York; markusbi@umich.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">TGF-??</Keyword>
            <Keyword MajorTopicYN="N">cell survival</Keyword>
            <Keyword MajorTopicYN="N">diabetic glomerulopathy</Keyword>
            <Keyword MajorTopicYN="N">molecular biology</Keyword>
            <Keyword MajorTopicYN="N">podocyte</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2013121274</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2013121274</ArticleId>
            <ArticleId IdType="pubmed">25145934</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145933</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inactivation of Integrin-??1 Prevents the Development of Polycystic Kidney Disease after the Loss of Polycystin-1.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2013111179</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Dysregulation of polycystin-1 (PC1) leads to autosomal dominant polycystic kidney disease (ADPKD), a disorder characterized by the formation of multiple bilateral renal cysts, the progressive accumulation of extracellular matrix (ECM), and the development of tubulointerstitial fibrosis. Correspondingly, cystic epithelia express higher levels of integrins (ECM receptors that control various cellular responses, such as cell proliferation, migration, and survival) that are characteristically altered in cystic cells. To determine whether the altered expression of ECM and integrins could establish a pathologic autostimulatory loop, we tested the role of integrin-??1 in vitro and on the cystic development of ADPKD in vivo. Compared with wild-type cells, PC1-depleted immortalized renal collecting duct cells had higher levels of integrin-??1 and fibronectin and displayed increased integrin-mediated signaling in the presence of Mn(2+). In mice, conditional inactivation of integrin-??1 in collecting ducts resulted in a dramatic inhibition of Pkd1-dependent cystogenesis with a concomitant suppression of fibrosis and preservation of normal renal function. Our data provide genetic evidence that a functional integrin-??1 is required for the early events leading to renal cystogenesis in ADPKD and suggest that the integrin signaling pathway may be an effective therapeutic target for slowing disease progression.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Kyung</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; and kim.lee@mssm.edu luca.gusella@mssm.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Boctor</LastName>
                    <ForeName>Sylvia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Barisoni</LastName>
                    <ForeName>Laura M C</ForeName>
                    <Initials>LM</Initials>
                    <Affiliation>Department of Pathology, University of Miami, Miami, Florida.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gusella</LastName>
                    <ForeName>G Luca</ForeName>
                    <Initials>GL</Initials>
                    <Affiliation>Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; and kim.lee@mssm.edu luca.gusella@mssm.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">autosomal dominant polycystic kidney disease</Keyword>
            <Keyword MajorTopicYN="N">cell???matrix interactions</Keyword>
            <Keyword MajorTopicYN="N">fibrosis</Keyword>
            <Keyword MajorTopicYN="N">genetic renal disease</Keyword>
            <Keyword MajorTopicYN="N">polycystic kidney disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2013111179</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2013111179</ArticleId>
            <ArticleId IdType="pubmed">25145933</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145931</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Sphingosine 1-Phosphate Receptor-1 Enhances Mitochondrial Function and Reduces Cisplatin-Induced Tubule Injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2013121351</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Sphingosine 1-phosphate (S1P), the natural sphingolipid ligand for a family of five G protein- coupled receptors (S1P1-S1P5Rs), regulates cell survival and lymphocyte circulation. We have shown that the pan-S1PR agonist, FTY720, attenuates kidney ischemia-reperfusion injury by directly activating S1P1 on proximal tubule (PT) cells, independent of the canonical lymphopenic effects of S1P1 activation on B and T cells. FTY720 also reduces cisplatin-induced AKI. Therefore, in this study, we used conditional PT-S1P1-null (PepckCreS1pr1(fl/fl)) and control (PepckCreS1pr1(w/wt)) mice to determine whether the protective effect of FTY720 in AKI is mediated by PT-S1P1. Cisplatin induced more renal injury in PT-S1P1-null mice than in controls. Although FTY720 produced lymphopenia in both control and PT-S1P1-null mice, it reduced injury only in control mice. Furthermore, the increase in proinflammatory cytokine (CXCL1, MCP-1, TNF-??, and IL-6) expression and infiltration of neutrophils and macrophages induced by cisplatin treatment was attenuated by FTY720 in control mice but not in PT-S1P1-null mice. Similarly, S1P1 deletion rendered cultured PT cells more susceptible to cisplatin-induced injury, whereas S1P1 overexpression protected PT cells from injury and preserved mitochondrial function. We conclude that S1P1 may have an important role in stabilizing mitochondrial function and that FTY720 administration represents a novel strategy in the prevention of cisplatin-induced AKI.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bajwa</LastName>
                    <ForeName>Amandeep</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia ab9nh@virginia.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rosin</LastName>
                    <ForeName>Diane L</ForeName>
                    <Initials>DL</Initials>
                    <Affiliation>Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia Pharmacology, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chroscicki</LastName>
                    <ForeName>Piotr</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Sangju</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dondeti</LastName>
                    <ForeName>Krishna</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ye</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kinsey</LastName>
                    <ForeName>Gilbert R</ForeName>
                    <Initials>GR</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stevens</LastName>
                    <ForeName>Brian K</ForeName>
                    <Initials>BK</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jobin</LastName>
                    <ForeName>Katarzyna</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kenwood</LastName>
                    <ForeName>Brandon M</ForeName>
                    <Initials>BM</Initials>
                    <Affiliation>Pharmacology, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hoehn</LastName>
                    <ForeName>Kyle L</ForeName>
                    <Initials>KL</Initials>
                    <Affiliation>Pharmacology, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lynch</LastName>
                    <ForeName>Kevin R</ForeName>
                    <Initials>KR</Initials>
                    <Affiliation>Pharmacology, and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Okusa</LastName>
                    <ForeName>Mark D</ForeName>
                    <Initials>MD</Initials>
                    <Affiliation>Departments of Medicine and Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ARF</Keyword>
            <Keyword MajorTopicYN="N">cisplatin</Keyword>
            <Keyword MajorTopicYN="N">mitochondria</Keyword>
            <Keyword MajorTopicYN="N">proximal tubule</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2013121351</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2013121351</ArticleId>
            <ArticleId IdType="pubmed">25145931</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145929</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1533-3450</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of the American Society of Nephrology : JASN</Title>
                <ISOAbbreviation>J. Am. Soc. Nephrol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Deficiency of the Planar Cell Polarity Protein Vangl2 in Podocytes Affects Glomerular Morphogenesis and Increases Susceptibility to Injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">ASN.2014040340</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The planar cell polarity (PCP) signaling pathway is crucial for tissue morphogenesis. Van Gogh-like protein 2 (Vangl2) is central in the PCP pathway; in mice, Vangl2 loss is embryonically lethal because of neural tube defects, and mutations in Vangl2 are associated with human neural tube defects. In the kidney, PCP signaling may be important for tubular morphogenesis and organization of glomerular epithelial cells (podocytes) along the glomerular basement membrane. Podocyte cell protrusions (foot processes) are critical for glomerular permselectivity; loss of foot process architecture results in proteinuria and FSGS. Previously, we showed a profound effect of PCP signaling on podocyte shape, actin rearrangement, cell motility, and nephrin endocytosis. To test our hypothesis that the PCP pathway is involved in glomerular development and function and circumvent lethality of the ubiquitous Vangl2 mutation in the Looptail mouse, we generated a mouse model with a podocyte-specific ablation of the Vangl2 gene. We report here that podocyte-specific deletion of Vangl2 leads to glomerular maturation defects in fetal kidneys. In adult mice, we detected significantly smaller glomeruli, but it did not affect glomerular permselectivity in aging animals. However, in the context of glomerular injury induced by injection of antiglomerular basement membrane antibody, deletion of Vangl2 resulted in exacerbation of injury and accelerated progression to chronic segmental and global glomerular sclerosis. Our results indicate that Vangl2 function in podocytes is important for glomerular development and protects against glomerular injury in adult animals.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the American Society of Nephrology.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Rocque</LastName>
                    <ForeName>Brittany L</ForeName>
                    <Initials>BL</Initials>
                    <Affiliation>Departments of Medicine and Physiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Babayeva</LastName>
                    <ForeName>Sima</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Departments of Medicine and Physiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Jane</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Departments of Medicine and Physiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Leung</LastName>
                    <ForeName>Vicki</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Departments of Human Genetics and Complex Traits Group, McGill University, Montreal, Quebec, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nezvitsky</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Departments of Medicine and Physiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cybulsky</LastName>
                    <ForeName>Andrey V</ForeName>
                    <Initials>AV</Initials>
                    <Affiliation>Departments of Medicine and Physiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gros</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Complex Traits Group, McGill University, Montreal, Quebec, Canada Biochemistry and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Torban</LastName>
                    <ForeName>Elena</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Departments of Medicine and Physiology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada; and elena.torban@mcgill.ca.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Am Soc Nephrol</MedlineTA>
            <NlmUniqueID>9013836</NlmUniqueID>
            <ISSNLinking>1046-6673</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">genetics and development</Keyword>
            <Keyword MajorTopicYN="N">glomerular disease</Keyword>
            <Keyword MajorTopicYN="N">kidney development</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ASN.2014040340</ArticleId>
            <ArticleId IdType="doi">10.1681/ASN.2014040340</ArticleId>
            <ArticleId IdType="pubmed">25145929</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145878</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>89</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51264</ELocationID>
            <Abstract>
                <AbstractText>Opioid-induced hyperalgesia and tolerance severely impact the clinical efficacy of opiates as pain relievers in animals and humans. The molecular mechanisms underlying both phenomena are not well understood and their elucidation should benefit from the study of animal models and from the design of appropriate experimental protocols. We describe here a methodological approach for inducing, recording and quantifying morphine-induced hyperalgesia as well as for evidencing analgesic tolerance, using the tail-immersion and tail pressure tests in wild-type mice. As shown in the video, the protocol is divided into five sequential steps. Handling and habituation phases allow a safe determination of the basal nociceptive response of the animals. Chronic morphine administration induces significant hyperalgesia as shown by an increase in both thermal and mechanical sensitivity, whereas the comparison of analgesia time-courses after acute or repeated morphine treatment clearly indicates the development of tolerance manifested by a decline in analgesic response amplitude. This protocol may be similarly adapted to genetically modified mice in order to evaluate the role of individual genes in the modulation of nociception and morphine analgesia. It also provides a model system to investigate the effectiveness of potential therapeutic agents to improve opiate analgesic efficacy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Elhabazi</LastName>
                    <ForeName>Khadija</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Biotechnology and Cellular Signalling, UMR 7242 CNRS, Universit?? de Strasbourg.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ayachi</LastName>
                    <ForeName>Safia</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Biotechnology and Cellular Signalling, UMR 7242 CNRS, Universit?? de Strasbourg.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ilien</LastName>
                    <ForeName>Brigitte</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Biotechnology and Cellular Signalling, UMR 7242 CNRS, Universit?? de Strasbourg.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Simonin</LastName>
                    <ForeName>Fr??d??ric</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Biotechnology and Cellular Signalling, UMR 7242 CNRS, Universit?? de Strasbourg; simonin@unistra.fr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>29</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51264</ArticleId>
            <ArticleId IdType="pubmed">25145878</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145854</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomaterials</Title>
                <ISOAbbreviation>Biomaterials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0142-9612(14)00868-0</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.biomaterials.2014.07.059</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Peptide dendrimer drug conjugate based nanoparticles are recently developed as a potential candidate for drug delivery vehicle. In this study, we prepared and characterized the enzyme-sensitive amphiphilc mPEGylated dendron-GFLG-DOX conjugate via two-step highly efficient click reaction. Dynamic light scattering (DLS) and transmission electron microscope (TEM) studies demonstrated the mPEGylated dendron-GFLG-DOX conjugate self-assembled into compact nanoparticles with negatively charged surface. The nanoparticles with 9.62??wt% (weight percent) of DOX showed enzyme-sensitive property by drug release tests. The nanoparticles were shown to effectively kill cancer cells in??vitro. The fluorescent image indicated that the nanoparticles could accumulate and retain within tumor for a long time. Moreover, the nanoparticles substantially enhanced antitumor efficacy compared to the free DOX, exhibiting much higher effects on inhibiting proliferation and inducing apoptosis of the 4T1 murine breast cancer model confirmed as the evidences from tumor growth curves, tumor growth inhibition (TGI), immunohistochemical analysis and histological assessment. The nanoparticles reduced DOX-induced toxicities and presented no significant side effects to normal organs of both tumor bearing and healthy mice as measured by body weight shifts and histological analysis. Therefore, the mPEGylated dendron-GFLG-DOX conjugate based nanoparticle serves as a potential drug delivery vehicle for breast cancer therapy.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Ning</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Na</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yi</LastName>
                    <ForeName>Qiangying</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Kui</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China. Electronic address: luokui@scu.edu.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Chunhua</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pan</LastName>
                    <ForeName>Dayi</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Zhongwei</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China. Electronic address: zwgu@scu.edu.cn.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biomaterials</MedlineTA>
            <NlmUniqueID>8100316</NlmUniqueID>
            <ISSNLinking>0142-9612</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cancer therapy</Keyword>
            <Keyword MajorTopicYN="N">Conjugate</Keyword>
            <Keyword MajorTopicYN="N">Dendrimer</Keyword>
            <Keyword MajorTopicYN="N">Environment responsive</Keyword>
            <Keyword MajorTopicYN="N">Polymeric drug delivery system</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0142-9612(14)00868-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2014.07.059</ArticleId>
            <ArticleId IdType="pubmed">25145854</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145853</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-5905</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biomaterials</Title>
                <ISOAbbreviation>Biomaterials</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Polarized immune responses modulated by layered double hydroxides nanoparticle conjugated with CpG.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0142-9612(14)00864-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.biomaterials.2014.07.055</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Modulation of the immune response is an important step in the induction of protective humoral and cellular immunity against pathogens. In this study, we investigated the possibility of using a nanomaterial conjugated with the toll-like receptor (TLR) ligand CpG to modulate the immune response towards the preferred polarity. MgAl-layered double hydroxide (LDH) nanomaterial has a very similar chemical composition to Alum, an FDA approved adjuvant for human vaccination. We used a model antigen, ovalbumin (OVA) to demonstrate that MgAl-LDH had comparable adjuvant activity to Alum, but much weaker inflammation. Conjugation of TLR9 ligand CpG to LDH nanoparticles significantly enhanced the antibody response and promoted a switch from Th2 toward Th1 response, demonstrated by a change in the IgG2a:IgG1 ratio. Moreover, immunization of mice with CpG-OVA-conjugated LDH before challenge with OVA-expressing B16/F10 tumor cells retarded tumor growth. Together, these data indicate that LDH nanomaterial can be used as an immune adjuvant to promote Th1 or Th2 dominant immune responses suitable for vaccination purposes.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yan</LastName>
                    <ForeName>Shiyu</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rolfe</LastName>
                    <ForeName>Barbara E</ForeName>
                    <Initials>BE</Initials>
                    <Affiliation>Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Bing</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Vaccine Delivery, Animal Science, Agri-Science Queensland Department of Agriculture, Fisheries and Forestry, St Lucia, QLD 4067, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mohammed</LastName>
                    <ForeName>Yousuf H</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Therapeutics Research Centre, School of Medicine, Princess Alexandra Hospital, University of Queensland, Woolloongabba, QLD 4102, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Wenyi</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia. Electronic address: w.gu@uq.edu.au.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>Zhi P</ForeName>
                    <Initials>ZP</Initials>
                    <Affiliation>Australian Institute for Bioengineering and Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia. Electronic address: gordonxu@uq.eud.au.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biomaterials</MedlineTA>
            <NlmUniqueID>8100316</NlmUniqueID>
            <ISSNLinking>0142-9612</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Immunity polarization</Keyword>
            <Keyword MajorTopicYN="N">Layered double hydroxide nanomaterial</Keyword>
            <Keyword MajorTopicYN="N">Nanoadjuvant</Keyword>
            <Keyword MajorTopicYN="N">Th1 and Th2 immune responses</Keyword>
            <Keyword MajorTopicYN="N">Toll-like receptor (TLR) ligand CpG</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0142-9612(14)00864-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.biomaterials.2014.07.055</ArticleId>
            <ArticleId IdType="pubmed">25145853</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145813</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Assessment of murine exercise endurance without the use of a shock grid: an alternative to forced exercise.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51846</ELocationID>
            <Abstract>
                <AbstractText>Using laboratory mouse models, the molecular pathways responsible for the metabolic benefits of endurance exercise are beginning to be defined. The most common method for assessing exercise endurance in mice utilizes forced running on a motorized treadmill equipped with a shock grid. Animals who quit running are pushed by the moving treadmill belt onto a grid that delivers an electric foot shock; to escape the negative stimulus, the mice return to running on the belt. However, avoidance behavior and psychological stress due to use of a shock apparatus can interfere with quantitation of running endurance, as well as confound measurements of postexercise serum hormone and cytokine levels. Here, we demonstrate and validate a refined method to measure running endurance in na??ve C57BL/6 laboratory mice on a motorized treadmill without utilizing a shock grid. When mice are preacclimated to the treadmill, they run voluntarily with gait speeds specific to each mouse. Use of the shock grid is replaced by gentle encouragement by a human operator using a tongue depressor, coupled with sensitivity to the voluntary willingness to run on the part of the mouse. Clear endpoints for quantifying running time-to-exhaustion for each mouse are defined and reflected in behavioral signs of exhaustion such as splayed posture and labored breathing. This method is a humane refinement which also decreases the confounding effects of stress on experimental parameters.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Conner</LastName>
                    <ForeName>Jennifer D</ForeName>
                    <Initials>JD</Initials>
                    <Affiliation>Research Service, VA Puget Sound Health Care System; Seattle Institute for Biomedical and Clinical Research.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wolden-Hanson</LastName>
                    <ForeName>Tami</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Research Service, VA Puget Sound Health Care System.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Quinn</LastName>
                    <ForeName>LeBris S</ForeName>
                    <Initials>LS</Initials>
                    <Affiliation>Research Service, VA Puget Sound Health Care System; Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington; Geriatric Research, Education, and Clinical Center, VA Puget Sound Health Care System; quinnL@uw.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51846</ArticleId>
            <ArticleId IdType="pubmed">25145813</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145797</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In Situ Detection of Autoreactive CD4 T Cells in Brain and Heart Using Major Histocompatibility Complex Class II Dextramers.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51679</ELocationID>
            <Abstract>
                <AbstractText>This report demonstrates the use of major histocompatibility complex (MHC) class II dextramers for detection of autoreactive CD4 T cells in situ in myelin proteolipid protein (PLP) 139-151-induced experimental autoimmune encephalomyelitis (EAE) in SJL mice and cardiac myosin heavy chain-?? (Myhc) 334-352-induced experimental autoimmune myocarditis (EAM) in A/J mice. Two sets of cocktails of dextramer reagents were used, where dextramers(+) cells were analyzed by laser scanning confocal microscope (LSCM): EAE, IA(s)/PLP 139-151 dextramers (specific)/anti-CD4 and IA(s)/Theiler's murine encephalomyelitis virus (TMEV) 70-86 dextramers (control)/anti-CD4; and EAM, IA(k)/Myhc 334-352 dextramers/anti-CD4 and IA(k)/bovine ribonuclease (RNase) 43-56 dextramers (control)/anti-CD4. LSCM analysis of brain sections obtained from EAE mice showed the presence of cells positive for CD4 and PLP 139-151 dextramers, but not TMEV 70-86 dextramers suggesting that the staining obtained with PLP 139-151 dextramers was specific. Likewise, heart sections prepared from EAM mice also revealed the presence of Myhc 334-352, but not RNase 43-56-dextramer(+) cells as expected. Further, a comprehensive method has also been devised to quantitatively analyze the frequencies of antigen-specific CD4 T cells in the 'Z' serial images.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Massilamany</LastName>
                    <ForeName>Chandirasegaran</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gangaplara</LastName>
                    <ForeName>Arunakumar</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>Ting</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elowsky</LastName>
                    <ForeName>Christian</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Center for Biotechnology, University of Nebraska, Lincoln.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Qingsheng</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Nebraska Center for Virology and School of Biological Sciences, University of Nebraska, Lincoln.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>You</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Center for Biotechnology, University of Nebraska, Lincoln.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reddy</LastName>
                    <ForeName>Jay</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>School of Veterinary Medicine and Biomedical Sciences, University of Nebraska, Lincoln; jayreddy@unl.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>01</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51679</ArticleId>
            <ArticleId IdType="pubmed">25145797</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145789</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Reversible changes in pancreatic islet structure and function produced by elevated blood glucose.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4639</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5639</ELocationID>
            <Abstract>
                <AbstractText>Diabetes is characterized by hyperglycaemia due to impaired insulin secretion and aberrant glucagon secretion resulting from changes in pancreatic islet cell function and/or mass. The extent to which hyperglycaemia per se underlies these alterations remains poorly understood. Here we show that ??-cell-specific expression of a human activating KATP channel mutation in adult mice leads to rapid diabetes and marked alterations in islet morphology, ultrastructure and gene expression. Chronic hyperglycaemia is associated with a dramatic reduction in insulin-positive cells and an increase in glucagon-positive cells in islets, without alterations in cell turnover. Furthermore, some ??-cells begin expressing glucagon, whilst retaining many ??-cell characteristics. Hyperglycaemia, rather than KATP channel activation, underlies these changes, as they are prevented by insulin therapy and fully reversed by sulphonylureas. Our data suggest that many changes in islet structure and function associated with diabetes are attributable to hyperglycaemia alone and are reversed when blood glucose is normalized.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Brereton</LastName>
                    <ForeName>Melissa F</ForeName>
                    <Initials>MF</Initials>
                    <Affiliation>Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Iberl</LastName>
                    <ForeName>Michaela</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>1] Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK [2].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shimomura</LastName>
                    <ForeName>Kenju</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>1] Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK [2].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Quan</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>1] Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK [2].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adriaenssens</LastName>
                    <ForeName>Alice E</ForeName>
                    <Initials>AE</Initials>
                    <Affiliation>1] Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK [2].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Proks</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spiliotis</LastName>
                    <ForeName>Ioannis I</ForeName>
                    <Initials>II</Initials>
                    <Affiliation>Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dace</LastName>
                    <ForeName>William</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mattis</LastName>
                    <ForeName>Katia K</ForeName>
                    <Initials>KK</Initials>
                    <Affiliation>Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ramracheya</LastName>
                    <ForeName>Reshma</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gribble</LastName>
                    <ForeName>Fiona M</ForeName>
                    <Initials>FM</Initials>
                    <Affiliation>Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Reimann</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Cambridge Institute for Medical Research, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0XY, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clark</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rorsman</LastName>
                    <ForeName>Patrik</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford OX3 7LE, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ashcroft</LastName>
                    <ForeName>Frances M</ForeName>
                    <Initials>FM</Initials>
                    <Affiliation>Henry Wellcome Centre for Gene Function, Department of Physiology, Anatomy and Genetics and OXION, University of Oxford, Parks Road, Oxford OX1 3PT, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5639</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5639</ArticleId>
            <ArticleId IdType="pubmed">25145789</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145706</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1447-073X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Anatomical science international</Title>
                <ISOAbbreviation>Anat Sci Int</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Axons from the medial habenular nucleus are topographically sorted in the fasciculus retroflexus.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">We generated transgenic mice lines with a construct consisting of the zif268/egr1 promoter and the gene for the normal long-life yellow fluorescent protein (Venus) with a membrane localization sequence. One of the lines exhibited topographic labeling in the medial habenular nucleus (MHb) during postnatal development, which confirmed the previous findings that the medial, lateral, and dorsal areas of MHb project to the ventral, dorsal, and lateral parts of the interpeduncular nucleus, respectively. In addition, the membranous localization of the labeling allowed us to observe spacial arrangement of the labeled axons in the fasciculus retroflexus (FR) in the transgenic mice. Here, we report topographic sorting of the MHb axons in the FR. At postnatal day (P) 5 and P10, the labeled axons from the medial MHb were fasciculated and ran through the narrow path in the core of the FR. At P24, the labeled axons from the medial and dorsal MHb were fasciculated and ran through the broad path in the FR core. No labeling occurred in the lateral MHb throughout development; correspondingly, parts of the FR core remained unlabeled. The results indicated that the axons from the medial and dorsal areas of the MHb are grouped together in the FR of this transgenic line and are sorted out from the axons from the lateral MHb.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ichijo</LastName>
                    <ForeName>Hiroyuki</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Anatomy, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Sugitani 2630, Toyama, 930-0194, Japan, ichijo@med.u-toyama.ac.jp.</Affiliation>
                </Author>
                <Author>
                    <LastName>Toyama</LastName>
                    <ForeName>Tomoko</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Anat Sci Int</MedlineTA>
            <NlmUniqueID>101154140</NlmUniqueID>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12565-014-0252-z</ArticleId>
            <ArticleId IdType="pubmed">25145706</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145699</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ex vivo preparations of the intact vomeronasal organ and accessory olfactory bulb.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51813</ELocationID>
            <Abstract>
                <AbstractText>The mouse accessory olfactory system (AOS) is a specialized sensory pathway for detecting nonvolatile social odors, pheromones, and kairomones. The first neural circuit in the AOS pathway, called the accessory olfactory bulb (AOB), plays an important role in establishing sex-typical behaviors such as territorial aggression and mating. This small (&lt;1 mm(3)) circuit possesses the capacity to distinguish unique behavioral states, such as sex, strain, and stress from chemosensory cues in the secretions and excretions of conspecifics. While the compact organization of this system presents unique opportunities for recording from large portions of the circuit simultaneously, investigation of sensory processing in the AOB remains challenging, largely due to its experimentally disadvantageous location in the brain. Here, we demonstrate a multi-stage dissection that removes the intact AOB inside a single hemisphere of the anterior mouse skull, leaving connections to both the peripheral vomeronasal sensory neurons (VSNs) and local neuronal circuitry intact. The procedure exposes the AOB surface to direct visual inspection, facilitating electrophysiological and optical recordings from AOB circuit elements in the absence of anesthetics. Upon inserting a thin cannula into the vomeronasal organ (VNO), which houses the VSNs, one can directly expose the periphery to social odors and pheromones while recording downstream activity in the AOB. This procedure enables controlled inquiries into AOS information processing, which can shed light on mechanisms linking pheromone exposure to changes in behavior.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Doyle</LastName>
                    <ForeName>Wayne I</ForeName>
                    <Initials>WI</Initials>
                    <Affiliation>Department of Neuroscience, UT Southwestern Medical Center.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hammen</LastName>
                    <ForeName>Gary F</ForeName>
                    <Initials>GF</Initials>
                    <Affiliation>Department of Anatomy and Neurobiology, Washington University in St. Louis.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Meeks</LastName>
                    <ForeName>Julian P</ForeName>
                    <Initials>JP</Initials>
                    <Affiliation>Department of Neuroscience, UT Southwestern Medical Center; Julian.Meeks@utsouthwestern.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51813</ArticleId>
            <ArticleId IdType="pubmed">25145699</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145672</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-7445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer research</Title>
                <ISOAbbreviation>Cancer Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SAR405838: An optimized inhibitor of MDM2-p53 interaction that induces complete and durable tumor regression.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">canres.0799.2014</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Blocking the MDM2-p53 protein-protein interaction has long been considered by many to offer a broad cancer therapeutic strategy, despite the potential risks of selecting tumors harboring p53 mutations that escape MDM2 control. In this study, we report a novel small molecule inhibitor of the MDM2-p53 interaction, SAR405838 (MI-77301) that has been advanced into Phase I clinical trials. SAR405838 binds to MDM2 with Ki = 0.88 nM and has high specificity over other proteins. A co-crystal structure of the SAR405838:MDM2 complex shows that in addition to mimicking three key p53 amino acid residues, the inhibitor captures additional interactions not observed in the p53-MDM2 complex and induces refolding of the short, unstructured MDM2 N-terminal region to achieve its high affinity. SAR405838 effectively activates wild-type p53 in vitro and in xenograft tumor tissue of leukemia and solid tumors, leading to p53-dependent cell cycle arrest and/or apoptosis. At well-tolerated dose schedules, SAR405838 achieves either durable tumor regression or complete tumor growth inhibition in mouse xenograft models of SJSA-1 osteosarcoma, RS4;11 acute leukemia, LNCaP prostate cancer and HCT-116 colon cancer. Remarkably, a single oral dose of SAR405838 is sufficient to achieve complete tumor regression in the SJSA-1 osteosarcoma model. Mechanistically, robust transcriptional up-regulation of PUMA induced by SAR405838 results in strong apoptosis in tumor tissue, leading to complete tumor regression. Our findings provide a preclinical basis upon which to evaluate SAR405838 as a therapeutic agent in patients whose tumors retain wild-type p53.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Association for Cancer Research.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Shaomeng</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>School of Medicine, University of Michigan shaomeng@umich.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Yujun</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>McEachern</LastName>
                    <ForeName>Donna</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>School of Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Meaux</LastName>
                    <ForeName>Isabelle</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Oncology, Sanofi Oncology.</Affiliation>
                </Author>
                <Author>
                    <LastName>Barriere</LastName>
                    <ForeName>Cedric</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Oncology, Sanofi Oncology.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stuckey</LastName>
                    <ForeName>Jeanne A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Life Sciences Institute, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Meagher</LastName>
                    <ForeName>Jennifer L</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Life Sciences Institute, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bai</LastName>
                    <ForeName>Longchuan</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Liu</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>School of Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hoffman-Luca</LastName>
                    <ForeName>Cassandra Gianna</ForeName>
                    <Initials>CG</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Jianfeng</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shangary</LastName>
                    <ForeName>Sanjeev</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Shanghai</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bernard</LastName>
                    <ForeName>Denzil</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Internal Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Aguilar</LastName>
                    <ForeName>Angelo</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>School of Medicine, University of Michigan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dos-Santos</LastName>
                    <ForeName>Odette</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>Oncology, Sanofi.</Affiliation>
                </Author>
                <Author>
                    <LastName>Besret</LastName>
                    <ForeName>Laurent</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Oncology, Sanofi.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guerif</LastName>
                    <ForeName>Stephane</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Oncology, Sanofi.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pannier</LastName>
                    <ForeName>Pascal</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Oncology, Sanofi.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gorge-Bernat</LastName>
                    <ForeName>Dimitri</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Oncology, Sanofi.</Affiliation>
                </Author>
                <Author>
                    <LastName>Debussche</LastName>
                    <ForeName>Laurent</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Oncology, Sanofi.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Res</MedlineTA>
            <NlmUniqueID>2984705R</NlmUniqueID>
            <ISSNLinking>0008-5472</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0008-5472.CAN-14-0799</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-14-0799</ArticleId>
            <ArticleId IdType="pubmed">25145672</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145670</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-7445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer research</Title>
                <ISOAbbreviation>Cancer Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development of novel ADCs: conjugation of tubulysin analogs to trastuzumab monitored by dual radiolabeling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">canres.1141.2014</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Tubulysins are highly toxic tubulin-targeting agents with a narrow therapeutic window that are interesting for application in antibody-drug-conjugates (ADCs). For full control over drug-antibody-ratio (DAR) and the effect thereof on pharmacokinetics and tumor targeting a dual-labeling approach was developed, wherein the drug, tubulysin variants, and the antibody, the anti-HER2 mAb trastuzumab, are radiolabeled. 131I-radioiodination of two synthetic tubulysin A analogues, the less potent TUB-OH (IC50 &gt;100nM) and the potent TUB-OMOM (IC50 ~1nM), and their direct covalent conjugation to 89Zr-trastuzumab were established. Radioiodination of tubulysins was 92-98% efficient, conversion to NHS-esters &gt;99%, esters were isolated in an overall yield of 68??5% with radiochemical purity of &gt;99.5%. Conjugation of 131I-tubulysin-NHS-esters to 89Zr-trastuzumab was 45-55% efficient, resulting in ADCs with 96-98% radiochemical purity after size-exclusion-chromatography. ADCs were evaluated for their tumor-targeting potential and anti-tumor effects in nude mice with tumors that were sensitive or resistant to trastuzumab, using ado-trastuzumab emtansine as a reference. ADCs appeared stable in vivo. An average DAR of 2 and 4 conferred pharmacokinetics and tumor targeting behavior similar to parental trastuzumab. Efficacy studies using single-dose TUB-OMOM-trastuzumab (DAR 4) showed dose-dependent anti-tumor effects, including complete tumor eradications in trastuzumab-sensitive tumors in vivo. TUB-OMOM-trastuzumab (60mg/kg) displayed efficacy similar to ado-trastuzumab emtansine (15mg/kg) yet more effective than trastuzumab. Our findings illustrate the potential of synthetic tubulysins in ADCs for cancer treatment.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Association for Cancer Research.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cohen</LastName>
                    <ForeName>Ruth</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Otolaryngology/Head and Neck Surgery, Vrije Universiteit Medical Center.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vugts</LastName>
                    <ForeName>Danielle Johanna</ForeName>
                    <Initials>DJ</Initials>
                    <Affiliation>Nuclear Medicine &amp; PET research, VU University Medical Center.</Affiliation>
                </Author>
                <Author>
                    <LastName>Visser</LastName>
                    <ForeName>Gerard W M</ForeName>
                    <Initials>GW</Initials>
                    <Affiliation>Department of Radiology &amp; Nuclear Medicine, Vrije Universiteit Medical Center.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stigter-van Walsum</LastName>
                    <ForeName>Marijke</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Otolaryngology/Head and Neck Surgery, VU University Medical Center.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bolijn</LastName>
                    <ForeName>Marije</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Radiology &amp; Nuclear Medicine, Vrije Universiteit Medical Center.</Affiliation>
                </Author>
                <Author>
                    <LastName>Spiga</LastName>
                    <ForeName>Marco</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>KemoTech s.r.l., KemoTech.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lazzari</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>KemoTech s.r.l., KemoTech.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shankar</LastName>
                    <ForeName>Sreejith</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Dept. of Organic Chemistry, The Weizmann Institute of Science.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sani</LastName>
                    <ForeName>Monica</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Sezione 'A. Quilico', Istituto di Chimica del Riconoscimento Molecolare.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zanda</LastName>
                    <ForeName>Matteo</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Kosterlitz Centre for Therapeutics, Institute of Medical Sciences, University of Aberdeen.</Affiliation>
                </Author>
                <Author>
                    <LastName>van Dongen</LastName>
                    <ForeName>Guus A M S</ForeName>
                    <Initials>GA</Initials>
                    <Affiliation>Department of Otolaryngology/Head and Neck Surgery, Vrije Universiteit Medical Center gams.vandongen@vumc.nl.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Res</MedlineTA>
            <NlmUniqueID>2984705R</NlmUniqueID>
            <ISSNLinking>0008-5472</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0008-5472.CAN-14-1141</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-14-1141</ArticleId>
            <ArticleId IdType="pubmed">25145670</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145669</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-7445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer research</Title>
                <ISOAbbreviation>Cancer Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Synergy between the NAMPT inhibitor GMX1777(8) and pemetrexed in non-small cell lung cancer cells is mediated by PARP activation and enhanced NAD consumption.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">canres.0809.2014</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">GMX1778 and its pro-drug GMX1777 represent a new class of cancer drugs that target nicotinamide phosphoribosyltransferase (NAMPT), as a new strategy to interfere with biosynthesis of the key enzymatic co-factor NAD, which is critical for a number of cell functions including DNA repair. Using a genome-wide synthetic lethal siRNA screen, we identified the folate pathway related genes deoxyuridine triphosphate and dihydrofolate reductase, the silencing of which sensitized non-small cell lung carcinoma (NSCLC) cells to the cytotoxic effects of GMX. Pemetrexed is an inhibitor of dihydrofolate reductase currently used to treat patients with non-squamous NSCLC. We found that combining pemetrexed with GMX1777 produced a synergistic therapeutic benefit in A549 and H1299 NSCLC cells in vitro and in a mouse A549 xenograft model of lung cancer. Pemetrexed is known to activate poly-ADP ribose polymerases (PARP) thereby accelerating NAD consumption. Genetic or pharmacologic blockade of PARP activity inhibited this effect, impairing cell death by pemetrexed either alone or in combination with GMX1777. Conversely, inhibiting the base excision repair pathway accentuated NAD decline in response to GMX and the cytotoxicity of both agents either alone or in combination. These findings provide a mechanistic rationale for combining GMX1777 with pemetrexed as an effective new therapeutic strategy to treat non-squamous NSCLC.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, American Association for Cancer Research.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chan</LastName>
                    <ForeName>Manuel</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gravel</LastName>
                    <ForeName>Michel</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bramoulle</LastName>
                    <ForeName>Alexandre</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bridon</LastName>
                    <ForeName>Gaelle</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University.</Affiliation>
                </Author>
                <Author>
                    <LastName>Avizonis</LastName>
                    <ForeName>Daina</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shore</LastName>
                    <ForeName>Gordon C</ForeName>
                    <Initials>GC</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University.</Affiliation>
                </Author>
                <Author>
                    <LastName>Roulston</LastName>
                    <ForeName>Anne</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Rosalind and Morris Goodman Cancer Research Centre, McGill University anne.roulston@mcgill.ca.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Res</MedlineTA>
            <NlmUniqueID>2984705R</NlmUniqueID>
            <ISSNLinking>0008-5472</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">0008-5472.CAN-14-0809</ArticleId>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-14-0809</ArticleId>
            <ArticleId IdType="pubmed">25145669</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145657</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0929</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicological sciences : an official journal of the Society of Toxicology</Title>
                <ISOAbbreviation>Toxicol. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Human Hepatocytes Support The Hypertrophic But Not The Hyperplastic Response To The Murine Nongenotoxic Hepatocarcinogen Sodium Phenobarbital In An In Vivo Study Using A Chimeric Mouse With Humanized Liver.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">kfu173</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">High doses of sodium phenobarbital (NaPB), a constitutive androstane receptor (CAR) activator, have been shown to produce hepatocellular tumors in rodents by a mitogenic mode of action (MOA) involving CAR activation. The effect of 1 week dietary treatment with NaPB on liver weight and histopathology, hepatic CYP2B enzyme activity and CYP2B/3A mRNA expression, replicative DNA synthesis and selected genes related to cell proliferation and functional transcriptomic and metabolomic analyses was studied in male CD-1 mice, Wistar Hannover (WH) rats and chimeric mice with human hepatocytes. The treatment of chimeric mice with 1000-1500 ppm NaPB resulted in plasma levels around 3-5 fold higher than those observed in human subjects given therapeutic doses of NaPB. NaPB produced dose-dependent increases in hepatic CYP2B activity and CYP2B/3A mRNA levels in all animal models. Integrated functional metabolomic and transcriptomic analyses demonstrated the responses to NaPB in human liver were clearly different from those in rodents. While NaPB produced a dose-dependent increase in hepatocyte replicative DNA synthesis in CD-1 mice and WH rats, no increase in replicative DNA synthesis was observed in human hepatocyte-originated areas of chimeric mice. In addition, treatment with NaPB had no effect on Ki-67, PCNA, GADD45??, and MDM2 mRNA expression in chimeric mice, whereas significant increases were observed in CD-1 mice and/or WH rats. However, increases in hepatocyte replicative DNA synthesis were observed in chimeric mice both in vivo and in vitro after treatment epidermal growth factor. Thus, while NaPB could activate CAR in both rodent and human hepatocytes, NaPB did not increase replicative DNA synthesis in human hepatocytes of chimeric mice, whereas it was mitogenic to rat and mouse hepatocytes. As human hepatocytes are refractory to the mitogenic effects of NaPB, the MOA for NaPB-induced rodent liver tumor formation is thus not relevant for humans.</AbstractText>
                <CopyrightInformation>?? The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yamada</LastName>
                    <ForeName>Tomoya</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan yamadat8@sc.sumitomo-chem.co.jp.</Affiliation>
                </Author>
                <Author>
                    <LastName>Okuda</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kushida</LastName>
                    <ForeName>Masahiko</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sumida</LastName>
                    <ForeName>Kayo</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Takeuchi</LastName>
                    <ForeName>Hayato</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nagahori</LastName>
                    <ForeName>Hirohisa</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fukuda</LastName>
                    <ForeName>Takako</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lake</LastName>
                    <ForeName>Brian G</ForeName>
                    <Initials>BG</Initials>
                    <Affiliation>Centre for Toxicology, Faculty of Health and Medical Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cohen</LastName>
                    <ForeName>Samuel M</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Department of Pathology and Microbiology, Havlik-Wall Professor of Oncology, University of Nebraska Medical Center, 983135 Nebraska Medical Center, Omaha, NE 68198-3135, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kawamura</LastName>
                    <ForeName>Satoshi</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Environmental Health Science Laboratory, Sumitomo Chemical Company, Ltd., 3-1-98 Kasugade-naka, Konohana-ku, Osaka 554-8558, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Toxicol Sci</MedlineTA>
            <NlmUniqueID>9805461</NlmUniqueID>
            <ISSNLinking>1096-0929</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cell proliferation</Keyword>
            <Keyword MajorTopicYN="N">cytochrome P450</Keyword>
            <Keyword MajorTopicYN="N">human risk assessment</Keyword>
            <Keyword MajorTopicYN="N">humanized mice</Keyword>
            <Keyword MajorTopicYN="N">liver tumors</Keyword>
            <Keyword MajorTopicYN="N">mode of action</Keyword>
            <Keyword MajorTopicYN="N">sodium phenobarbital</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">kfu173</ArticleId>
            <ArticleId IdType="doi">10.1093/toxsci/kfu173</ArticleId>
            <ArticleId IdType="pubmed">25145657</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145654</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-0929</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Toxicological sciences : an official journal of the Society of Toxicology</Title>
                <ISOAbbreviation>Toxicol. Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Novel Hg2+-Induced Nephropathy In Rats And Mice Lacking Mrp2: Evidence Of Axial Heterogeneity In The Handling Of Hg2+ Along The Proximal Tubule.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">kfu171</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The role of the multi-resistance protein 2 (Mrp2) in the nephropathy induced by inorganic mercuric mercury (Hg(2+)) was studied in rats (TR(???)) and mice (Mrp2(-/-)), which lack functional Mrp2, and control animals. Animals were exposed to nephrotoxic doses of HgCl2. Forty-eight or 24 hours after exposure, tissues were harvested and analyzed for Hg content and markers of injury. Histological analyses revealed that the proximal tubular segments affected pathologically by Hg(2+) were significantly different between Mrp2-deficient animals and controls. In the absence of Mrp2, cellular injury localized almost exclusively in proximal tubular segments in the subcapsular (S1) to mid-cortical regions (early S2) of the kidney. In control animals, cellular death occurred mainly in the proximal tubular segments in the inner cortex (late S2) and outer stripe of the outer medulla (OSOM; S3). These differences in renal pathology indicate that axial heterogeneity exists along the proximal tubule with respect to how mercuric ions are handled. Total renal and hepatic accumulation of mercury was also greater in animals lacking Mrp2 than in controls, indicating that Mrp2 normally plays a significant role in eliminating mercuric ions from within proximal tubular cells and hepatocytes. Analyses of plasma creatinine, BUN, and renal expression of Kim-1 and Ngal tend to support the severity of the nephropathies detected histologically. Collectively, our findings indicate that a fraction of mercuric ions is normally secreted by Mrp2 in early portions of proximal tubules into the lumen and then is absorbed downstream in straight portions, where mercuric species typically induce toxic effects.</AbstractText>
                <CopyrightInformation>?? The Author 2014. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zalups</LastName>
                    <ForeName>Rudolfs K</ForeName>
                    <Initials>RK</Initials>
                    <Affiliation>Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, GA 31207.</Affiliation>
                </Author>
                <Author>
                    <LastName>Joshee</LastName>
                    <ForeName>Lucy</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, GA 31207.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bridges</LastName>
                    <ForeName>Christy C</ForeName>
                    <Initials>CC</Initials>
                    <Affiliation>Division of Basic Medical Sciences, Mercer University School of Medicine, Macon, GA 31207 bridges_cc@mercer.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Toxicol Sci</MedlineTA>
            <NlmUniqueID>9805461</NlmUniqueID>
            <ISSNLinking>1096-0929</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">kfu171</ArticleId>
            <ArticleId IdType="doi">10.1093/toxsci/kfu171</ArticleId>
            <ArticleId IdType="pubmed">25145654</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145636</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1535-3907</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of proteome research</Title>
                <ISOAbbreviation>J. Proteome Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Exploring potential virulence regulators in Paracoccidioides brasiliensis isolates of varying virulence through quantitative proteomics.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Few virulence factors have been identified for Paracoccidioides brasiliensis, the agent of paracoccidioidomycosis. In this study, we quantitatively evaluated the protein composition of P. brasiliensis in the yeast phase using minimal and rich media to obtain a better understanding of its virulence and to gain new insights into pathogen adaptation strategies. This analysis was performed on two isolates of the Pb18 strain showing distinct infection profiles in B10.A mice. Using liquid chromatography/tandem mass spectrometry (LC-MS/MS) analysis, we identified and quantified 316 proteins in minimal medium, 29 of which were overexpressed in virulent Pb18. In rich medium, 29 out of 295 proteins were overexpressed in the virulent fungus. Three proteins were found up-regulated in both media, suggesting potential roles of these proteins in virulence regulation in P. brasiliensis. Moreover, genes up-regulated in virulent Pb18 showed increase in its expression after the recovery of virulence of attenuated Pb18. Proteins up-regulated in both isolates were grouped according to their functional categories. Virulent Pb18 undergoes metabolic reorganization and increased expression of proteins involved in fermentative respiration. This approach allowed us to identify potential virulence regulators and provided a foundation for achieving a molecular understanding of how Paracoccidioides modulates the host-pathogen interaction to its advantage.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Castilho</LastName>
                    <ForeName>Daniele Gon??alves</ForeName>
                    <Initials>DG</Initials>
                </Author>
                <Author>
                    <LastName>Chaves</LastName>
                    <ForeName>Alison Felipe Alencar</ForeName>
                    <Initials>AF</Initials>
                </Author>
                <Author>
                    <LastName>Xander</LastName>
                    <ForeName>Patricia</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Zelanis</LastName>
                    <ForeName>Andr??</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Kitano</LastName>
                    <ForeName>Eduardo S</ForeName>
                    <Initials>ES</Initials>
                </Author>
                <Author>
                    <LastName>Serrano</LastName>
                    <ForeName>Solange M T</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Tashima</LastName>
                    <ForeName>Alexandre K</ForeName>
                    <Initials>AK</Initials>
                </Author>
                <Author>
                    <LastName>Batista</LastName>
                    <ForeName>Wagner Luiz</ForeName>
                    <Initials>WL</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Proteome Res</MedlineTA>
            <NlmUniqueID>101128775</NlmUniqueID>
            <ISSNLinking>1535-3893</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/pr5002274</ArticleId>
            <ArticleId IdType="pubmed">25145636</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145631</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1757-6512</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Stem cell research &amp; therapy</Title>
                <ISOAbbreviation>Stem Cell Res Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Improvement of cardiac function by placenta-derived mesenchymal stem cells does not require permanent engraftment and is independent of the insulin signaling pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn>102</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The objective of this work was to evaluate the efficacy of placenta-derived mesenchymal stem cell (MSC) therapy in a mouse model of myocardial infarction (MI). Since MSCs can be obtained from two different regions of the human term placenta (chorionic plate or villi), cells obtained from both these regions were compared so that the best candidate for cell therapy could be selected.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">For the in vitro studies, chorionic plate MSCs (cp-MSCs) and chorionic villi MSCs (cv-MSCs) were extensively characterized for their genetic stability, clonogenic and differentiation potential, gene expression and immunophenotype. For the in vivo studies, C57Bl/6 mice were submitted to MI and, after 21 days, received weekly intramyocardial injections of cp-MSCs for 3 weeks. Cells were also stably transduced with a viral construct expressing luciferase, under the control of the murine stem cell virus (MSCV) promoter, and they were used in a bioluminescence assay. The expression of genes associated to the insulin signaling pathway was analyzed in the cardiac tissue from cp-MSCs and placebo groups.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Morphology, differentiation, immunophenotype and proliferation were quite similar between these cells. However, cp-MSCs had a greater clonogenic potential, and higher expression of genes related to cell cycle progression and genome stability. Therefore, we considered that the chorionic plate was preferable to the chorionic villi for the isolation of MSC. Sixty days after MI, cell-treated mice had a significant increase in ejection fraction and a reduction in end-systolic volume. This improvement was not caused by a reduction in infarct size. In addition, tracking of cp-MSCs transduced with luciferase revealed that cells remained in the heart for 4 days after the first injection, but the survival period was reduced after the second and third injections. Quantitative reverse transcription-PCR revealed similar expression of genes involved in the insulin signaling pathway when comparing cell-treated and placebo groups.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Improvement of cardiac function by cp-MSCs did not require permanent engraftment and was not mediated by the insulin signaling pathway.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Passipieri</LastName>
                    <ForeName>Juliana A</ForeName>
                    <Initials>JA</Initials>
                </Author>
                <Author>
                    <LastName>Kasai-Brunswick</LastName>
                    <ForeName>Tais H</ForeName>
                    <Initials>TH</Initials>
                </Author>
                <Author>
                    <LastName>Suhett</LastName>
                    <ForeName>Grazielle</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Martins</LastName>
                    <ForeName>Andreza B</ForeName>
                    <Initials>AB</Initials>
                </Author>
                <Author>
                    <LastName>Brasil</LastName>
                    <ForeName>Guilherme V</ForeName>
                    <Initials>GV</Initials>
                </Author>
                <Author>
                    <LastName>Campos</LastName>
                    <ForeName>Dilza B</ForeName>
                    <Initials>DB</Initials>
                </Author>
                <Author>
                    <LastName>Rocha</LastName>
                    <ForeName>Nazareth N</ForeName>
                    <Initials>NN</Initials>
                </Author>
                <Author>
                    <LastName>Ramos</LastName>
                    <ForeName>Isalira P</ForeName>
                    <Initials>IP</Initials>
                </Author>
                <Author>
                    <LastName>Mello</LastName>
                    <ForeName>Debora B</ForeName>
                    <Initials>DB</Initials>
                </Author>
                <Author>
                    <LastName>Rodrigues</LastName>
                    <ForeName>Deivid C</ForeName>
                    <Initials>DC</Initials>
                </Author>
                <Author>
                    <LastName>Christie</LastName>
                    <ForeName>Beatriz B</ForeName>
                    <Initials>BB</Initials>
                </Author>
                <Author>
                    <LastName>Silva-Mendes</LastName>
                    <ForeName>Bernardo J</ForeName>
                    <Initials>BJ</Initials>
                </Author>
                <Author>
                    <LastName>Baldu??no</LastName>
                    <ForeName>Alex</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>S??</LastName>
                    <ForeName>Renato M</ForeName>
                    <Initials>RM</Initials>
                </Author>
                <Author>
                    <LastName>Lopes</LastName>
                    <ForeName>Laudelino M</ForeName>
                    <Initials>LM</Initials>
                </Author>
                <Author>
                    <LastName>Goldenberg</LastName>
                    <ForeName>Regina C</ForeName>
                    <Initials>RC</Initials>
                </Author>
                <Author>
                    <LastName>Campos de Carvalho</LastName>
                    <ForeName>Antonio C</ForeName>
                    <Initials>AC</Initials>
                </Author>
                <Author>
                    <LastName>Carvalho</LastName>
                    <ForeName>Adriana B</ForeName>
                    <Initials>AB</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Stem Cell Res Ther</MedlineTA>
            <NlmUniqueID>101527581</NlmUniqueID>
            <ISSNLinking>1757-6512</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">scrt490</ArticleId>
            <ArticleId IdType="doi">10.1186/scrt490</ArticleId>
            <ArticleId IdType="pubmed">25145631</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145629</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-6860</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
                <ISOAbbreviation>FASEB J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Local receptors as novel regulators for peripheral clock expression.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">fj.13-243295</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Mammalian circadian control is determined by a central clock in the brain suprachiasmatic nucleus (SCN) and synchronized peripheral clocks in other tissues. Increasing evidence suggests that SCN-independent regulation of peripheral clocks also occurs. We examined how activation of excitatory receptors influences the clock protein PERIOD 2 (PER2) in a contractile organ, the urinary bladder. PERIOD2::LUCIFERASE-knock-in mice were used to report real-time PER2 circadian dynamics in the bladder tissue. Rhythmic PER2 activities occurred in the bladder wall with a cycle of ???24 h and peak at ???12 h. Activation of the muscarinic and purinergic receptors by agonists shifted the peak to an earlier time (7.2??2.0 and 7.2??0.9 h, respectively). PER2 expression was also sensitive to mechanical stimulation. Aging significantly dampened PER2 expression and its response to the agonists. Finally, muscarinic agonist-induced smooth muscle contraction also exhibited circadian rhythm. These data identified novel regulators, endogenous receptors, in determining local clock activity, in addition to mediating the central control. Furthermore, the local clock appears to reciprocally align receptor activity to circadian rhythm for muscle contraction. The interaction between receptors and peripheral clock represents an important mechanism for maintaining physiological functions and its dysregulation may contribute to age-related organ disorders.-Wu, C., Sui, G., Archer, S. N., Sassone-Corsi, P., Aitken, K., Bagli, D., Chen, Y. Local receptors as novel regulators for peripheral clock expression.</AbstractText>
                <CopyrightInformation>?? FASEB.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Changhao</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Biochemistry and Physiology, University of Surrey, Surrey, UK; c.wu@surrey.ac.uk.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sui</LastName>
                    <ForeName>Guiping</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Oesophageal Laboratory, Guy's and St. Thomas Hospitals National Health Service Trust, London, UK;</Affiliation>
                </Author>
                <Author>
                    <LastName>Archer</LastName>
                    <ForeName>Simon N</ForeName>
                    <Initials>SN</Initials>
                    <Affiliation>Department of Biochemistry and Physiology, University of Surrey, Surrey, UK;</Affiliation>
                </Author>
                <Author>
                    <LastName>Sassone-Corsi</LastName>
                    <ForeName>Paolo</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Biological Chemistry, University of California, Irvine, California, USA; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Aitken</LastName>
                    <ForeName>Karen</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Urology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bagli</LastName>
                    <ForeName>Darius</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Urology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Ying</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Biochemistry and Physiology, University of Surrey, Surrey, UK;</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>FASEB J</MedlineTA>
            <NlmUniqueID>8804484</NlmUniqueID>
            <ISSNLinking>0892-6638</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">aging</Keyword>
            <Keyword MajorTopicYN="N">circadian</Keyword>
            <Keyword MajorTopicYN="N">muscarinic</Keyword>
            <Keyword MajorTopicYN="N">purinergic</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">fj.13-243295</ArticleId>
            <ArticleId IdType="doi">10.1096/fj.13-243295</ArticleId>
            <ArticleId IdType="pubmed">25145629</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145628</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-6860</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</Title>
                <ISOAbbreviation>FASEB J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">fj.14-253856</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Expression of microRNA-652 (miR-652) increases in the diseased heart, decreases in a setting of cardioprotection, and is inversely correlated with heart function. The aim of this study was to assess the therapeutic potential of inhibiting miR-652 in a mouse model with established pathological hypertrophy and cardiac dysfunction due to pressure overload. Mice were subjected to a sham operation or transverse aortic constriction (TAC) for 4 wk to induce hypertrophy and cardiac dysfunction, followed by administration of a locked nucleic acid (LNA)-antimiR-652 (miR-652 inhibitor) or LNA control. Cardiac function was assessed before and 8 wk post-treatment. Expression of miR-652 increased in hearts subjected to TAC compared to sham surgery (2.9-fold), and this was suppressed by ???95% in LNA-antimiR-652-treated TAC mice. Inhibition of miR-652 improved cardiac function in TAC mice (fractional shortening:29??1% at 4 wk post-TAC compared to 35??1% post-treatment) and attenuated cardiac hypertrophy. Improvement in heart function was associated with reduced cardiac fibrosis, less apoptosis and B-type natriuretic peptide gene expression, and preserved angiogenesis. Mechanistically, we identified Jagged1 (a Notch1 ligand) as a novel direct target of miR-652. In summary, these studies provide the first evidence that silencing of miR-652 protects the heart against pathological remodeling and improves heart function.-Bernardo, B. C., Nguyen, S. S., Winbanks, C. E., Gao, X.-M., Boey, E. J. H., Tham, Y. K., Kiriazis, H., Ooi, J. Y. Y., Porrello, E. R., Igoor, S., Thomas, C. J., Gregorevic, P., Lin, R. C. Y., Du, X.-J., McMullen, J. R. Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.</AbstractText>
                <CopyrightInformation>?? FASEB.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bernardo</LastName>
                    <ForeName>Bianca C</ForeName>
                    <Initials>BC</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; julie.mcmullen@bakeridi.edu.au bianca.bernardo@bakeridi.edu.au.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nguyen</LastName>
                    <ForeName>Sally S</ForeName>
                    <Initials>SS</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Department of Human Biosciences, La Trobe University, Bundoora, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Winbanks</LastName>
                    <ForeName>Catherine E</ForeName>
                    <Initials>CE</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Gao</LastName>
                    <ForeName>Xiao-Ming</ForeName>
                    <Initials>XM</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Boey</LastName>
                    <ForeName>Esther J H</ForeName>
                    <Initials>EJ</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Tham</LastName>
                    <ForeName>Yow Keat</ForeName>
                    <Initials>YK</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Kiriazis</LastName>
                    <ForeName>Helen</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Ooi</LastName>
                    <ForeName>Jenny Y Y</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Porrello</LastName>
                    <ForeName>Enzo R</ForeName>
                    <Initials>ER</Initials>
                    <Affiliation>School of Biomedical Sciences, University of Queensland, St. Lucia, Queensland, Australia; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Igoor</LastName>
                    <ForeName>Sindhu</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>School of Biomedical Sciences, University of Queensland, St. Lucia, Queensland, Australia; and.</Affiliation>
                </Author>
                <Author>
                    <LastName>Thomas</LastName>
                    <ForeName>Colleen J</ForeName>
                    <Initials>CJ</Initials>
                    <Affiliation>Department of Human Biosciences, La Trobe University, Bundoora, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Gregorevic</LastName>
                    <ForeName>Paul</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Ruby C Y</ForeName>
                    <Initials>RC</Initials>
                    <Affiliation>Ramaciotti Centre for Genomics and School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Du</LastName>
                    <ForeName>Xiao-Jun</ForeName>
                    <Initials>XJ</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia;</Affiliation>
                </Author>
                <Author>
                    <LastName>McMullen</LastName>
                    <ForeName>Julie R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; julie.mcmullen@bakeridi.edu.au bianca.bernardo@bakeridi.edu.au.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>FASEB J</MedlineTA>
            <NlmUniqueID>8804484</NlmUniqueID>
            <ISSNLinking>0892-6638</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">LNA-therapeutics</Keyword>
            <Keyword MajorTopicYN="N">heart failure</Keyword>
            <Keyword MajorTopicYN="N">microRNAs</Keyword>
            <Keyword MajorTopicYN="N">pressure overload</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">fj.14-253856</ArticleId>
            <ArticleId IdType="doi">10.1096/fj.14-253856</ArticleId>
            <ArticleId IdType="pubmed">25145628</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145595</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4644</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of cellular biochemistry</Title>
                <ISOAbbreviation>J. Cell. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ability of circulating human hematopoietic lineage negative cells to support hematopoiesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jcb.24942</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Hematopoietic stem cell (HSC) self-renewal is regulated by osteoblast and/or endothelial cells within the hematopoietic niche. However, the true identity of the supporting cells and the nature of the secreted factors remain uncertain. We developed a novel mouse model and analyzed whether circulating human peripheral hematopoietic lineage negative/AP+ (lin-/AP???+) cells support hematopoiesis in vivo. Thus, immuno-compromised (Rag) mice expressing thymidine kinase (Tk) under the control of the 3.6Col1??1 promoter (Tk-Rag) were treated with ganciclovir, resulting in osteoblast progenitor cell ablation and subsequent loss of hematopoiesis (evaluated by measuring mouse Ter119+ erythroid cells). Following hematopoietic cell depletion, human bone marrow-derived marrow stromal cells (MSCs) or lin-/AP+ cells were infused into Tk-Rag mice and compared with saline infusions. Ganciclovir significantly reduced (7.4-fold) Ter119+ cells in the bone marrow of Tk-Rag mice compared to saline injections. Infusion of either MSCs or lin-/AP+ cells into ganciclovir-treated mice resulted in a 3.3-fold and 2.7-fold increase (P???&lt;???0.01), respectively, in Ter119+ cells compared to mice receiving saline. Relative to lin-/AP- cells, lin-/AP+ cells expressed high levels of mesenchymal, endothelial, and hematopoiesis supporting genes. Thus, human peripheral blood lin-/AP+ cells represent a novel cell type capable of supporting hematopoiesis in a manner comparable to MSCs. J. Cell. Biochem. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Peris</LastName>
                    <ForeName>Pilar</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Endocrine Research Unit, College of Medicine, Mayo Clinic, Rochester, Minnesota, USA; Rheumatology Department, Hospital Clinic, IDIBAPS, CIBERehd, Barcelona, Spain.</Affiliation>
                </Author>
                <Author>
                    <LastName>Roforth</LastName>
                    <ForeName>Matthew M</ForeName>
                    <Initials>MM</Initials>
                </Author>
                <Author>
                    <LastName>Nicks</LastName>
                    <ForeName>Kristy M</ForeName>
                    <Initials>KM</Initials>
                </Author>
                <Author>
                    <LastName>Fraser</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Fujita</LastName>
                    <ForeName>Koji</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Jilka</LastName>
                    <ForeName>Robert L</ForeName>
                    <Initials>RL</Initials>
                </Author>
                <Author>
                    <LastName>Khosla</LastName>
                    <ForeName>Sundeep</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>McGregor</LastName>
                    <ForeName>Ulrike</ForeName>
                    <Initials>U</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Cell Biochem</MedlineTA>
            <NlmUniqueID>8205768</NlmUniqueID>
            <ISSNLinking>0730-2312</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">endothelial cells</Keyword>
            <Keyword MajorTopicYN="N">hematopoiesis</Keyword>
            <Keyword MajorTopicYN="N">lin-/AP+ cells</Keyword>
            <Keyword MajorTopicYN="N">mesenchymal cells</Keyword>
            <Keyword MajorTopicYN="N">mouse model</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.24942</ArticleId>
            <ArticleId IdType="pubmed">25145595</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145583</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras protooncogenes.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27396</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Concomitant expression of activated forms of AKT and Ras in the mouse liver (AKT/Ras) leads to rapid tumor development via strong activation of the mTORC1 pathway. mTORC1 functions via regulating p70S6K/RPS6 and 4EBP1/eIF4E cascades. How these cascades contribute to hepatocarcinogenesis remains unknown. Here, we show that inhibition of RPS6 pathway via Rapamycin effectively suppressed, whereas blockade of the 4EBP1/eIF4E cascade by 4EBP1A4, an unphosphorylatable form of 4EBP1, significantly delayed, AKT/Ras induced hepatocarcinogenesis. Combined treatment with Rapamycin and 4EBP1A4 completely inhibited AKT/Ras hepatocarcinogenesis. This strong anti-neoplastic effect was successfully recapitulated by ablating Raptor, the major subunit of mTORC1, in AKT/Ras-overexpressing livers. Furthermore, we demonstrate that overexpression of eIF4E, the protooncogene whose activity is specifically inhibited by 4EBP1, resulted in HCC development in cooperation with activated Ras. Mechanistically, we identified the ENTPD5/AK1/CMPK1 axis and the mitochondrial biogenesis pathway as targets of the 4EBP1/eIF4E cascade in AKT/Ras and Ras/eIF4E livers as well as in human HCC cell lines and tissues. Conclusions: Complete inhibition of mTORC1 is required to suppress liver cancer development induced by AKT and Ras protooncogenes in mice. The mTORC1 effectors, RPS6 and eIF4E, play distinct roles and are both necessary for AKT/Ras hepatocarcinogenesis. These new findings might open the way for innovative therapies against human hepatocellular carcinoma. (Hepatology 2014).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Chunmei</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cigliano</LastName>
                    <ForeName>Antonio</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Jiang</LastName>
                    <ForeName>Lijie</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Xiaolei</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Fan</LastName>
                    <ForeName>Biao</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Pilo</LastName>
                    <ForeName>Maria G</ForeName>
                    <Initials>MG</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Gui</LastName>
                    <ForeName>Bing</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Sini</LastName>
                    <ForeName>Marcella</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>Jeffrey W</ForeName>
                    <Initials>JW</Initials>
                </Author>
                <Author>
                    <LastName>Dombrowski</LastName>
                    <ForeName>Frank</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Calvisi</LastName>
                    <ForeName>Diego F</ForeName>
                    <Initials>DF</Initials>
                </Author>
                <Author>
                    <LastName>Evert</LastName>
                    <ForeName>Matthias</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27396</ArticleId>
            <ArticleId IdType="pubmed">25145583</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145547</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1432-0428</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Diabetologia</Title>
                <ISOAbbreviation>Diabetologia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Erratum to: Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetes.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <AuthorList>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Yi-Chun</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Department of Cellular &amp; Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Colvin</LastName>
                    <ForeName>E Scott</ForeName>
                    <Initials>ES</Initials>
                </Author>
                <Author>
                    <LastName>Griffin</LastName>
                    <ForeName>Katherine E</ForeName>
                    <Initials>KE</Initials>
                </Author>
                <Author>
                    <LastName>Maier</LastName>
                    <ForeName>Bernhard F</ForeName>
                    <Initials>BF</Initials>
                </Author>
                <Author>
                    <LastName>Fueger</LastName>
                    <ForeName>Patrick T</ForeName>
                    <Initials>PT</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Diabetologia</MedlineTA>
            <NlmUniqueID>0006777</NlmUniqueID>
            <ISSNLinking>0012-186X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00125-014-3357-y</ArticleId>
            <ArticleId IdType="pubmed">25145547</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145540</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1757-6512</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Stem cell research &amp; therapy</Title>
                <ISOAbbreviation>Stem Cell Res Ther</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mesenchymal stem cells, not conditioned medium, contribute to kidney repair after ischemia-reperfusion injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn>101</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Studies have shown that stem cells exert their therapeutic effects on acute kidney injury (AKI) through paracrine/endocrine actions. If the protective effect is mediated in an endocrine manner, the injection of the factors that these cells secrete could be effective, but the effect of conditioned medium (CM) remains controversial.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">In this study, we cultured mesenchymal stem cells (MSCs) and then transplanted them into an ischemia-reperfusion (I/R) injury model. CM was also injected into mice, and the histological changes, level of cell proliferation, loss of peritubular capillaries and anti-inflammatory and anti-apoptotic effects were examined at different time points.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The results showed that MSC infusion improved renal function and histological alterations, leading to significantly reduced mortality. MSC administration also promoted kidney microvasculature repair, attenuated kidney peritubular capillary loss, increased the proliferation of parenchymal cells and decreased CD68-positive macrophage infiltration and apoptotic cells. Although we determined that CM contained proangiogenic factors, including hepatocyte growth factor (HGF), vascular endothelial growth factor-A (VEGF-A) and insulin-like growth factor-1 (IGF-1), no favorable effects were observed during the course of repair.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our data show that MSC infusion promotes kidney repair in a variety of ways, including enhancement of the repair of peritubular capillaries and tubular epithelial cells and anti-inflammatory and anti-apoptotic effects. MSCs can secrete high levels of proangiogenic growth factors, but CM results in a nonsignificant improvement, indicating that MSCs play a role in kidney repair through paracrine rather than endocrine mechanisms. These results indicate that MSC infusion is a promising therapeutic strategy for promoting kidney repair after injury.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Xing</LastName>
                    <ForeName>Li</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Cui</LastName>
                    <ForeName>Rui</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Peng</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>Jing</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Xie</LastName>
                    <ForeName>Ru-Juan</ForeName>
                    <Initials>RJ</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Bing</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Stem Cell Res Ther</MedlineTA>
            <NlmUniqueID>101527581</NlmUniqueID>
            <ISSNLinking>1757-6512</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>5</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">scrt489</ArticleId>
            <ArticleId IdType="doi">10.1186/scrt489</ArticleId>
            <ArticleId IdType="pubmed">25145540</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145536</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-6825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of allergy and clinical immunology</Title>
                <ISOAbbreviation>J. Allergy Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Perinatal antibiotic-induced shifts in gut microbiota have differential effects on inflammatory lung diseases.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0091-6749(14)00893-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.jaci.2014.06.027</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Resident gut microbiota are now recognized as potent modifiers of host immune responses in various scenarios. Recently, we demonstrated that perinatal exposure to vancomycin, but not streptomycin, profoundly alters gut microbiota and enhances susceptibility to a TH2 model of allergic asthma.</AbstractText>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Here we sought to further clarify the etiology of these changes by determining whether perinatal antibiotic treatment has a similar effect on the TH1/TH17-mediated lung disease, hypersensitivity pneumonitis.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Hypersensitivity pneumonitis was induced in C57BL/6 wild-type or recombination-activating gene 1-deficient mice treated perinatally with vancomycin or streptomycin by repeated intranasal administration of Saccharopolyspora rectivirgula antigen. Disease severity was assessed by measuring lung inflammation, pathology, cytokine responses, and serum antibodies. Microbial community analyses were performed on stool samples via 16S ribosomal RNA pyrosequencing and correlations between disease severity and specific bacterial taxa were identified.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Surprisingly, in contrast to our findings in an allergic asthma model, we found that the severity of hypersensitivity pneumonitis was unaffected by vancomycin, but increased dramatically after streptomycin treatment. This likely reflects an effect on the adaptive, rather than innate, immune response because the effects of streptomycin were not observed during the early phases of disease and were abrogated in recombination-activating gene 1-deficient mice. Interestingly, Bacteroidetes dominated the intestinal microbiota of streptomycin-treated animals, while vancomycin promoted the expansion of the Firmicutes.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Perinatal antibiotics exert highly selective effects??on resident gut flora, which, in turn, lead to very specific??alterations in susceptibility to TH2- or TH1/TH17-driven lung inflammatory disease.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Academy of Allergy, Asthma &amp; Immunology. Published by Mosby, Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Russell</LastName>
                    <ForeName>Shannon L</ForeName>
                    <Initials>SL</Initials>
                    <Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gold</LastName>
                    <ForeName>Matthew J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Biomedical Research Center, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Reynolds</LastName>
                    <ForeName>Lisa A</ForeName>
                    <Initials>LA</Initials>
                    <Affiliation>Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Willing</LastName>
                    <ForeName>Benjamin P</ForeName>
                    <Initials>BP</Initials>
                    <Affiliation>Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada; Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dimitriu</LastName>
                    <ForeName>Pedro</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Thorson</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Redpath</LastName>
                    <ForeName>Stephen A</ForeName>
                    <Initials>SA</Initials>
                    <Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Perona-Wright</LastName>
                    <ForeName>Georgia</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Blanchet</LastName>
                    <ForeName>Marie-Ren??e</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>Centre de Recherche, Institut Universitaire de Cardiologie et de Pneumologie de Qu??bec, Quebec City, Quebec, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mohn</LastName>
                    <ForeName>William W</ForeName>
                    <Initials>WW</Initials>
                    <Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; Life Sciences Institute, University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Brett Finlay</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada; Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: bfinlay@interchange.ubc.ca.</Affiliation>
                </Author>
                <Author>
                    <LastName>McNagny</LastName>
                    <ForeName>Kelly M</ForeName>
                    <Initials>KM</Initials>
                    <Affiliation>Biomedical Research Center, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: Kelly@brc.ubc.ca.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Allergy Clin Immunol</MedlineTA>
            <NlmUniqueID>1275002</NlmUniqueID>
            <ISSNLinking>0091-6749</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antibiotics</Keyword>
            <Keyword MajorTopicYN="N">Bacteroidetes</Keyword>
            <Keyword MajorTopicYN="N">Firmicutes</Keyword>
            <Keyword MajorTopicYN="N">asthma</Keyword>
            <Keyword MajorTopicYN="N">gut microbiota</Keyword>
            <Keyword MajorTopicYN="N">hypersensitivity pneumonitis</Keyword>
            <Keyword MajorTopicYN="N">perinatal</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0091-6749(14)00893-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jaci.2014.06.027</ArticleId>
            <ArticleId IdType="pubmed">25145536</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145474</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4644</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of cellular biochemistry</Title>
                <ISOAbbreviation>J. Cell. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>VEGF and angiopoietins promote inflammatory cell recruitment and mature blood vessel formation in murine sponge/Matrigel model.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jcb.24941</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">A key feature in the induction of pathological angiogenesis is that inflammation precedes and accompanies the formation of neovessels as evidenced by increased vascular permeability and the recruitment of inflammatory cells. Previously, we and other groups have shown that selected growth factors, namely vascular endothelial growth factor (VEGF) and angiopoietins (Ang1 and Ang2) do not only promote angiogenesis but can also induce inflammatory response. Herein, given a pro-inflammatory environment, we addressed the individual capacity of VEGF and angiopoietins to promote the formation of mature neovessels and to identify the different types of inflammatory cells accompanying the angiogenic process over time. Sterilized polyvinyl alcohol (PVA) sponges soaked in growth factor-depleted Matrigel mixed with PBS, VEGF, Ang1 or Ang2 (200 ng/200 ??l) were subcutaneously inserted into anesthetized mice. Sponges were removed at day 4, 7, 14 or 21 post-procedure for histological, immunohistological (IHC) and flow cytometry analyses. As compared to PBS-treated sponges, the three growth factors promoted the recruitment of inflammatory cells, mainly neutrophils and macrophages, and to a lesser extent, T- and B-cells. In addition, they were more potent and more rapid in the recruitment of endothelial cells (ECs) and in the formation and maturation (ensheating of smooth muscle cells around ECs) of neovessels. Thus, the autocrine/paracrine interaction among the different inflammatory cells in combination with VEGF, Ang1 or Ang2 provides a suitable microenvironment for the formation and maturation of blood vessels. J. Cell. Biochem. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sinnathamby</LastName>
                    <ForeName>Tharsika</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Research Center, Montreal Heart Institute, Montr??al, Canada; Department of pharmacology, Faculty of medicine, Universit?? de Montr??al, Montr??al, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yun</LastName>
                    <ForeName>Tae Jin</ForeName>
                    <Initials>TJ</Initials>
                </Author>
                <Author>
                    <LastName>Clavet-Lanthier</LastName>
                    <ForeName>Marie-??laine</ForeName>
                    <Initials>ME</Initials>
                </Author>
                <Author>
                    <LastName>Cheong</LastName>
                    <ForeName>Cheolho</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Sirois</LastName>
                    <ForeName>Martin G</ForeName>
                    <Initials>MG</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Cell Biochem</MedlineTA>
            <NlmUniqueID>8205768</NlmUniqueID>
            <ISSNLinking>0730-2312</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">VEGF</Keyword>
            <Keyword MajorTopicYN="N">angiogenesis</Keyword>
            <Keyword MajorTopicYN="N">angiopoietins</Keyword>
            <Keyword MajorTopicYN="N">inflammatory cells</Keyword>
            <Keyword MajorTopicYN="N">neovessel maturation</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcb.24941</ArticleId>
            <ArticleId IdType="pubmed">25145474</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145462</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1757-9708</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Integrative biology : quantitative biosciences from nano to macro</Title>
                <ISOAbbreviation>Integr Biol (Camb)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Exploitation of the hepatic stellate cell Raman signature for their detection in native tissue samples.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Hepatic stellate cells (HSCs) surround liver sinusoids and store retinol while they are quiescent. During fibrotic liver diseases and acute-on-chronic liver failure they change to the activated state in which they proliferate, lose their retinol content and deposit extracellular matrix molecules. The process of HSC activation is of utmost interest, but so far only insufficiently understood, because there is a lack of techniques to address the function of single HSCs in the tissue context. In this contribution, the potential of Raman micro-spectroscopy for the label-free detection of HSCs in mouse liver samples is demonstrated. First, culture-induced activation of primary mouse HSCs is followed in vitro and characterized by means of Raman spectroscopy. The HSC activation state is confirmed by immunofluorescence labeling of glial fibrillary acidic protein (GFAP) and ??-smooth muscle actin (ASMA). As expected, the unique Raman spectrum of retinol in quiescent HSCs is lost during activation. Nevertheless, successful discrimination of HSCs from primary hepatocytes is possible during all states of activation. A classification model based on principal component analysis followed by linear discriminant analysis (PCA-LDA) of the lipid droplet Raman data yields a prediction accuracy of 99%. The in vitro results are transferred to fresh liver slices and freshly sampled livers. Quiescent HSCs and a HSC transforming from quiescent to activated state are identified based on their Raman signature. This provides valuable information on HSC activation state in the liver.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Galler</LastName>
                    <ForeName>Kerstin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Leibniz Institute of Photonic Technology, Jena, Germany. ute.neugebauer@med.uni-jena.de.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schleser</LastName>
                    <ForeName>Franziska</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Fr??hlich</LastName>
                    <ForeName>Esther</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Requardt</LastName>
                    <ForeName>Robert Pascal</ForeName>
                    <Initials>RP</Initials>
                </Author>
                <Author>
                    <LastName>Kortgen</LastName>
                    <ForeName>Andreas</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Bauer</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Popp</LastName>
                    <ForeName>J??rgen</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Neugebauer</LastName>
                    <ForeName>Ute</ForeName>
                    <Initials>U</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Integr Biol (Camb)</MedlineTA>
            <NlmUniqueID>101478378</NlmUniqueID>
            <ISSNLinking>1757-9694</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c4ib00130c</ArticleId>
            <ArticleId IdType="pubmed">25145462</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145440</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1470-8728</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>462</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Biochemical journal</Title>
                <ISOAbbreviation>Biochem. J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Nitrogen monoxide inhibits haem synthesis in mouse reticulocytes.</ArticleTitle>
            <Pagination>
                <MedlinePgn>603</MedlinePgn>
            </Pagination>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mikhael</LastName>
                    <ForeName>M R</ForeName>
                    <Initials>MR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soe-Lin</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Apte</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ponka</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biochem J</MedlineTA>
            <NlmUniqueID>2984726R</NlmUniqueID>
            <ISSNLinking>0264-6021</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25145440</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145393</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-650X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Food &amp; function</Title>
                <ISOAbbreviation>Food Funct</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Octaphlorethol A: a potent ??-glucosidase inhibitor isolated from Ishige foliacea shows an anti-hyperglycemic effect in mice with streptozotocin-induced diabetes.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">??-Glucosidase inhibitors are important agents for decreasing postprandial hyperglycemia. The current study examined the inhibitory effects of octaphlorethol A (OPA) isolated from Ishige foliacea, a brown alga, on ??-glucosidase, and analyzed the inhibitor's binding modes using the crystal structure of ??-glucosidase. The effects of OPA on postprandial blood glucose levels after meals were also investigated. The IC50 value of OPA against ??-glucosidase was 0.11 mM, which is higher than that of the commercial inhibitor acarbose. For further insights, we predicted the 3D structure of ??-glucosidase and used a docking algorithm to simulate binding between ??-glucosidase and OPA. These molecular modeling studies were successful, and indicated that OPA interacts with Phe575, His600, Arg526, Met444, Asp542, Tyr605, Ser448, Asp203, Lys480, and Phe450. Furthermore, increases in postprandial blood glucose levels were significantly suppressed in the OPA-treated group compared with those in the streptozotocin-induced diabetic or normal mice. Additionally, the area under the curve was significantly reduced following OPA administration (907 versus 1034 mg h dL(-1)) in the diabetic mice, along with a delay in the absorption of dietary carbohydrates. Collectively, these results indicated that OPA is a potent inhibitor of ??-glucosidase, and shows potential to be used as an anti-diabetic agent.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Seung-Hong</ForeName>
                    <Initials>SH</Initials>
                    <Affiliation>Division of Food Bioscience and Korea Nokyong Research Center, Konkuk University, Chungju 380-701, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kang</LastName>
                    <ForeName>Sung-Myung</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Ko</LastName>
                    <ForeName>Seok-Chun</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author>
                    <LastName>Moon</LastName>
                    <ForeName>Sang-Ho</ForeName>
                    <Initials>SH</Initials>
                </Author>
                <Author>
                    <LastName>Jeon</LastName>
                    <ForeName>Byong-Tae</ForeName>
                    <Initials>BT</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Dae Ho</ForeName>
                    <Initials>DH</Initials>
                </Author>
                <Author>
                    <LastName>Jeon</LastName>
                    <ForeName>You-Jin</ForeName>
                    <Initials>YJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Food Funct</MedlineTA>
            <NlmUniqueID>101549033</NlmUniqueID>
            <ISSNLinking>2042-6496</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c4fo00420e</ArticleId>
            <ArticleId IdType="pubmed">25145393</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145386</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1470-8728</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Biochemical journal</Title>
                <ISOAbbreviation>Biochem. J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MondoA Deficiency Enhances Sprint Performance in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">MondoA is a bHLH/ZIP transcription factor that is expressed predominantly in skeletal muscle [1]. Studies in vitro suggest that the MondoA:Mlx heterodimer senses the intracellular energy status and directly targets the promoter region of thioredoxin interacting protein (Txnip), and possibly glycolytic enzymes [2;3]. We generated MondoA-inactivated (MondoA-/-) mice by gene targeting. MondoA-/- mice had normal body weight at birth, exhibited normal growth, and appeared to be healthy. However, they exhibited unique metabolic characteristics. MondoA-/- mice built up serum lactate and alanine levels, and utilized fatty acids for fuel during exercise. Gene expression and promoter analysis suggested that MondoA functionally represses PGC-1a mediated activation of pyruvate dehydrogenase kinase 4 (PDK-4) transcription. PDK4 normally downregulates the activity of pyruvate dehydrogenase, an enzyme complex that catalyzes the decarboxylation of pyruvate to acetyl-CoA for entry into the Krebs cycle; in the absence of MondoA, pyruvate is diverted toward lactate and alanine, both products of glycolysis. Dynamic testing revealed that MondoA-/- mice excel in sprinting as their skeletal muscles display an enhanced glycolytic capacity. Our studies uncover a hitherto unappreciated function of MondoA in fuel selection in vivo. Lack of MondoA results in enhanced exercise capacity with sprinting.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Imamura</LastName>
                    <ForeName>Minako</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Benny</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Kohjima</LastName>
                    <ForeName>Motoyuki</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Ming</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Hwang</LastName>
                    <ForeName>Byounghoon</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Taegtmeyer</LastName>
                    <ForeName>Heinrich</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Harris</LastName>
                    <ForeName>Robert A</ForeName>
                    <Initials>RA</Initials>
                </Author>
                <Author>
                    <LastName>Chan</LastName>
                    <ForeName>Lawrence</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biochem J</MedlineTA>
            <NlmUniqueID>2984726R</NlmUniqueID>
            <ISSNLinking>0264-6021</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">BJ20140530</ArticleId>
            <ArticleId IdType="doi">10.1042/BJ20140530</ArticleId>
            <ArticleId IdType="pubmed">25145386</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145384</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Isolation, identification, and purification of murine thymic epithelial cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51780</ELocationID>
            <Abstract>
                <AbstractText>The thymus is a vital organ for T lymphocyte development. Of thymic stromal cells, thymic epithelial cells (TECs) are particularly crucial at multiple stages of T cell development: T cell commitment, positive selection and negative selection. However, the function of TECs in the thymus remains incompletely understood. In the article, we provide a method to isolate TEC subsets from fresh mouse thymus using a combination of mechanical disruption and enzymatic digestion. The method allows thymic stromal cells and thymocytes to be efficiently released from cell-cell and cell-extracellular matrix connections and to form a single-cell suspension. Using the isolated cells, multiparameter flow cytometry can be applied to identification and characterization of TECs and dendritic cells. Because TECs are a rare cell population in the thymus, we also describe an effective way to enrich and purify TECs by depleting thymocytes, the most abundant cell type in the thymus. Following the enrichment, cell sorting time can be decreased so that loss of cell viability can be minimized during purification of TECs. Purified cells are suitable for various downstream analyses like Real Time-PCR, Western blot and gene expression profiling. The protocol will promote research of TEC function and as well as the development of in vitro T cell reconstitution.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Xing</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Laboratory Medicine &amp; Pathology, Center for Immunology, University of Minnesota; yanxx147@umn.edu.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hogquist</LastName>
                    <ForeName>Kristin A</ForeName>
                    <Initials>KA</Initials>
                    <Affiliation>Department of Laboratory Medicine &amp; Pathology, Center for Immunology, University of Minnesota.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>08</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51780</ArticleId>
            <ArticleId IdType="pubmed">25145384</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145360</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1748-7838</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell research</Title>
                <ISOAbbreviation>Cell Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Rbpj links uterine transformation and embryo orientation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/cr.2014.110</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Implantation involves complex signaling networks, which direct morphological and molecular transformation of the embryo and the uterus and establish the trajectory of normal pregnancy. The recent work by Zhang et al. published in Cell Research, identifies the transcriptional regulator, Rbpj, as essential for uterine closure and proper embryo alignment during implantation in the mouse, raising the possibility that aberrant Rbpj signaling could contribute to infertility in humans.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Robinson</LastName>
                    <ForeName>Joshua F</ForeName>
                    <Initials>JF</Initials>
                    <Affiliation>1] Center for Reproductive Sciences, San Francisco, CA 94143, USA [2] Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco, CA 94143, USA [3] The Eli &amp; Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, CA 94143, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fisher</LastName>
                    <ForeName>Susan J</ForeName>
                    <Initials>SJ</Initials>
                    <Affiliation>1] Center for Reproductive Sciences, San Francisco, CA 94143, USA [2] Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco, CA 94143, USA [3] The Eli &amp; Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, CA 94143, USA [4] Division of Maternal Fetal Medicine, San Francisco, CA 94143, USA [5] Department of Anatomy, San Francisco, CA 94143, USA [6] Human Embryonic Stem Cell Program, UCSF, San Francisco, CA 94143, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Res</MedlineTA>
            <NlmUniqueID>9425763</NlmUniqueID>
            <ISSNLinking>1001-0602</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cr2014110</ArticleId>
            <ArticleId IdType="doi">10.1038/cr.2014.110</ArticleId>
            <ArticleId IdType="pubmed">25145360</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145356</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1748-7838</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell research</Title>
                <ISOAbbreviation>Cell Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Blocking autocrine VEGF signaling by sunitinib, an anti-cancer drug, promotes embryonic stem cell self-renewal and somatic cell reprogramming.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/cr.2014.112</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Maintaining the self-renewal of embryonic stem cells (ESCs) could be achieved by activating the extrinsic signaling, i.e., the use of leukemia inhibitory factor (LIF), or blocking the intrinsic differentiation pathways, i.e., the use of GSK3 and MEK inhibitors (2i). Here we found that even in medium supplemented with LIF, mESCs still tend to differentiate toward meso-endoderm lineages after long-term culture and the culture spontaneously secretes vascular endothelial growth factors (VEGFs). Blocking VEGF signaling with sunitinib, an anti-cancer drug and a receptor tyrosine kinase (RTK) inhibitor mainly targeting VEGF receptors (VEGFRs), is capable of maintaining the mESCs in the undifferentiated state without the need for feeder cells or LIF. Sunitinib facilitates the derivation of mESCs from blastocysts, and the mESCs maintained in sunitinib-containing medium remain pluripotent and are able to contribute to chimeric mice. Sunitinib also promotes iPSC generation from MEFs with only Oct4. Knocking down VEGFR2 or blocking it with neutralizing antibody mimicks the effect of sunitinib, indicating that blocking VEGF/VEGFR signaling is indeed beneficial to the self-renewal of mESCs. We also found that hypoxia-inducible factor alpha (HIF1??) and endoplasmic reticulum (ER) stress are involved in the production of VEGF in mESCs. Blocking both pathways inhibits the expression of VEGF and prevents spontaneous differentiation of mESCs. Interestingly, LIF may also exert its effect by downregulating HIF1?? and ER stress pathways and subsequent VEGF expression. These results indicate the existence of an intrinsic differentiation pathway in mESCs by activating the autocrine VEGF signaling. Blocking VEGF signaling with sunitinib or other small molecules help to maintain the mESCs in the ground state of pluripotency.Cell Research advance online publication 22 August 2014; doi:10.1038/cr.2014.112.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Guofang</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>Xinxiu</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>1] CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China [2] Shanghai Key Laboratory of Signaling and Disease Research, Laboratory of Receptor-based Bio-medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Lihong</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fu</LastName>
                    <ForeName>Yanbin</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Shanghai Key Laboratory of Signaling and Disease Research, Laboratory of Receptor-based Bio-medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Min</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Haifeng</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xie</LastName>
                    <ForeName>Xin</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>1] CAS Key Laboratory of Receptor Research, the National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 189 Guo Shou Jing Road, Shanghai 201203, China [2] Shanghai Key Laboratory of Signaling and Disease Research, Laboratory of Receptor-based Bio-medicine, School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Res</MedlineTA>
            <NlmUniqueID>9425763</NlmUniqueID>
            <ISSNLinking>1001-0602</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cr2014112</ArticleId>
            <ArticleId IdType="doi">10.1038/cr.2014.112</ArticleId>
            <ArticleId IdType="pubmed">25145356</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145352</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Grail controls Th2 cell development by targeting STAT6 for degradation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4732</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5732</ELocationID>
            <Abstract>
                <AbstractText>T helper (Th)-2 cells are the major players in allergic asthma; however, the mechanisms that control Th2-mediated inflammation are poorly understood. Here we find that enhanced expression of Grail, an E3 ubiquitin ligase, in Th2 cells depends on interleukin (IL)-4-signalling components, signal transducer and activator of transcription 6 (Stat6) and Gata3, that bind to and transactivate the Grail promoter. Grail deficiency in T cells leads to increased expression of Th2 effector cytokines in vitro and in vivo and Grail-deficient mice are more susceptible to allergic asthma. Mechanistically, the enhanced effector function of Grail-deficient Th2 cells is mediated by increased expression of Stat6 and IL-4 receptor ??-chain. Grail interacts with Stat6 and targets it for ubiquitination and degradation. Thus, our results indicate that Grail plays a critical role in controlling Th2 development through a negative feedback loop.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sahoo</LastName>
                    <ForeName>Anupama</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alekseev</LastName>
                    <ForeName>Andrei</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Obertas</LastName>
                    <ForeName>Lidiya</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nurieva</LastName>
                    <ForeName>Roza</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Immunology, M. D. Anderson Cancer Center, Houston, Texas 77030, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>09</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5732</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5732</ArticleId>
            <ArticleId IdType="pubmed">25145352</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145341</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2958</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular microbiology</Title>
                <ISOAbbreviation>Mol. Microbiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dominant negative mutant of Plasmodium Rad51 causes reduced parasite burden in host by abrogating DNA double strand break repair.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/mmi.12762</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Malaria parasites survive through repairing a plethora of DNA double stranded breaks (DSBs) experienced during their asexual growth. In Plasmodium Rad51 mediated homologous recombination (HR) mechanism and homology independent alternative end-joining mechanism have been identified. Here we address whether loss of HR activity can be compensated by other DSB repair mechanisms. Creating a transgenic Plasmodium line defective in HR function, we demonstrate that HR is the most important DSB repair pathway in malarial parasite. Using mouse malaria model we have characterized the dominant negative effect of PfRad51(K143R) mutant on Plasmodium DSB repair and host-parasite interaction. Our work illustrates that Plasmodium berghei harboring the mutant protein (PfRad51(K143R) ) failed to repair DSBs as evidenced by hypersensitivity to DNA damaging agent. Mice infected with mutant parasites lived significantly longer with markedly reduced parasite burden. To better understand the effect of mutant PfRad51(K143R) on HR, we used yeast as a surrogate model and established that the presence of PfRad51(K143R) completely inhibited DNA repair, gene conversion and gene targeting. Biochemical experiment confirmed that very low level of mutant protein was sufficient for complete disruption of wild-type PfRad51 activity. Hence our work provides evidence that HR pathway of Plasmodium could be efficiently targeted to curb malaria.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Roy</LastName>
                    <ForeName>Nabamita</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Biochemistry, School of Life Sciences, University of Hyderabad, Gachibowli, Hyderabad 500046, Andhra Pradesh, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bhattacharyya</LastName>
                    <ForeName>Sunanda</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Chakrabarty</LastName>
                    <ForeName>Swati</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Laskar</LastName>
                    <ForeName>Shyamasree</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Babu</LastName>
                    <ForeName>Somepalli Mastan</ForeName>
                    <Initials>SM</Initials>
                </Author>
                <Author>
                    <LastName>Bhattacharyya</LastName>
                    <ForeName>Mrinal Kanti</ForeName>
                    <Initials>MK</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Microbiol</MedlineTA>
            <NlmUniqueID>8712028</NlmUniqueID>
            <ISSNLinking>0950-382X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">DNA double strand break repair</Keyword>
            <Keyword MajorTopicYN="N">Malaria</Keyword>
            <Keyword MajorTopicYN="N">Plasmodium</Keyword>
            <Keyword MajorTopicYN="N">dominant negative PfRad51 mutan</Keyword>
            <Keyword MajorTopicYN="N">homologous recombination</Keyword>
            <Keyword MajorTopicYN="N">transgenic parasite</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/mmi.12762</ArticleId>
            <ArticleId IdType="pubmed">25145341</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145340</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-Print">
            <Journal>
                <ISSN IssnType="Electronic">1758-0463</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>2014</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Database : the journal of biological databases and curation</Title>
                <ISOAbbreviation>Database (Oxford)</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mouse IDGenes: a reference database for genetic interactions in the developing mouse brain.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/database/bau083</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">bau083</ELocationID>
            <Abstract>
                <AbstractText>The study of developmental processes in the mouse and other vertebrates includes the understanding of patterning along the anterior-posterior, dorsal-ventral and medial-??lateral axis. Specifically, neural development is also of great clinical relevance because several human neuropsychiatric disorders such as schizophrenia, autism disorders or drug addiction and also brain malformations are thought to have neurodevelopmental origins, i.e. pathogenesis initiates during childhood and adolescence. Impacts during early neurodevelopment might also predispose to late-onset neurodegenerative disorders, such as Parkinson's disease. The neural tube develops from its precursor tissue, the neural plate, in a patterning process that is determined by compartmentalization into morphogenetic units, the action of local signaling centers and a well-defined and locally restricted expression of genes and their interactions. While public databases provide gene expression data with spatio-temporal resolution, they usually neglect the genetic interactions that govern neural development. Here, we introduce Mouse IDGenes, a reference database for genetic interactions in the developing mouse brain. The database is highly curated and offers detailed information about gene expressions and the genetic interactions at the developing mid-/hindbrain boundary. To showcase the predictive power of interaction data, we infer new Wnt/??-catenin target genes by machine learning and validate one of them experimentally. The database is updated regularly. Moreover, it can easily be extended by the research community. Mouse IDGenes will contribute as an important resource to the research on mouse brain development, not exclusively by offering data retrieval, but also by allowing data input. Database URL: http://mouseidgenes.helmholtz-muenchen.de.</AbstractText>
                <CopyrightInformation>?? The Author(s) 2014. Published by Oxford University Press.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Matthes</LastName>
                    <ForeName>Michaela</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-In</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Preusse</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-In</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Jingzhong</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schechter</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mayer</LastName>
                    <ForeName>Daniela</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lentes</LastName>
                    <ForeName>Bernd</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Theis</LastName>
                    <ForeName>Fabian</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-In</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prakash</LastName>
                    <ForeName>Nilima</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany dietrich.truembach@helmholtz-muenchen.de.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wurst</LastName>
                    <ForeName>Wolfgang</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-In</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tr??mbach</LastName>
                    <ForeName>Dietrich</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-Institute of Psychiatry, Kraepelinstr. 2-10, 80804 M??nchen, Germany, Deutsches Zentrum f??r Neurodegenerative Erkrankungen e. V. (DZNE), Standort M??nchen, Schillerstr. 44, 80336 M??nchen, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Entwicklungsgenetik, c/o Helmholtz Zentrum M??nchen, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany and Munich Cluster for Systems Neurology (SyNergy), Adolf-Butenandt-Institut, Ludwig-Maximilians-Universit??t M??nchen, Schillerstr. 44, 80336 M??nchen, Germany Institute of Developmental Genetics, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen-Weihenstephan, Lehrstuhl f??r Genetik, Emil-Ramannstr. 8, 85354 Freising, Germany, Institute of Diabetes and Regeneration Research, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Institute of Computational Biology, Helmholtz Zentrum M??nchen, German Research Center for Environmental Health, Ingolst??dter Landstr. 1, 85764 Neuherberg, Germany, Technische Universit??t M??nchen, Zentrum Mathematik, Boltzmannstr. 3, 85747 Garching, Germany, Max-Planck-In</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Database (Oxford)</MedlineTA>
            <NlmUniqueID>101517697</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ppublish">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">bau083</ArticleId>
            <ArticleId IdType="doi">10.1093/database/bau083</ArticleId>
            <ArticleId IdType="pubmed">25145340</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145330</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-9932</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>AAPS PharmSciTech</Title>
                <ISOAbbreviation>AAPS PharmSciTech</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Development and Characterization of siRNA Lipoplexes: Effect of Different Lipids, In Vitro Evaluation in Cancerous Cell Lines and In Vivo Toxicity Study.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Cationic liposomes have long been used as non-viral vectors for small interfering RNA (siRNA) delivery but are associated with high toxicity, less transfection efficiency, and in vivo instability. In this investigation, we have developed siRNA targeted to RRM1 that is responsible for development of resistance to gemcitabine in cancer cells. Effect of different lipid compositions has been evaluated on formation of stable and less toxic lipoplexes. Optimized cationic lipoplex (D2CH) system was comprised of dioleoyl-trimethylammoniumpropane (DOTAP), dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), hydrogenated soya phosphocholine (HSPC), cholesterol, and methoxy(polyethyleneglycol)2000-1,2-distearoyl-sn-glycero-3-phosphoethanolamine (mPEG2000-DSPE). D2CH lipoplexes have shown particle size (147.5????????2.89 nm) and zeta potential (12.26????????0.54 mV) characteristics essential for their in vivo use. In vitro cytotoxicity study has shown low toxicity of developed lipoplexes as compared with lipofectamine-2000 up to N/P ratio as high as 7.5. Cell uptake studies and gene expression studies have confirmed intracellular availability of siRNA. In addition, developed lipoplexes also showed ~3 times less hemolytic potential as compared with DOTAP/DOPE lipoplexes at lipid concentration of 5 mg/mL. Lipoplexes also maintained particle size less than 200 nm on exposure to high electrolyte concentration and showed &gt;70% siRNA retention in presence of serum showing siRNA protection conferred by lipoplexes. Furthermore, in vivo acute toxicity studies in mice showed that formulation was non-toxic up to a dosage of 0.75 mg of siRNA/kg as lipoplexes and 300 mg lipid/kg as blank liposomes indicating tolerability of lipoplexes at a dose much higher than required for therapeutic use. Promising results of this study warrant further investigation of developed siRNA lipoplexes for cancer treatment.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Khatri</LastName>
                    <ForeName>Nirav</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Pharmacy Department, The Maharaja Sayajirao University of Baroda, Kalabhavan, Vadodara, 390001, Gujarat, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Baradia</LastName>
                    <ForeName>Dipesh</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Vhora</LastName>
                    <ForeName>Imran</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Rathi</LastName>
                    <ForeName>Mohan</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Misra</LastName>
                    <ForeName>Ambikanandan</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>AAPS PharmSciTech</MedlineTA>
            <NlmUniqueID>100960111</NlmUniqueID>
            <ISSNLinking>1530-9932</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1208/s12249-014-0193-9</ArticleId>
            <ArticleId IdType="pubmed">25145330</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145327</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>90</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RNA Isolation from Mouse Pancreas: A Ribonuclease-rich Tissue.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51779</ELocationID>
            <Abstract>
                <AbstractText>Isolation of high-quality RNA from ribonuclease-rich tissue such as mouse pancreas presents a challenge. As a primary function of the pancreas is to aid in digestion, mouse pancreas may contain as much a 75 mg of ribonuclease. We report modifications of standard phenol/guanidine thiocyanate lysis reagent protocols to isolate RNA from mouse pancreas. Guanidine thiocyanate is a strong protein denaturant and will effectively disrupt the activity of ribonuclease under most conditions. However, critical modifications to standard protocols are necessary to successfully isolate RNA from ribonuclease-rich tissues. Key steps include a high lysis reagent to tissue ratio, removal of undigested tissue prior to phase separation and inclusion of a ribonuclease inhibitor to the RNA solution. Using these and other modifications, we routinely isolate RNA with RNA Integrity Number (RIN) greater than 7. The isolated RNA is of suitable quality for routine gene expression analysis. Adaptation of this protocol to isolate RNA from ribonuclease rich tissues besides the pancreas should be readily achievable.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Azevedo-Pouly</LastName>
                    <ForeName>Ana Clara P</ForeName>
                    <Initials>AC</Initials>
                    <Affiliation>Pharmaceutics &amp; Pharmaceutical Chemistry, The Ohio State University.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elgamal</LastName>
                    <ForeName>Ola A</ForeName>
                    <Initials>OA</Initials>
                    <Affiliation>Pharmaceutics &amp; Pharmaceutical Chemistry, The Ohio State University.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmittgen</LastName>
                    <ForeName>Thomas D</ForeName>
                    <Initials>TD</Initials>
                    <Affiliation>Pharmaceutics &amp; Pharmaceutical Chemistry, The Ohio State University; schmittgen.2@osu.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>02</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51779</ArticleId>
            <ArticleId IdType="pubmed">25145327</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25145316</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1940-087X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Issue>89</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of visualized experiments : JoVE</Title>
                <ISOAbbreviation>J Vis Exp</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Modeling stroke in mice: permanent coagulation of the distal middle cerebral artery.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3791/51729</ELocationID>
            <Abstract>
                <AbstractText>Stroke is the third most common cause of death and a main cause of acquired adult disability in developed countries. Only very limited therapeutical options are available for a small proportion of stroke patients in the acute phase. Current research is intensively searching for novel therapeutic strategies and is increasingly focusing on the sub-acute and chronic phase after stroke because more patients might be eligible for therapeutic interventions in a prolonged time window. These delayed mechanisms include important pathophysiological pathways such as post-stroke inflammation, angiogenesis, neuronal plasticity and regeneration. In order to analyze these mechanisms and to subsequently evaluate novel drug targets, experimental stroke models with clinical relevance, low mortality and high reproducibility are sought after. Moreover, mice are the smallest mammals in which a focal stroke lesion can be induced and for which a broad spectrum of transgenic models are available. Therefore, we describe here the mouse model of transcranial, permanent coagulation of the middle cerebral artery via electrocoagulation distal of the lenticulostriatal arteries, the so-called &quot;coagulation model&quot;. The resulting infarct in this model is located mainly in the cortex; the relative infarct volume in relation to brain size corresponds to the majority of human strokes. Moreover, the model fulfills the above-mentioned criteria of reproducibility and low mortality. In this video we demonstrate the surgical methods of stroke induction in the &quot;coagulation model&quot; and report histological and functional analysis tools.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Llovera</LastName>
                    <ForeName>Gemma</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Institute for Stroke and Dementia Research, University Hospital Munich; Munich Cluster for Systems Neurology (SyNergy).</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roth</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Institute for Stroke and Dementia Research, University Hospital Munich; Munich Cluster for Systems Neurology (SyNergy).</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Plesnila</LastName>
                    <ForeName>Nikolaus</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Institute for Stroke and Dementia Research, University Hospital Munich; Munich Cluster for Systems Neurology (SyNergy).</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Veltkamp</LastName>
                    <ForeName>Roland</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Neurology, University Heidelberg; Imperial College, Charing Cross Hospital.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liesz</LastName>
                    <ForeName>Arthur</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute for Stroke and Dementia Research, University Hospital Munich; Munich Cluster for Systems Neurology (SyNergy); Arthur.Liesz@med.uni-muenchen.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>31</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>J Vis Exp</MedlineTA>
            <NlmUniqueID>101313252</NlmUniqueID>
            <ISSNLinking>1940-087X</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3791/51729</ArticleId>
            <ArticleId IdType="pubmed">25145316</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25145286</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>22</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Myeloid-specific disruption of RBP-J ameliorates hepatic fibrosis by attenuating inflammation through cylindromatosis in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27394</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Macrophages play multi-dimensional roles in hepatic fibrosis, but their control has not been fully understood. Literatures have shown that the Notch pathway mediated by RBP-J, the transcription factor transactivated by signals from four mammalian Notch receptors, is implicated in macrophage activation and plasticity. In this study, by using mouse hepatic fibrosis models, we show that myeloid-specific disruption of RBP-J resulted in attenuated fibrosis. The activation of hepatic stellate cells and production of pro-fibrotic factors including PDGF-B and TGF-??1 reduced significantly in myeloid-specific RBP-J deficient mice. The infiltration of inflammatory cells and production of pro-inflammatory factors reduced in liver of myeloid-specific RBP-J deficient mice during fibrosis. In RBP-J deficient macrophages, the NF-??B activation was remarkably attenuated as compared with the control. This could be attributed to the upregulation of cylindromatosis (CYLD), a negative regulator of NF-??B, in Notch signal-compromised macrophages, because the knockdown of CYLD in RBP-J-deficient macrophages or overexpression of p65 in RBP-J knockdown cells both restored NF-??B activation and the production of pro-inflammatory and/or pro-fibrotic factors by macrophages. In human hepatic fibrosis biopsies, stronger Notch activation is correlated with more severe fibrosis, which is accompanied by lower level of CYLD but irrespective of etiological reasons. Conclusion: RBP-J-mediated Notch signaling is required for macrophages to promote hepatic fibrosis by up-regulation of NF-??B activation through CYLD. (Hepatology 2014).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>He</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Hepatic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Feng-Cheng</ForeName>
                    <Initials>FC</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Zhi</ForeName>
                    <Initials>Z</Initials>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Heng-Chao</ForeName>
                    <Initials>HC</Initials>
                </Author>
                <Author>
                    <LastName>Ma</LastName>
                    <ForeName>Peng-Fei</ForeName>
                    <Initials>PF</Initials>
                </Author>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Jun-Long</ForeName>
                    <Initials>JL</Initials>
                </Author>
                <Author>
                    <LastName>Feng</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Wei-Na</ForeName>
                    <Initials>WN</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Xiao-Wei</ForeName>
                    <Initials>XW</Initials>
                </Author>
                <Author>
                    <LastName>Qin</LastName>
                    <ForeName>Hong-Yan</ForeName>
                    <Initials>HY</Initials>
                </Author>
                <Author>
                    <LastName>Dou</LastName>
                    <ForeName>Ke-Feng</ForeName>
                    <Initials>KF</Initials>
                </Author>
                <Author>
                    <LastName>Han</LastName>
                    <ForeName>Hua</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CYLD</Keyword>
            <Keyword MajorTopicYN="N">NF-??B</Keyword>
            <Keyword MajorTopicYN="N">Notch/RBP-J</Keyword>
            <Keyword MajorTopicYN="N">hepatic fibrosis</Keyword>
            <Keyword MajorTopicYN="N">macrophage</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27394</ArticleId>
            <ArticleId IdType="pubmed">25145286</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25143705</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1089-988X</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>26</Volume>
                    <Issue>2</Issue>
                    <PubDate>
                        <Year>2012</Year>
                        <Month>Oct</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Gravitational and space biology bulletin : publication of the American Society for Gravitational and Space Biology</Title>
                <ISOAbbreviation>Gravit Space Biol Bull</ISOAbbreviation>
            </Journal>
            <ArticleTitle>For Application to Human Spaceflight and ISS Experiments: VESGEN Mapping of Microvascular Network Remodeling during Intestinal Inflammation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2-12</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Challenges to long-duration space exploration and colonization in microgravity and cosmic radiation environments by humans include poorly understood risks for gastrointestinal function and cancer. Nonetheless, constant remodeling of the intestinal microvasculature is critical for tissue viability, healthy wound healing, and successful prevention or recovery from vascular-mediated inflammatory or ischemic diseases such as cancer. Currently no automated image analysis programs provide quantitative assessments of the complex structure of the mucosal vascular system that are necessary for tracking disease development and tissue recovery. Increasing abnormalities to the microvascular network geometry were therefore mapped with VESsel GENeration Analysis (VESGEN) software from 3D tissue reconstructions of developing intestinal inflammation in a dextran sulfate sodium (DSS) mouse model. By several VESGEN parameters and a novel vascular network linking analysis, inflammation strongly disrupted the regular, lattice-like geometry that defines the normal microvascular network, correlating positively with the increased recruitment of dendritic cells during mucosal defense responses.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Parsons-Wingerter</LastName>
                    <ForeName>Patricia</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Research &amp; Technology Directorate, John H. Glenn Research Center, National Aeronautics and Space Administration, Cleveland, OH 44135.</Affiliation>
                </Author>
                <Author>
                    <LastName>Reinecker</LastName>
                    <ForeName>Hans-Christian</ForeName>
                    <Initials>HC</Initials>
                    <Affiliation>Department of Medicine, Division of Gastroenterology and Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital and Harvard Medical School, GRJ R708, Fruit Street, Boston, MA 02114.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Gravit Space Biol Bull</MedlineTA>
            <NlmUniqueID>9816128</NlmUniqueID>
            <ISSNLinking>1089-988X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Avascular Space</Keyword>
            <Keyword MajorTopicYN="N">Crohn???s Disease (CD)</Keyword>
            <Keyword MajorTopicYN="N">Dendritic Cell</Keyword>
            <Keyword MajorTopicYN="N">Gastrointestinal (GI)</Keyword>
            <Keyword MajorTopicYN="N">Inflammatory Bowel Disease (IBD)</Keyword>
            <Keyword MajorTopicYN="N">Ulcerative Colitis</Keyword>
            <Keyword MajorTopicYN="N">VESsel GENeration Analysis</Keyword>
            <Keyword MajorTopicYN="N">Vascular Connectivity</Keyword>
            <Keyword MajorTopicYN="N">Vascular Lattice</Keyword>
            <Keyword MajorTopicYN="N">Vascular Network</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2012</Year>
                <Month>10</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25143705</ArticleId>
        </ArticleIdList>
        <?nihms?>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25142640</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0931-0509</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>5 Suppl 1</Volume>
                    <PubDate>
                        <Year>1989</Year>
                        <Month>Apr</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association</Title>
                <ISOAbbreviation>Nephrol. Dial. Transplant.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The role of cationic proteins in the pathogenesis of immune complex glomerulonephritis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>6-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1093/ndt/5.suppl_1.6</ELocationID>
            <Abstract>
                <AbstractText>In spite of intensive endeavours, attempts to identify nephritogenic antigens in cases of immune complex glomerulonephritis have not yielded convincing results. Cationic antigens can have high affinity for the glomerular basement membrane and are prime candidates as nephritogens. They can be expected to play a role in post-infectious and in autoimmune glomerular disease. Histones show great promise in the latter case: we are able to demonstrate (1) a high affinity for the glomerular basement membrane and (2) their ability to promote glomerular deposition of anionic antigens as an additional target. Histones were detectable in glomerular deposits in two murine models of glomerulonephritis: the spontaneous lupus-like disease of NZB/W Fl mice and in graft-versus-host disease. We propose that histones may be responsible for the induction of glomerulonephritis in lupus-like syndromes, as well as other types of autoimmune renal disease. As an analogue, histone-like proteins from micro-organisms may also be responsible for glomerular disease in post-infectious nephritis.</AbstractText>
                <CopyrightInformation>?? 1990 European Renal Association ??? European Dialysis and Transplant Assoc.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Vogt</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Immunology, Institute of Microbiology, University of Freiburg, Freiburg, FRG.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schmiedeke</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Immunology, Institute of Microbiology, University of Freiburg, Freiburg, FRG.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>St??ckl</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Immunology, Institute of Microbiology, University of Freiburg, Freiburg, FRG.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sugisaki</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Immunology, Institute of Microbiology, University of Freiburg, Freiburg, FRG.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mertz</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Immunology, Institute of Microbiology, University of Freiburg, Freiburg, FRG.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Batsford</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Immunology, Institute of Microbiology, University of Freiburg, Freiburg, FRG.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nephrol Dial Transplant</MedlineTA>
            <NlmUniqueID>8706402</NlmUniqueID>
            <ISSNLinking>0931-0509</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cationic antigen</Keyword>
            <Keyword MajorTopicYN="N">DNA</Keyword>
            <Keyword MajorTopicYN="N">Glomerulonephritis</Keyword>
            <Keyword MajorTopicYN="N">Histone</Keyword>
            <Keyword MajorTopicYN="N">Immune complex</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>1989</Year>
                <Month>4</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>1989</Year>
                <Month>4</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">5.suppl_1.6</ArticleId>
            <ArticleId IdType="doi">10.1093/ndt/5.suppl_1.6</ArticleId>
            <ArticleId IdType="pubmed">25142640</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25142008</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCompleted>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">2040-1744</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>1</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of developmental origins of health and disease</Title>
                <ISOAbbreviation>J Dev Orig Health Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effect of a low-protein diet during pregnancy on expression of genes involved in cardiac hypertrophy in fetal and adult mouse offspring.</ArticleTitle>
            <Pagination>
                <MedlinePgn>371-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1017/S2040174410000541</ELocationID>
            <Abstract>
                <AbstractText>Gene markers for cardiomyocyte growth, proliferation and remodeling were examined in mouse fetuses and adult male offspring exposed to maternal low-protein (LP) diet during pregnancy. Whole heart volume, measured by magnetic resonance imaging, was smaller in day 15 LP fetuses v. those from chow-fed dams (C), whereas heart volume was greater in adult LP v. C offspring. These LP offspring were hypertensive and had larger cardiomyocytes v. C animals. The mRNA levels of cyclin G1, a marker for cell growth, were lower in LP fetal hearts v. C hearts, but similar in the left ventricle of adult LP and C offspring. Opposite trends were found in brain natriuretic peptide levels (a marker of cardiac hypertrophy). Thus, maternal LP during pregnancy results in smaller fetal hearts and is accompanied by changes in expression of genes involved in cardiomyocyte growth, which are associated with cardiac hypertrophy and hypertension in adulthood.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Asopa</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1Developmental Origins of Health and Disease Division, Institute of Developmental Sciences, University of Southampton School of Medicine, Southampton General Hospital, Southampton, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cagampang</LastName>
                    <ForeName>F R</ForeName>
                    <Initials>FR</Initials>
                    <Affiliation>1Developmental Origins of Health and Disease Division, Institute of Developmental Sciences, University of Southampton School of Medicine, Southampton General Hospital, Southampton, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Anthony</LastName>
                    <ForeName>F W</ForeName>
                    <Initials>FW</Initials>
                    <Affiliation>1Developmental Origins of Health and Disease Division, Institute of Developmental Sciences, University of Southampton School of Medicine, Southampton General Hospital, Southampton, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lanham</LastName>
                    <ForeName>S A</ForeName>
                    <Initials>SA</Initials>
                    <Affiliation>1Developmental Origins of Health and Disease Division, Institute of Developmental Sciences, University of Southampton School of Medicine, Southampton General Hospital, Southampton, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schneider</LastName>
                    <ForeName>J E</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>3Department of Cardiovascular Medicine, British Heart Foundation Molecular Cardiology Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ohri</LastName>
                    <ForeName>S K</ForeName>
                    <Initials>SK</Initials>
                    <Affiliation>2Wessex Cardiothoracic Centre, Southampton General Hospital, Southampton, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hanson</LastName>
                    <ForeName>M A</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>1Developmental Origins of Health and Disease Division, Institute of Developmental Sciences, University of Southampton School of Medicine, Southampton General Hospital, Southampton, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Dev Orig Health Dis</MedlineTA>
            <NlmUniqueID>101517692</NlmUniqueID>
            <ISSNLinking>2040-1744</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>12</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>12</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2040174410000541</ArticleId>
            <ArticleId IdType="doi">10.1017/S2040174410000541</ArticleId>
            <ArticleId IdType="pubmed">25142008</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
        <PMID Version="1">25141786</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>21</Day>
        </DateCreated>
        <DateCompleted>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCompleted>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">2040-1744</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>1</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2010</Year>
                        <Month>Jun</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of developmental origins of health and disease</Title>
                <ISOAbbreviation>J Dev Orig Health Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Altered hepatic insulin signalling in male offspring of obese mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>184-91</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1017/S2040174410000231</ELocationID>
            <Abstract>
                <AbstractText>Individuals exposed in utero to maternal obesity have increased risk of developing type 2 diabetes mellitus and obesity in adulthood. The molecular mechanisms underlying this association are unknown. We have therefore used a murine model of maternal obesity, in which the offspring of obese dams develop hyperinsulinaemia by 3 months of age indicative of insulin resistance. Here, we investigate the effects of maternal diet-induced obesity on the expression/phosphorylation of key hepatic insulin signalling proteins and the expression of anti-oxidant enzymes in male offspring. At 3 months of age, offspring of obese dams had decreased levels of insulin receptor substrate (IRS) 1 (P &lt; 0.01), whereas the ratio of phosphorylated IRS1 Ser307 to total IRS1 was significantly increased (P &lt; 0.001), suggesting that it was less active. Protein expression of the PI3K p85?? subunit was decreased (P &lt; 0.01) and there was a tendency for phosphorylation of Akt at Ser473 to be reduced (P = 0.08) in the offspring of obese dams. protein kinase C?? (P &lt; 0.001) and glycogen synthase kinase 3?? (P &lt; 0.05) levels were increased in these animals in comparison with controls. Maternal obesity also resulted in increased phosphorylation of p38 mitogen-activated protein kinase at Thr180/Tyr182 (P &lt; 0.01) and raised c-Jun N-terminal kinase 1 expression (P &lt; 0.5) in the offspring. The expression of antioxidant enzymes was also affected by maternal obesity with CuZnSOD (P &lt; 0.001) and glutathione reductase (P &lt; 0.05) being increased, whereas glutathione peroxidase 1 was reduced (P &lt; 0.05) in the offspring. We conclude that maternal obesity leads to alterations in hepatic insulin signalling protein expression and phosphorylation. These molecular changes may contribute to the development of insulin resistance.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Martin-Gronert</LastName>
                    <ForeName>M S</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>1Addenbrooke's Hospital, Institute of Metabolic Science, University of Cambridge Metabolic Research Laboratories, Cambridge, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fernandez-Twinn</LastName>
                    <ForeName>D S</ForeName>
                    <Initials>DS</Initials>
                    <Affiliation>1Addenbrooke's Hospital, Institute of Metabolic Science, University of Cambridge Metabolic Research Laboratories, Cambridge, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Poston</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>2Division of Reproduction and Endocrinology, St Thomas's Hospital, King's College London, London, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ozanne</LastName>
                    <ForeName>S E</ForeName>
                    <Initials>SE</Initials>
                    <Affiliation>1Addenbrooke's Hospital, Institute of Metabolic Science, University of Cambridge Metabolic Research Laboratories, Cambridge, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>J Dev Orig Health Dis</MedlineTA>
            <NlmUniqueID>101517692</NlmUniqueID>
            <ISSNLinking>2040-1744</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2010</Year>
                <Month>6</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2010</Year>
                <Month>6</Month>
                <Day>1</Day>
                <Hour>0</Hour>
                <Minute>1</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2040174410000231</ArticleId>
            <ArticleId IdType="doi">10.1017/S2040174410000231</ArticleId>
            <ArticleId IdType="pubmed">25141786</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144937</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2050-084X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>eLife</Title>
                <ISOAbbreviation>Elife</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Ribosomal protein S27-like is a physiological regulator of p53 that suppresses genomic instability and tumorigenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e02236</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi">10.7554/eLife.02236</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Cell-based studies showed that several Mdm2-binding ribosomal proteins, upon overexpression, stabilize and activate p53. In contrast, here we show in a mouse knockout study that Mdm2-binding ribosomal protein S27-like (Rps27l), upon disruption, activates p53. Germline inactivation of Rps27l triggers ribosomal stress to stabilize Mdm2, which degrades Mdm4 to reduce Mdm2-Mdm4 E3 ligase towards p53, leading to p53-dependent apoptotic depletion of hematopoietic stem cells and postnatal death, which is rescued by Trp53 deletion. Paradoxically, while increased p53 is expected to inhibit tumorigenesis, Rps27l(-/-);Trp53(+/-) mice develop lymphomas at higher incidence with p53 loss-of-heterozygosity and severe genome aneuploidy, suggesting that Rps27l disruption impose a selection pressure against p53. Thus, Rps27l has dual functions in p53 regulation: under Trp53(+/+) background, Rps27l disruption triggers ribosomal stress to induce p53 and apoptosis, whereas under Trp53(+/-) background, Rps27l disruption triggers genomic instability and Trp53 deletion to promote tumorigenesis. Our study provides a new paradigm of p53 regulation.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014, Xiong et al.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Xiong</LastName>
                    <ForeName>Xiufang</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Yongchao</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tang</LastName>
                    <ForeName>Fei</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wei</LastName>
                    <ForeName>Dongping</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Thomas</LastName>
                    <ForeName>Daffyd</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Pathology, University of Michigan Medical School and Comprehensive Cancer Center, Ann Arbor, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Xiang</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zheng</LastName>
                    <ForeName>Pan</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Center for Cancer and Immunology Research, Children's National Medical center, Washington, DC, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Radiation and Cancer Biology, Department of Radiation Oncology, University of Michigan, Ann Arbor, United Statessunyi@umich.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Elife</MedlineTA>
            <NlmUniqueID>101579614</NlmUniqueID>
            <ISSNLinking>2050-084X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Human</Keyword>
            <Keyword MajorTopicYN="N">Mouse</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.02236</ArticleId>
            <ArticleId IdType="pubmed">25144937</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144922</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1945-7170</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Endocrinology</Title>
                <ISOAbbreviation>Endocrinology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Leptin resistance is not the primary cause of weight gain associated with reduced sex hormone levels in female mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>en20141276</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Several studies have shown that estrogens mimic leptin's effects on energy balance regulation. However, the findings regarding the consequences of reduced sex hormone levels on leptin sensitivity are divergent. In the present study, we employed different experimental paradigms to elucidate the interaction between estrogens, leptin and energy balance regulation. We confirmed previous reports showing that ovariectomy caused a reduction in locomotor activity and energy expenditure leading mice to obesity and glucose intolerance. However, the acute and chronic anorexigenic effects of leptin were preserved in ovariectomized (OVX) mice despite their increased serum leptin levels. We studied hypothalamic gene expression at different time points after ovariectomy and observed that changes in the expression of genes involved in leptin resistance (suppressors of cytokine signaling and protein-tyrosine phosphatases) did not precede the early onset of obesity in OVX mice. On the contrary, reduced sex hormone levels caused an up-regulation of the long form of the leptin receptor (LepR), resulting in increased activation of leptin signaling pathways in OVX leptin-treated animals. The up-regulation of the LepR was observed in long-term OVX mice (30 days or 24 weeks after ovariectomy), but not 7 days after the surgery. In addition, we observed a progressive decrease in the co-expression of LepR and estrogen receptor-?? in the hypothalamus after the ovariectomy resulting in a low percentage of dual-labeled cells in OVX mice. Taken together, our findings suggest that the weight gain caused by reduced sex hormone levels is not primarily caused by induction of a leptin resistance state.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>da Silva</LastName>
                    <ForeName>Regina P</ForeName>
                    <Initials>RP</Initials>
                    <Affiliation>Department of Anatomy, Institute of Biomedical Sciences, University of S??o Paulo, S??o Paulo, SP, Brazil.;</Affiliation>
                </Author>
                <Author>
                    <LastName>Zampieri</LastName>
                    <ForeName>Thais T</ForeName>
                    <Initials>TT</Initials>
                </Author>
                <Author>
                    <LastName>Pedroso</LastName>
                    <ForeName>Jo??o A B</ForeName>
                    <Initials>JA</Initials>
                </Author>
                <Author>
                    <LastName>Nagaishi</LastName>
                    <ForeName>Vanessa S</ForeName>
                    <Initials>VS</Initials>
                </Author>
                <Author>
                    <LastName>Ramos-Lobo</LastName>
                    <ForeName>Angela M</ForeName>
                    <Initials>AM</Initials>
                </Author>
                <Author>
                    <LastName>Furigo</LastName>
                    <ForeName>Isadora C</ForeName>
                    <Initials>IC</Initials>
                </Author>
                <Author>
                    <LastName>C??mara</LastName>
                    <ForeName>Niels O</ForeName>
                    <Initials>NO</Initials>
                </Author>
                <Author>
                    <LastName>Fraz??o</LastName>
                    <ForeName>Renata</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Donato</LastName>
                    <ForeName>Jose</ForeName>
                    <Initials>J</Initials>
                    <Suffix>Jr</Suffix>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Endocrinology</MedlineTA>
            <NlmUniqueID>0375040</NlmUniqueID>
            <ISSNLinking>0013-7227</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1210/en.2014-1276</ArticleId>
            <ArticleId IdType="pubmed">25144922</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144871</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1097-4199</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>83</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuron</Title>
                <ISOAbbreviation>Neuron</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Measuring the functional organization of the neocortex at large and small scales.</ArticleTitle>
            <Pagination>
                <MedlinePgn>756-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neuron.2014.08.008</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0896-6273(14)00683-7</ELocationID>
            <Abstract>
                <AbstractText>Sensory cortices are commonly structured topographically; however, the extent to which this organization principle is preserved at the microcircuit level is debated. In this issue of Neuron, Issa et??al. (2014) revisit this question by combining calcium imaging in awake mice at large scales encompassing the whole auditory cortex and small scales providing single-cell resolution.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Aschauer</LastName>
                    <ForeName>Dominik F</ForeName>
                    <Initials>DF</Initials>
                    <Affiliation>Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), 1030 Vienna, Austria.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rumpel</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), 1030 Vienna, Austria. Electronic address: rumpel@imp.ac.at.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Neuron</MedlineTA>
            <NlmUniqueID>8809320</NlmUniqueID>
            <ISSNLinking>0896-6273</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0896-6273(14)00683-7</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuron.2014.08.008</ArticleId>
            <ArticleId IdType="pubmed">25144871</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144860</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2168-619X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>JAMA otolaryngology-- head &amp; neck surgery</Title>
                <ISOAbbreviation>JAMA Otolaryngol Head Neck Surg</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An In Situ, In Vivo Murine Model for the Study of Laryngotracheal Stenosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1001/jamaoto.2014.1663</ELocationID>
            <Abstract>
                <AbstractText Label="Importance" NlmCategory="UNASSIGNED">Laryngotracheal stenosis (LTS) lacks an ideal animal model to study its unique wound-healing pathophysiology and the effect of interventions.</AbstractText>
                <AbstractText Label="Objective" NlmCategory="UNASSIGNED">To present an in vivo, in situ mouse model of LTS that can be used to investigate its pathophysiology, mechanisms, and interventions for treatment.</AbstractText>
                <AbstractText Label="Design, Setting, and Subjects" NlmCategory="UNASSIGNED">Prospective controlled animal study performed at an academic animal research facility on 87 C57BL/6 mice.</AbstractText>
                <AbstractText Label="Interventions" NlmCategory="UNASSIGNED">Experimental mice (n???=???40) underwent bleomycin-coated wire-brush injury to the larynx and trachea, while mechanical injury controls (n???=???32) underwent phosphate-buffered saline-coated wire-brush injury. Normal controls (n???=???9) underwent no intervention, and mock surgery controls (n???=???6) underwent anterior transcervical tracheal exposure only. Laryngotracheal complexes were harvested at days 7, 14, and 21 after injury. At the respective time points, mice in the chemomechanical and mechanical injury groups were killed, and their laryngotracheal complexes were harvested for histologic analysis. Normal and mock surgery controls were killed and then underwent histologic analysis.</AbstractText>
                <AbstractText Label="Main Outcomes and Measures" NlmCategory="UNASSIGNED">The primary outcome measure was lamina propria thickness.</AbstractText>
                <AbstractText Label="Results" NlmCategory="UNASSIGNED">The chemomechanical injury group maintained a significant increase in lamina propria thickness through day 21 compared with uninjured controls at day 7 (82.7 vs 41.8 ??m; P&lt;.05), day 14 (93.5 vs 26.0 ??m; P&lt;.05), and day 21 (91.2 vs 40.8 ??m; P&lt;.05). Compared with the mechanical injury group, the chemomechanical injury group demonstrated a significantly increased thickness at 21 days (91.2 vs 33.7 ??m; P&lt;.05).</AbstractText>
                <AbstractText Label="Conclusions and Relevance" NlmCategory="UNASSIGNED">Chemomechanical initiation of fibrosis in situ creates a viable mouse model of LTS that incorporates the physiologic circulatory supply and airflow. This small-animal model may be used to investigate the pathogenesis and inflammatory mechanisms of iatrogenic LTS and test therapeutic interventions to reverse or reduce the development of fibrosis.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hillel</LastName>
                    <ForeName>Alexander T</ForeName>
                    <Initials>AT</Initials>
                    <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Namba</LastName>
                    <ForeName>Daryan</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ding</LastName>
                    <ForeName>Dacheng</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pandian</LastName>
                    <ForeName>Vinciya</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Elisseeff</LastName>
                    <ForeName>Jennifer H</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Horton</LastName>
                    <ForeName>Maureen R</ForeName>
                    <Initials>MR</Initials>
                    <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>JAMA Otolaryngol Head Neck Surg</MedlineTA>
            <NlmUniqueID>101589542</NlmUniqueID>
            <ISSNLinking>2168-6181</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1897400</ArticleId>
            <ArticleId IdType="doi">10.1001/jamaoto.2014.1663</ArticleId>
            <ArticleId IdType="pubmed">25144860</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144854</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-4812</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Bioconjugate chemistry</Title>
                <ISOAbbreviation>Bioconjug. Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Impact of Multiple Negative Charges on Blood Clearance and Biodistribution Characteristics of (99m)Tc-Labeled Dimeric Cyclic RGD Peptides.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">This study sought to evaluate the impact of multiple negative charges on blood clearance kinetics and biodistribution properties of (99m)Tc-labeled RGD peptide dimers. Bioconjugates HYNIC-P6G-RGD2 and HYNIC-P6D-RGD2 were prepared by reacting P6G-RGD2 and P6D-RGD2, respectively, with excess HYNIC-OSu in the presence of diisopropylethylamine. Their IC50 values were determined to be 31 ?? 5 and 41 ?? 6 nM, respectively, against (125)I-echistatin bound to U87MG glioma cells in a whole-cell displacement assay. Complexes [(99m)Tc(HYNIC-P6G-RGD2)(tricine)(TPPTS)] ((99m)Tc-P6G-RGD2) and [(99m)Tc(HYNIC-P6D-RGD2)(tricine)(TPPTS)] ((99m)Tc-P6D-RGD2) were prepared in high radiochemical purity (RCP &gt; 95%) and specific activity (37-110 GBq/??mol). They were evaluated in athymic nude mice bearing U87MG glioma xenografts for their biodistribution. The most significant difference between (99m)Tc-P6D-RGD2 and (99m)Tc-P6G-RGD2 was their blood radioactivity levels and tumor uptake. The initial blood radioactivity level for (99m)Tc-P6D-RGD2 (4.71 ?? 1.00%ID/g) was ???5?? higher than that of (99m)Tc-P6G-RGD2 (0.88 ?? 0.05%ID/g), but this difference disappeared at 60 min p.i. (99m)Tc-P6D-RGD2 had much lower tumor uptake (2.20-3.11%ID/g) than (99m)Tc-P6G-RGD2 (7.82-9.27%ID/g) over a 2 h period. Since HYNIC-P6D-RGD2 and HYNIC-P6G-RGD2 shared a similar integrin ??v??3 binding affinity (41 ?? 6 nM versus 31 ?? 5 nM), the difference in their blood activity and tumor uptake is most likely related to the nine negative charges and high protein binding of (99m)Tc-P6D-RGD2. Despite its low uptake in U87MG tumors, the tumor uptake of (99m)Tc-P6D-RGD2 was integrin ??v??3-specific. SPECT/CT studies were performed using (99m)Tc-P6G-RGD2 in athymic nude mice bearing U87MG glioma and MDA-MB-231 breast cancer xenografts. The SPECT/CT data demonstrated the tumor-targeting capability of (99m)Tc-P6G-RGD2, and its tumor uptake depends on the integrin ??v??3 expression levels on tumor cells and neovasculature. It was concluded that the multiple negative charges have a significant impact on the blood clearance kinetics and tumor uptake of (99m)Tc-labeled dimeric cyclic RGD peptides.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Yong</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>School of Health Sciences, Purdue University , 550 Stadium Mall Drive, West Lafayette, Indiana 47907, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ji</LastName>
                    <ForeName>Shundong</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Shuang</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Bioconjug Chem</MedlineTA>
            <NlmUniqueID>9010319</NlmUniqueID>
            <ISSNLinking>1043-1802</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/bc500309r</ArticleId>
            <ArticleId IdType="pubmed">25144854</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144834</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-1723</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Nature communications</Title>
                <ISOAbbreviation>Nat Commun</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Enhanced synapse remodelling as a common phenotype in mouse models of autism.</ArticleTitle>
            <Pagination>
                <MedlinePgn>4742</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/ncomms5742</ELocationID>
            <Abstract>
                <AbstractText>Developmental deficits in neuronal connectivity are considered to be present in patients with autism spectrum disorders (ASDs). Here we examine this possibility by using in vivo spine imaging in the early postnatal cortex of ASD mouse models. Spines are classified by the presence of either the excitatory postsynaptic marker PSD-95 or the inhibitory postsynaptic marker gephyrin. ASD mouse models show consistent upregulation in the dynamics of PSD-95-positive spines, which may subsequently contribute to stable synaptic connectivity. In contrast, spines receiving inputs from the thalamus, detected by the presence of gephyrin clusters, are larger, highly stable and unaffected in ASD mouse models. Importantly, two distinct mouse models, human 15q11-13 duplication and neuroligin-3 R451C point mutation, show highly similar phenotypes in spine dynamics. This selective impairment in dynamics of PSD-95-positive spines receiving intracortical projections may be a core component of early pathological changes and be a potential target of early intervention.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Isshiki</LastName>
                    <ForeName>Masaaki</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>1] Department of Cellular Neurobiology, Graduate School of Medicine, the University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan [2].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tanaka</LastName>
                    <ForeName>Shinji</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1] Department of Cellular Neurobiology, Graduate School of Medicine, the University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan [2].</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuriu</LastName>
                    <ForeName>Toshihiko</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Neurophysiology, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, Kagawa 769-2193, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tabuchi</LastName>
                    <ForeName>Katsuhiko</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>1] Department of Molecular and Cellular Physiology, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan [2] PRESTO, Japan Science and Technology Agency (JST), 4-1-8 Honcho Kawaguchi, Saitama 332-0012, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Takumi</LastName>
                    <ForeName>Toru</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>1] RIKEN Brain Science Institute, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan [2] CREST, Japan Science and Technology Agency (JST), 4-1-8 Honcho Kawaguchi, Saitama 332-0012, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Okabe</LastName>
                    <ForeName>Shigeo</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Cellular Neurobiology, Graduate School of Medicine, the University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Nat Commun</MedlineTA>
            <NlmUniqueID>101528555</NlmUniqueID>
            <ISSNLinking>2041-1723</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">ncomms5742</ArticleId>
            <ArticleId IdType="doi">10.1038/ncomms5742</ArticleId>
            <ArticleId IdType="pubmed">25144834</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144771</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1935-2735</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS neglected tropical diseases</Title>
                <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Immunization with Hexon Modified Adenoviral Vectors Integrated with gp83 Epitope Provides Protection against Trypanosoma cruzi Infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e3089</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0003089</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Trypanosoma cruzi is the causative agent of Chagas disease. Chagas disease is an endemic infection that affects over 8 million people throughout Latin America and now has become a global challenge. The current pharmacological treatment of patients is unsuccessful in most cases, highly toxic, and no vaccines are available. The results of inadequate treatment could lead to heart failure resulting in death. Therefore, a vaccine that elicits neutralizing antibodies mediated by cell-mediated immune responses and protection against Chagas disease is necessary.</AbstractText>
                <AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">The &quot;antigen capsid-incorporation&quot; strategy is based upon the display of the T. cruzi epitope as an integral component of the adenovirus' capsid rather than an encoded transgene. This strategy is predicted to induce a robust humoral immune response to the presented antigen, similar to the response provoked by native Ad capsid proteins. The antigen chosen was T. cruzi gp83, a ligand that is used by T. cruzi to attach to host cells to initiate infection. The gp83 epitope, recognized by the neutralizing MAb 4A4, along with His6 were incorporated into the Ad serotype 5 (Ad5) vector to generate the vector Ad5-HVR1-gp83-18 (Ad5-gp83). This vector was evaluated by molecular and immunological analyses. Vectors were injected to elicit immune responses against gp83 in mouse models. Our findings indicate that mice immunized with the vector Ad5-gp83 and challenged with a lethal dose of T. cruzi trypomastigotes confer strong immunoprotection with significant reduction in parasitemia levels, increased survival rate and induction of neutralizing antibodies.</AbstractText>
                <AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">This data demonstrates that immunization with adenovirus containing capsid-incorporated T. cruzi antigen elicits a significant anti-gp83-specific response in two different mouse models, and protection against T. cruzi infection by eliciting neutralizing antibodies mediated by cell-mediated immune responses, as evidenced by the production of several Ig isotypes. Taken together, these novel results show that the recombinant Ad5 presenting T. cruzi gp83 antigen is a useful candidate for the development of a vaccine against Chagas disease.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Farrow</LastName>
                    <ForeName>Anitra L</ForeName>
                    <Initials>AL</Initials>
                    <Affiliation>Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rachakonda</LastName>
                    <ForeName>Girish</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, Tennessee, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gu</LastName>
                    <ForeName>Linlin</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krendelchtchikova</LastName>
                    <ForeName>Valentina</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nde</LastName>
                    <ForeName>Pius N</ForeName>
                    <Initials>PN</Initials>
                    <Affiliation>Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, Tennessee, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pratap</LastName>
                    <ForeName>Siddharth</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, Tennessee, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lima</LastName>
                    <ForeName>Maria F</ForeName>
                    <Initials>MF</Initials>
                    <Affiliation>Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, Tennessee, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Villalta</LastName>
                    <ForeName>Fernando</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Microbiology and Immunology, School of Medicine, Meharry Medical College, Nashville, Tennessee, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matthews</LastName>
                    <ForeName>Qiana L</ForeName>
                    <Initials>QL</Initials>
                    <Affiliation>Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Center for AIDS Research, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
            <NlmUniqueID>101291488</NlmUniqueID>
            <ISSNLinking>1935-2727</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0003089</ArticleId>
            <ArticleId IdType="pii">PNTD-D-14-00763</ArticleId>
            <ArticleId IdType="pubmed">25144771</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144769</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The N-Reductive System Composed of Mitochondrial Amidoxime Reducing Component (mARC), Cytochrome b5 (CYB5B) and Cytochrome b5 Reductase (CYB5R) Is Regulated by Fasting and High Fat Diet in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105371</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105371</ELocationID>
            <Abstract>
                <AbstractText>The mitochondrial amidoxime reducing component mARC is the fourth mammalian molybdenum enzyme. The protein is capable of reducing N-oxygenated structures, but requires cytochrome b5 and cytochrome b5 reductase for electron transfer to catalyze such reactions. It is well accepted that the enzyme is involved in N-reductive drug metabolism such as the activation of amidoxime prodrugs. However, the endogenous function of the protein is not fully understood. Among other functions, an involvement in lipogenesis is discussed. To study the potential involvement of the protein in energy metabolism, we tested whether the mARC protein and its partners are regulated due to fasting and high fat diet in mice. We used qRT-PCR for expression studies, Western Blot analysis to study protein levels and an N-reductive biotransformation assay to gain activity data. Indeed all proteins of the N-reductive system are regulated by fasting and its activity decreases. To study the potential impact of these changes on prodrug activation in vivo, another mice experiment was conducted. Model compound benzamidoxime was injected to mice that underwent fasting and the resulting metabolite of the N-reductive reaction, benzamidine, was determined. Albeit altered in vitro activity, no changes in the metabolite concentration in vivo were detectable and we can dispel concerns that fasting alters prodrug activation in animal models. With respect to high fat diet, changes in the mARC proteins occur that result in increased N-reductive activity. With this study we provide further evidence that the endogenous function of the mARC protein is linked with lipid metabolism.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jakobs</LastName>
                    <ForeName>Heyka H</ForeName>
                    <Initials>HH</Initials>
                    <Affiliation>Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-Universit??t zu Kiel, Kiel, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mikula</LastName>
                    <ForeName>Michal</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Havemeyer</LastName>
                    <ForeName>Antje</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-Universit??t zu Kiel, Kiel, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Strzalkowska</LastName>
                    <ForeName>Adriana</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Borowa-Chmielak</LastName>
                    <ForeName>Monika</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dzwonek</LastName>
                    <ForeName>Artur</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gajewska</LastName>
                    <ForeName>Marta</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hennig</LastName>
                    <ForeName>Ewa E</ForeName>
                    <Initials>EE</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Department of Gastroenterology and Hepatology, Medical Center for Postgraduate Education, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ostrowski</LastName>
                    <ForeName>Jerzy</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Genetics, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; Department of Gastroenterology and Hepatology, Medical Center for Postgraduate Education, Warsaw, Poland.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clement</LastName>
                    <ForeName>Bernd</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Pharmaceutical and Medicinal Chemistry, Christian-Albrechts-Universit??t zu Kiel, Kiel, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105371</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-19396</ArticleId>
            <ArticleId IdType="pubmed">25144769</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144766</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Fetal growth retardation and lack of hypotaurine in ezrin knockout mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105423</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105423</ELocationID>
            <Abstract>
                <AbstractText>Ezrin is a membrane-associated cytoplasmic protein that serves to link cell-membrane proteins with the actin-based cytoskeleton, and also plays a role in regulation of the functional activities of some transmembrane proteins. It is expressed in placental trophoblasts. We hypothesized that placental ezrin is involved in the supply of nutrients from mother to fetus, thereby influencing fetal growth. The aim of this study was firstly to clarify the effect of ezrin on fetal growth and secondly to determine whether knockout of ezrin is associated with decreased concentrations of serum and placental nutrients. Ezrin knockout mice (Ez-/-) were confirmed to exhibit fetal growth retardation. Metabolome analysis of fetal serum and placental extract of ezrin knockout mice by means of capillary electrophoresis-time-of-flight mass spectrometry revealed a markedly decreased concentration of hypotaurine, a precursor of taurine. However, placental levels of cysteine and cysteine sulfinic acid (precursors of hypotaurine) and taurine were not affected. Lack of hypotaurine in Ez-/- mice was confirmed by liquid chromatography with tandem mass spectrometry. Administration of hypotaurine to heterogenous dams significantly decreased the placenta-to-maternal plasma ratio of hypotaurine in wild-type fetuses but only slightly decreased it in ezrin knockout fetuses, indicating that the uptake of hypotaurine from mother to placenta is saturable and that disruption of ezrin impairs the uptake of hypotaurine by placental trophoblasts. These results indicate that ezrin is required for uptake of hypotaurine from maternal serum by placental trophoblasts, and plays an important role in fetal growth.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nishimura</LastName>
                    <ForeName>Tomohiro</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Higuchi</LastName>
                    <ForeName>Kei</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sai</LastName>
                    <ForeName>Yoshimichi</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan; Department of Pharmacy, Kanazawa University Hospital, Kanazawa, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sugita</LastName>
                    <ForeName>Yuki</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoshida</LastName>
                    <ForeName>Yuko</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomi</LastName>
                    <ForeName>Masatoshi</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wada</LastName>
                    <ForeName>Masami</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan; Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wakayama</LastName>
                    <ForeName>Tomohiko</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Histology and Embryology, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tamura</LastName>
                    <ForeName>Atsushi</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tsukita</LastName>
                    <ForeName>Sachiko</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Biological Science, Graduate School of Frontier Biosciences and Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Soga</LastName>
                    <ForeName>Tomoyoshi</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Institute for Advanced Biosciences, Keio University, Tsuruoka, Yamagata, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakashima</LastName>
                    <ForeName>Emi</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Division of Pharmaceutics, Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105423</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-05045</ArticleId>
            <ArticleId IdType="pubmed">25144766</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144761</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Sox17 Regulates Insulin Secretion in the Normal and Pathologic Mouse ?? Cell.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e104675</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0104675</ELocationID>
            <Abstract>
                <AbstractText>SOX17 is a key transcriptional regulator that can act by regulating other transcription factors including HNF1?? and FOXA2, which are known to regulate postnatal ?? cell function. Given this, we investigated the role of SOX17 in the developing and postnatal pancreas and found a novel role for SOX17 in regulating insulin secretion. Deletion of the Sox17 gene in the pancreas (Sox17-paLOF) had no observable impact on pancreas development. However, Sox17-paLOF mice had higher islet proinsulin protein content, abnormal trafficking of proinsulin, and dilated secretory organelles suggesting that Sox17-paLOF adult mice are prediabetic. Consistant with this, Sox17-paLOF mice were more susceptible to aged-related and high fat diet-induced hyperglycemia and diabetes. Overexpression of Sox17 in mature ?? cells using Ins2-rtTA driver mice resulted in precocious secretion of proinsulin. Transcriptionally, SOX17 appears to broadly regulate secretory networks since a 24-hour pulse of SOX17 expression resulted in global transcriptional changes in factors that regulate hormone transport and secretion. Lastly, transient SOX17 overexpression was able to reverse the insulin secretory defects observed in MODY4 animals and restored euglycemia. Together, these data demonstrate a critical new role for SOX17 in regulating insulin trafficking and secretion and that modulation of Sox17-regulated pathways might be used therapeutically to improve cell function in the context of diabetes.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jonatan</LastName>
                    <ForeName>Diva</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Spence</LastName>
                    <ForeName>Jason R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Department of Internal Medicine, Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, United States of America; Department of Cell and Developmental Biology, University of Michigan Medical School, Ann Arbor, MI, United States of America; Center for Organogenesis, University of Michigan Medical School, Ann Arbor, MI, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Method</LastName>
                    <ForeName>Anna M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kofron</LastName>
                    <ForeName>Matthew</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sinagoga</LastName>
                    <ForeName>Katie</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haataja</LastName>
                    <ForeName>Leena</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, MI, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Arvan</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Division of Metabolism, Endocrinology, and Diabetes, University of Michigan Medical School, Ann Arbor, MI, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Deutsch</LastName>
                    <ForeName>Gail H</ForeName>
                    <Initials>GH</Initials>
                    <Affiliation>Seattle Children's Hospital, Seattle, WA, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wells</LastName>
                    <ForeName>James M</ForeName>
                    <Initials>JM</Initials>
                    <Affiliation>Division of Developmental Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America; Division of Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States of America.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0104675</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-55227</ArticleId>
            <ArticleId IdType="pubmed">25144761</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144756</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1935-2735</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS neglected tropical diseases</Title>
                <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Schistosome Syntenin Partially Protects Vaccinated Mice against Schistosoma mansoni Infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e3107</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0003107</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Schistosomiasis is a neglected tropical disease caused by several species of trematode of the genus Schistosoma. The disease affects more than 200 million people in the world and causes up to 280,000 deaths per year, besides having high morbidity due to chronic illness that damages internal organs. Current schistosomiasis control strategies are mainly based on chemotherapy, but many researchers believe that the best long-term strategy to control disease is a combination of drug treatment and immunization with an anti-schistosome vaccine. Among the most promising molecules as vaccine candidates are the proteins present in the tegument and digestive tract of the parasite.</AbstractText>
                <AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">In this study, we describe for the first time Schistosoma mansoni syntenin (SmSynt) and we evaluate its potential as a recombinant vaccine. We demonstrate by real-time PCR that syntenin is mainly expressed in intravascular life stages (schistosomula and adult worms) of the parasite life cycle and, by confocal microscopy, we localize it in digestive epithelia in adult worms and schistosomula. Administration of siRNAs targeting SmSynt leads to the knock-down of syntenin gene and protein levels, but this has no demonstrable impact on parasite morphology or viability, suggesting that high SmSynt gene expression is not essential for the parasites in vitro. Mice immunization with rSmSynt, formulated with Freund's adjuvant, induces a Th1-type response, as suggested by the production of IFN-?? and TNF-?? by rSmSynt-stimulated cultured splenocytes. The protective effect conferred by vaccination with rSmSynt was demonstrated by 30-37% reduction of worm burden, 38-43% reduction in the number, and 35-37% reduction in the area, of liver granulomas.</AbstractText>
                <AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">Our report is the first characterization of syntenin in Schistosoma mansoni and our data suggest that this protein is a potential candidate for the development of a multi-antigen vaccine to control schistosomiasis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Figueiredo</LastName>
                    <ForeName>Barbara C</ForeName>
                    <Initials>BC</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil; Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Assis</LastName>
                    <ForeName>Natan R G</ForeName>
                    <Initials>NR</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morais</LastName>
                    <ForeName>Suellen B</ForeName>
                    <Initials>SB</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ricci</LastName>
                    <ForeName>Natasha D</ForeName>
                    <Initials>ND</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pinheiro</LastName>
                    <ForeName>Carina S</ForeName>
                    <Initials>CS</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil; Departamento de Biointera????o do Instituto de Ci??ncias da Sa??de, Universidade Federal da Bahia, Salvador, Bahia, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martins</LastName>
                    <ForeName>Vicente P</ForeName>
                    <Initials>VP</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil; Departamento de Biologia Celular do Instituto de Ci??ncias Biol??gicas, Universidade de Bras??lia, Bras??lia, Distrito Federal, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bicalho</LastName>
                    <ForeName>Rodrigo M</ForeName>
                    <Initials>RM</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Da'dara</LastName>
                    <ForeName>Akram A</ForeName>
                    <Initials>AA</Initials>
                    <Affiliation>Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Skelly</LastName>
                    <ForeName>Patrick J</ForeName>
                    <Initials>PJ</Initials>
                    <Affiliation>Department of Infectious Disease and Global Health, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oliveira</LastName>
                    <ForeName>Sergio C</ForeName>
                    <Initials>SC</Initials>
                    <Affiliation>Departamento de Bioqu??mica e Imunologia do Instituto de Ci??ncias Biol??gicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Instituto Nacional de Ci??ncia e Tecnologia em Doen??as Tropicais (INCT-DT), CNPq MCT, Bahia, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
            <NlmUniqueID>101291488</NlmUniqueID>
            <ISSNLinking>1935-2727</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0003107</ArticleId>
            <ArticleId IdType="pii">PNTD-D-14-00817</ArticleId>
            <ArticleId IdType="pubmed">25144756</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144744</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lactobacillus gasseri SBT2055 Induces TGF-?? Expression in Dendritic Cells and Activates TLR2 Signal to Produce IgA in the Small Intestine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105370</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105370</ELocationID>
            <Abstract>
                <AbstractText>Probiotic bacteria provide benefits in enhancing host immune responses and protecting against infection. Induction of IgA production by oral administration of probiotic bacteria in the intestine has been considered to be one reason for this beneficial effect, but the mechanisms of the effect are poorly understood. Lactobacillus gasseri SBT2055 (LG2055) is a probiotic bacterium with properties such as bile tolerance, ability to improve the intestinal environment, and it has preventive effects related to abdominal adiposity. In this study, we have found that oral administration of LG2055 induced IgA production and increased the rate of IgA+ cell population in Peyer's patch and in the lamina propria of the mouse small intestine. The LG2055 markedly increased the amount of IgA in a co-culture of B cells and bone marrow derived dendritic cells (BMDC), and TLR2 signal is critical for it. In addition, it is demonstrated that LG2055 stimulates BMDC to promote the production of TGF-??, BAFF, IL-6, and IL-10, all critical for IgA production from B cells. Combined stimulation of B cells with BAFF and LG2055 enhanced the induction of IgA production. Further, TGF-?? signal was shown to be critical for LG2055-induced IgA production in the B cell and BMDC co-culture system, but TGF-?? did not induce IgA production in a culture of only B cells stimulated with LG2055. Furthermore, TGF-?? was critical for the production of BAFF, IL-6, IL-10, and TGF-?? itself from LG2055-stimulated BMDC. These results demonstrate that TGF-?? was produced by BMDC stimulated with LG2055 and it has an autocrine/paracrine function essential for BMDC to induce the production of BAFF, IL-6, and IL-10.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sakai</LastName>
                    <ForeName>Fumihiko</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hosoya</LastName>
                    <ForeName>Tomohiro</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ono-Ohmachi</LastName>
                    <ForeName>Aiko</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ukibe</LastName>
                    <ForeName>Ken</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ogawa</LastName>
                    <ForeName>Akihiro</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Moriya</LastName>
                    <ForeName>Tomohiro</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kadooka</LastName>
                    <ForeName>Yukio</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Milk Science Research Institute, Megmilk Snow Brand Co. Ltd., Minamidai, Kawagoe, Saitama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shiozaki</LastName>
                    <ForeName>Takuya</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakagawa</LastName>
                    <ForeName>Hisako</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nakayama</LastName>
                    <ForeName>Yosuke</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Miyazaki</LastName>
                    <ForeName>Tadaaki</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Probiotics Immunology, Institute for Genetic Medicine, Hokkaido University, Kita-ku, Sapporo, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105370</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-03998</ArticleId>
            <ArticleId IdType="pubmed">25144744</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144740</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>SH3BP2 Gain-Of-Function Mutation Exacerbates Inflammation and Bone Loss in a Murine Collagen-Induced Arthritis Model.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105518</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105518</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">SH3BP2 is a signaling adapter protein which regulates immune and skeletal systems. Gain-of-function mutations in SH3BP2 cause cherubism, characterized by jawbone destruction. This study was aimed to examine the role of SH3BP2 in inflammatory bone loss using a collagen-induced arthritis (CIA) model.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">CIA was induced in wild-type (Sh3bp2+/+) and heterozygous P416R SH3BP2 cherubism mutant knock-in (Sh3bp2KI/+) mice, an SH3BP2 gain-of-function model. Severity of the arthritis was determined by assessing the paw swelling and histological analyses of the joints. Micro-CT analysis was used to determine the levels of bone loss. Inflammation and osteoclastogenesis in the joints were evaluated by quantitating the gene expression of inflammatory cytokines and osteoclast markers. Furthermore, involvement of the T- and B-cell responses was determined by draining lymph node cell culture and measurement of the serum anti-mouse type II collagen antibody levels, respectively. Finally, roles of the SH3BP2 mutation in macrophage activation and osteoclastogenesis were determined by evaluating the TNF-?? production levels and osteoclast formation in bone marrow-derived M-CSF-dependent macrophage (BMM) cultures.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sh3bp2KI/+ mice exhibited more severe inflammation and bone loss, accompanying an increased number of osteoclasts. The mRNA levels for TNF-?? and osteoclast marker genes were higher in the joints of Sh3bp2KI/+ mice. Lymph node cell culture showed that lymphocyte proliferation and IFN-?? and IL-17 production were comparable between Sh3bp2+/+ and Sh3bp2KI/+ cells. Serum anti-type II collagen antibody levels were comparable between Sh3bp2+/+ and Sh3bp2KI/+ mice. In vitro experiments showed that TNF-?? production in Sh3bp2KI/+ BMMs is elevated compared with Sh3bp2+/+ BMMs and that RANKL-induced osteoclastogenesis is enhanced in Sh3bp2KI/+ BMMs associated with increased NFATc1 nuclear localization.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Gain-of-function of SH3BP2 augments inflammation and bone loss in the CIA model through increased macrophage activation and osteoclast formation. Therefore, modulation of the SH3BP2 expression may have therapeutic potential for the treatment of rheumatoid arthritis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Mukai</LastName>
                    <ForeName>Tomoyuki</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gallant</LastName>
                    <ForeName>Richard</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ishida</LastName>
                    <ForeName>Shu</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, Missouri, United States of America; Department of Periodontal Medicine, Applied life Sciences, Institute of Biomedical and Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoshitaka</LastName>
                    <ForeName>Teruhito</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kittaka</LastName>
                    <ForeName>Mizuho</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nishida</LastName>
                    <ForeName>Keiichiro</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Orthopaedic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Human Morphology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fox</LastName>
                    <ForeName>David A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Morita</LastName>
                    <ForeName>Yoshitaka</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Rheumatology, Kawasaki Medical School, Kurashiki, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ueki</LastName>
                    <ForeName>Yasuyoshi</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Oral and Craniofacial Sciences, School of Dentistry, University of Missouri-Kansas City, Kansas City, Missouri, United States of America.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105518</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-21416</ArticleId>
            <ArticleId IdType="pubmed">25144740</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144738</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Neuroantigen-Specific Autoregulatory CD8+ T Cells Inhibit Autoimmune Demyelination through Modulation of Dendritic Cell Function.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105763</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105763</ELocationID>
            <Abstract>
                <AbstractText>Experimental autoimmune encephalomyelitis (EAE) is a well-established murine model of multiple sclerosis, an immune-mediated demyelinating disorder of the central nervous system (CNS). We have previously shown that CNS-specific CD8+ T cells (CNS-CD8+) ameliorate EAE, at least in part through modulation of CNS-specific CD4+ T cell responses. In this study, we show that CNS-CD8+ also modulate the function of CD11c+ dendritic cells (DC), but not other APCs such as CD11b+ monocytes or B220+ B cells. DC from mice receiving either myelin oligodendrocyte glycoprotein-specific CD8+ (MOG-CD8+) or proteolipid protein-specific CD8+ (PLP-CD8+) T cells were rendered inefficient in priming T cell responses from na??ve CD4+ T cells (OT-II) or supporting recall responses from CNS-specific CD4+ T cells. CNS-CD8+ did not alter DC subset distribution or MHC class II and CD86 expression, suggesting that DC maturation was not affected. However, the cytokine profile of DC from CNS-CD8+ recipients showed lower IL-12 and higher IL-10 production. These functions were not modulated in the absence of immunization with CD8-cognate antigen, suggesting an antigen-specific mechanism likely requiring CNS-CD8-DC interaction. Interestingly, blockade of IL-10 in vitro rescued CD4+ proliferation and in vivo expression of IL-10 was necessary for the suppression of EAE by MOG-CD8+. These studies demonstrate a complex interplay between CNS-specific CD8+ T cells, DC and pathogenic CD4+ T cells, with important implications for therapeutic interventions in this disease.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kashi</LastName>
                    <ForeName>Venkatesh P</ForeName>
                    <Initials>VP</Initials>
                    <Affiliation>Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ortega</LastName>
                    <ForeName>Sterling B</ForeName>
                    <Initials>SB</Initials>
                    <Affiliation>Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karandikar</LastName>
                    <ForeName>Nitin J</ForeName>
                    <Initials>NJ</Initials>
                    <Affiliation>Department of Pathology, The University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105763</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-20717</ArticleId>
            <ArticleId IdType="pubmed">25144738</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144735</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Optogenetic modulation and multi-electrode analysis of cerebellar networks in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105589</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105589</ELocationID>
            <Abstract>
                <AbstractText>The firing patterns of cerebellar Purkinje cells (PCs), as the sole output of the cerebellar cortex, determine and tune motor behavior. PC firing is modulated by various inputs from different brain regions and by cell-types including granule cells (GCs), climbing fibers and inhibitory interneurons. To understand how signal integration in PCs occurs and how subtle changes in the modulation of PC firing lead to adjustment of motor behaviors, it is important to precisely record PC firing in vivo and to control modulatory pathways in a spatio-temporal manner. Combining optogenetic and multi-electrode approaches, we established a new method to integrate light-guides into a multi-electrode system. With this method we are able to variably position the light-guide in defined regions relative to the recording electrode with micrometer precision. We show that PC firing can be precisely monitored and modulated by light-activation of channelrhodopsin-2 (ChR2) expressed in PCs, GCs and interneurons. Thus, this method is ideally suited to investigate the spatio/temporal modulation of PCs in anesthetized and in behaving mice.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kruse</LastName>
                    <ForeName>Wolfgang</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Zoology and Neurobiology, Faculty for Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany; International Graduate School of Neuroscience, Ruhr University Bochum, Bochum, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Krause</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Zoology and Neurobiology, Faculty for Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Aarse</LastName>
                    <ForeName>Janna</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Neurophysiology, Medical Faculty, Ruhr University Bochum, Bochum, Germany; International Graduate School of Neuroscience, Ruhr University Bochum, Bochum, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mark</LastName>
                    <ForeName>Melanie D</ForeName>
                    <Initials>MD</Initials>
                    <Affiliation>Department of Zoology and Neurobiology, Faculty for Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Manahan-Vaughan</LastName>
                    <ForeName>Denise</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Neurophysiology, Medical Faculty, Ruhr University Bochum, Bochum, Germany; International Graduate School of Neuroscience, Ruhr University Bochum, Bochum, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Herlitze</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Zoology and Neurobiology, Faculty for Biology and Biotechnology, Ruhr University Bochum, Bochum, Germany; International Graduate School of Neuroscience, Ruhr University Bochum, Bochum, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105589</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-16340</ArticleId>
            <ArticleId IdType="pubmed">25144735</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144721</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-4889</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Cell death &amp; disease</Title>
                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1386</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2014.359</ELocationID>
            <Abstract>
                <AbstractText>Intravenous transplantation of neural progenitor cells (NPCs) induces functional recovery after stroke, albeit grafted cells are not integrated into residing neural networks. However, a systematic analysis of intravenous NPC delivery at acute and post-acute time points and their long-term consequences does not exist. Male C57BL6 mice were exposed to cerebral ischemia, and NPCs were intravenously grafted on day 0, on day 1 or on day 28. Animals were allowed to survive for up to 84 days. Mice and tissues were used for immunohistochemical analysis, flow cytometry, ELISA and behavioral tests. Density of grafted NPCs within the ischemic hemisphere was increased when cells were transplanted on day 28 as compared with transplantation on days 0 or 1. Likewise, transplantation on day 28 yielded enhanced neuronal differentiation rates of grafted cells. Post-ischemic brain injury, however, was only reduced when NPCs were grafted at acute time points. On the contrary, reduced post-ischemic functional deficits due to NPC delivery were independent of transplantation paradigms. NPC-induced neuroprotection after acute cell delivery was due to stabilization of the blood-brain barrier (BBB), reduction in microglial activation and modulation of both peripheral and central immune responses. On the other hand, post-acute NPC transplantation stimulated post-ischemic regeneration via enhanced angioneurogenesis and increased axonal plasticity. Acute NPC delivery yields long-term neuroprotection via enhanced BBB integrity and modulation of post-ischemic immune responses, whereas post-acute NPC delivery increases post-ischemic angioneurogenesis and axonal plasticity. Post-ischemic functional recovery, however, is independent of NPC delivery timing, which offers a broad therapeutic time window for stroke treatment.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Doeppner</LastName>
                    <ForeName>T R</ForeName>
                    <Initials>TR</Initials>
                    <Affiliation>Department of Neurology, University of Duisburg-Essen Medical School, Essen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaltwasser</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Neurology, University of Duisburg-Essen Medical School, Essen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Teli</LastName>
                    <ForeName>M K</ForeName>
                    <Initials>MK</Initials>
                    <Affiliation>1] Department of Neurology, University of Duisburg-Essen Medical School, Essen, Germany [2] National Institute of Technology Calicut, Calicut, Kerala, India.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bretschneider</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>1] Department of Otorhinolaryngology, Johannes Wesling Klinikum, Minden, Germany [2] Department of Neurology, University of Goettingen Medical School, Goettingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>B??hr</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Neurology, University of Goettingen Medical School, Goettingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hermann</LastName>
                    <ForeName>D M</ForeName>
                    <Initials>DM</Initials>
                    <Affiliation>Department of Neurology, University of Duisburg-Essen Medical School, Essen, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cell Death Dis</MedlineTA>
            <NlmUniqueID>101524092</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cddis2014359</ArticleId>
            <ArticleId IdType="doi">10.1038/cddis.2014.359</ArticleId>
            <ArticleId IdType="pubmed">25144721</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144719</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-4889</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Cell death &amp; disease</Title>
                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>RIP3 is downregulated in human myeloid leukemia cells and modulates apoptosis and caspase-mediated p65/RelA cleavage.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1384</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2014.347</ELocationID>
            <Abstract>
                <AbstractText>The receptor-interacting protein kinase 3 (RIP3) associates with RIP1 in a necrosome complex that can induce necroptosis, apoptosis, or cell proliferation. We analyzed the expression of RIP1 and RIP3 in CD34+ leukemia cells from a cohort of patients with acute myeloid leukemia (AML) and CD34+ cells from healthy donors. RIP3 expression was significantly reduced in most AML samples, whereas the expression of RIP1 did not differ significantly. When re-expressed in the mouse DA1-3b leukemia cell line, RIP3 induced apoptosis and necroptosis in the presence of caspase inhibitors. Transfection of RIP3 in the WEHI-3b leukemia cell line or in the mouse embryonic fibroblasts also resulted in increased cell death. Surprisingly, re-expression of a RIP3 mutant with an inactive kinase domain (RIP3-kinase dead (RIP3-KD)) induced significantly more and earlier apoptosis than wild-type RIP3 (RIP3-WT), indicating that the RIP3 kinase domain is an essential regulator of apoptosis/necroptosis in leukemia cells. The induced in vivo expression of RIP3-KD but not RIP3-WT prolonged the survival of mice injected with leukemia cells. The expression of RIP3-KD induced p65/RelA nuclear factor-??B (NF-??B) subunit caspase-dependent cleavage, and a non-cleavable p65/RelA D361E mutant rescued these cells from apoptosis. p65/RelA cleavage appears to be at least partially mediated by caspase-6. These data indicate that RIP3 silencing in leukemia cells results in suppression of the complex regulation of the apoptosis/necroptosis switch and NF-??B activity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Nugues</LastName>
                    <ForeName>A-L</ForeName>
                    <Initials>AL</Initials>
                    <Affiliation>Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>El Bouazzati</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>H??tuin</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berthon</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>1] Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France [2] Service des Maladies du Sang, Centre Hospitalier et Universitaire de Lille, Rue Polonovski, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Loyens</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bertrand</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jouy</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Universit?? Lille Nord de France, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Idziorek</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Quesnel</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>1] Inserm, U837, Institut pour la Recherche sur le Cancer de Lille, place de Verdun, Lille F-59045, France [2] Service des Maladies du Sang, Centre Hospitalier et Universitaire de Lille, Rue Polonovski, Lille F-59045, France [3] Universit?? Lille Nord de France, Lille F-59045, France.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cell Death Dis</MedlineTA>
            <NlmUniqueID>101524092</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cddis2014347</ArticleId>
            <ArticleId IdType="doi">10.1038/cddis.2014.347</ArticleId>
            <ArticleId IdType="pubmed">25144719</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144718</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-4889</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Cell death &amp; disease</Title>
                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>An unexpected role for caspase-2 in neuroblastoma.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1383</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2014.342</ELocationID>
            <Abstract>
                <AbstractText>Caspase-2 has been implicated in various cellular functions, including cell death by apoptosis, oxidative stress response, maintenance of genomic stability and tumor suppression. The loss of the caspase-2 gene (Casp2) enhances oncogene-mediated tumorigenesis induced by E1A/Ras in athymic nude mice, and also in the E??-Myc lymphoma and MMTV/c-neu mammary tumor mouse models. To further investigate the function of caspase-2 in oncogene-mediated tumorigenesis, we extended our studies in the TH-MYCN transgenic mouse model of neuroblastoma. Surprisingly, we found that loss of caspase-2 delayed tumorigenesis in the TH-MYCN neuroblastoma model. In addition, tumors from TH-MYCN/Casp2(-/-) mice were predominantly thoracic paraspinal tumors and were less vascularized compared with tumors from their TH-MYCN/Casp2(+/+) counterparts. We did not detect any differences in the expression of neuroblastoma-associated genes in TH-MYCN/Casp2(-/-) tumors, or in the activation of Ras/MAPK signaling pathway that is involved in neuroblastoma progression. Analysis of expression array data from human neuroblastoma samples showed a correlation between low caspase-2 levels and increased survival. However, caspase-2 levels correlated with clinical outcome only in the subset of MYCN-non-amplified human neuroblastoma. These observations indicate that caspase-2 is not a suppressor in MYCN-induced neuroblastoma and suggest a tissue and context-specific role for caspase-2 in tumorigenesis.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Dorstyn</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Centre for Cancer Biology, University of South Australia, Adelaide, SA 5001, Australia [2] Department of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Puccini</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Centre for Cancer Biology, University of South Australia, Adelaide, SA 5001, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nikolic</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Centre for Cancer Biology, University of South Australia, Adelaide, SA 5001, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shalini</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Centre for Cancer Biology, University of South Australia, Adelaide, SA 5001, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilson</LastName>
                    <ForeName>C H</ForeName>
                    <Initials>CH</Initials>
                    <Affiliation>Centre for Cancer Biology, University of South Australia, Adelaide, SA 5001, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Norris</LastName>
                    <ForeName>M D</ForeName>
                    <Initials>MD</Initials>
                    <Affiliation>Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW, Sydney, NSW 2052, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haber</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Children's Cancer Institute Australia for Medical Research, Lowy Cancer Research Centre, UNSW, Sydney, NSW 2052, Australia.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumar</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>1] Centre for Cancer Biology, University of South Australia, Adelaide, SA 5001, Australia [2] Department of Medicine, University of Adelaide, Adelaide, SA 5005, Australia.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cell Death Dis</MedlineTA>
            <NlmUniqueID>101524092</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cddis2014342</ArticleId>
            <ArticleId IdType="doi">10.1038/cddis.2014.342</ArticleId>
            <ArticleId IdType="pubmed">25144718</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144717</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2041-4889</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>Cell death &amp; disease</Title>
                <ISOAbbreviation>Cell Death Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Amyloid-?? induces NLRP1-dependent neuronal pyroptosis in models of Alzheimer's disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e1382</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1038/cddis.2014.348</ELocationID>
            <Abstract>
                <AbstractText>Increasing evidence has shown the aberrant expression of inflammasome-related proteins in Alzheimer's disease (AD) brain; these proteins, including NLRP1 inflammasome, are implicated in the execution of inflammatory response and pyroptotic death. Although current data are associated NLRP1 genetic variants with AD, the involvement of NLRP1 inflammasome in AD pathogenesis is still unknown. Using APPswe/PS1dE9 transgenic mice, we found that cerebral NLRP1 levels were upregulated. Our in vitro studies further showed that increased NLRP1-mediated caspase-1-dependent 'pyroptosis' in cultured cortical neurons in response to amyloid-??. Moreover, we employed direct in vivo infusion of non-viral small-interfering RNA to knockdown NLRP1 or caspase-1 in APPswe/PS1dE9 brain, and discovered that these NLRP1 or caspase-1 deficiency mice resulted in significantly reduced neuronal pyroptosis and reversed cognitive impairments. Taken together, our findings indicate an important role for NLRP1/caspase-1 signaling in AD progression, and point to the modulation of NLRP1 inflammasome as a promising strategy for AD therapy.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>M-S</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>Department of Neurology, Qingdao Municipal Hospital, College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>1] Department of Neurology, Qingdao Municipal Hospital, College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China [2] Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China [3] Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>X-C</ForeName>
                    <Initials>XC</Initials>
                    <Affiliation>Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>H-F</ForeName>
                    <Initials>HF</Initials>
                    <Affiliation>Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jia</LastName>
                    <ForeName>C-D</ForeName>
                    <Initials>CD</Initials>
                    <Affiliation>Chemical Sciences Division, Oak Ridge National Laboratory, Oak Ridge, TN 37831, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yu</LastName>
                    <ForeName>J-T</ForeName>
                    <Initials>JT</Initials>
                    <Affiliation>1] Department of Neurology, Qingdao Municipal Hospital, College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China [2] Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China [3] Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Qingdao, China [4] Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Cell Death Dis</MedlineTA>
            <NlmUniqueID>101524092</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cddis2014348</ArticleId>
            <ArticleId IdType="doi">10.1038/cddis.2014.348</ArticleId>
            <ArticleId IdType="pubmed">25144717</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144714</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Sertoli cells maintain leydig cell number and peritubular myoid cell activity in the adult mouse testis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105687</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105687</ELocationID>
            <Abstract>
                <AbstractText>The Sertoli cells are critical regulators of testis differentiation and development. In the adult, however, their known function is restricted largely to maintenance of spermatogenesis. To determine whether the Sertoli cells regulate other aspects of adult testis biology we have used a novel transgenic mouse model in which Amh-Cre induces expression of the receptor for Diphtheria toxin (iDTR) specifically within Sertoli cells. This causes controlled, cell-specific and acute ablation of the Sertoli cell population in the adult animal following Diphtheria toxin injection. Results show that Sertoli cell ablation leads to rapid loss of all germ cell populations. In addition, adult Leydig cell numbers decline by 75% with the remaining cells concentrated around the rete and in the sub-capsular region. In the absence of Sertoli cells, peritubular myoid cell activity is reduced but the cells retain an ability to exclude immune cells from the seminiferous tubules. These data demonstrate that, in addition to support of spermatogenesis, Sertoli cells are required in the adult testis both for retention of the normal adult Leydig cell population and for support of normal peritubular myoid cell function. This has implications for our understanding of male reproductive disorders and wider androgen-related conditions affecting male health.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Rebourcet</LastName>
                    <ForeName>Diane</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Shaughnessy</LastName>
                    <ForeName>Peter J</ForeName>
                    <Initials>PJ</Initials>
                    <Affiliation>Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Garscube Campus, Glasgow, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Monteiro</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Garscube Campus, Glasgow, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Milne</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cruickshanks</LastName>
                    <ForeName>Lyndsey</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jeffrey</LastName>
                    <ForeName>Nathan</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guillou</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Station de Physiologie de la Reproduction et des Comportements (PRC), Institut National de la Recherche Agronomique, UMR 6073 INRA-CNRS-Universit?? de Tours, Nouzilly, France.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Freeman</LastName>
                    <ForeName>Tom C</ForeName>
                    <Initials>TC</Initials>
                    <Affiliation>The Roslin Institute, University of Edinburgh, Easter Bush, Edinburgh, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mitchell</LastName>
                    <ForeName>Rod T</ForeName>
                    <Initials>RT</Initials>
                    <Affiliation>MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Smith</LastName>
                    <ForeName>Lee B</ForeName>
                    <Initials>LB</Initials>
                    <Affiliation>MRC Centre for Reproductive Health, University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105687</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-19027</ArticleId>
            <ArticleId IdType="pubmed">25144714</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144709</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-5118</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of agricultural and food chemistry</Title>
                <ISOAbbreviation>J. Agric. Food Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Novel Insulin Receptor-Binding Protein from Momordica charantia Enhances Glucose Uptake and Glucose Clearance In Vitro and In Vivo through Triggering Insulin Receptor Signaling Pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Diabetes, a common metabolic disorder, is characterized by hyperglycemia. Insulin is the principle mediator of glucose homeostasis. In previous study, we have identified a trypsin inhibitor, named as Momordica charantia insulin receptor (IR)-binding protein (mcIRBP) in this study, that might interact with IR. The physical and functional interactions between mcIRBP and IR were clearly analyzed in the present study. Photo-crosslinking coupled with mass spectrometry showed that three regions (17-21, 34-40, and 59-66 residues) located on mcIRBP physically interacted with leucine-rich repeat domain and cystein-rich region of IR. IR-binding assay showed that the binding behavior of mcIRBP and insulin displayed a cooperative manner. After binding to IR, mcIRBP activated the kinase activity of IR by 5.87 ?? 0.45-fold, increased the amount of phospho-IR protein by 1.31 ?? 0.03-fold, affected phosphoinositide-3-kinase/Akt pathways, and consequently stimulated the uptake of glucose in 3T3-L1 cells by 1.36 ?? 0.12-fold. Intraperitoneal injection of 2.5 nmol/kg mcIRBP significantly decreased the blood glucose levels by 20.9 ?? 3.2% and 10.8 ?? 3.6% in normal and diabetic mice, respectively. Microarray analysis showed that mcIRBP affected genes involved in insulin signaling transduction pathway in mice. In conclusion, our findings suggested that mcIRBP was a novel IRBP that bound to the sites different from the insulin-binding sites on IR and stimulated both the glucose uptake in cells and the glucose clearance in mice. ?????</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lo</LastName>
                    <ForeName>Hsin-Yi</ForeName>
                    <Initials>HY</Initials>
                </Author>
                <Author>
                    <LastName>Ho</LastName>
                    <ForeName>Tin-Yun</ForeName>
                    <Initials>TY</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Chia-Cheng</ForeName>
                    <Initials>CC</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Jaw-Chyun</ForeName>
                    <Initials>JC</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Jau-Jin</ForeName>
                    <Initials>JJ</Initials>
                </Author>
                <Author>
                    <LastName>Hsiang</LastName>
                    <ForeName>Chien-Yun</ForeName>
                    <Initials>CY</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Agric Food Chem</MedlineTA>
            <NlmUniqueID>0374755</NlmUniqueID>
            <ISSNLinking>0021-8561</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf5002099</ArticleId>
            <ArticleId IdType="pubmed">25144709</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144684</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Silver and gold nanoparticles exposure to in vitro cultured retina - studies on nanoparticle internalization, apoptosis, oxidative stress, glial- and microglial activity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105359</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105359</ELocationID>
            <Abstract>
                <AbstractText>The complex network of neuronal cells in the retina makes it a potential target of neuronal toxicity - a risk factor for visual loss. With growing use of nanoparticles (NPs) in commercial and medical applications, including ophthalmology, there is a need for reliable models for early prediction of NP toxicity in the eye and retina. Metal NPs, such as gold and silver, gain much of attention in the ophthalmology community due to their potential to cross the barriers of the eye. Here, NP uptake and signs of toxicity were investigated after exposure to 20 and 80 nm Ag- and AuNPs, using an in vitro tissue culture model of the mouse retina. The model offers long-term preservation of retinal cell types, numbers and morphology and is a controlled system for delivery of NPs, using serum-free defined culture medium. AgNO3-treatment was used as control for toxicity caused by silver ions. These end-points were studied; gross morphological organization, glial activity, microglial activity, level of apoptosis and oxidative stress, which are all well described as signs of insult to neural tissue. TEM analysis demonstrated cellular- and nuclear uptake of all NP types in all neuronal layers of the retina. Htx-eosin staining showed morphological disruption of the normal complex layered retinal structure, vacuole formation and pyknotic cells after exposure to all Ag- and AuNPs. Significantly higher numbers of apoptotic cells as well as an increased number of oxidative stressed cells demonstrated NP-related neuronal toxicity. NPs also caused increased glial staining and microglial cell activation, typical hallmarks of neural tissue insult. This study demonstrates that low concentrations of 20 and 80 nm sized Ag- and AuNPs have adverse effects on the retina, using an organotypic retina culture model. Our results motivate careful assessment of candidate NP, metallic or-non-metallic, to be used in neural systems for therapeutic approaches.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>S??derstjerna</LastName>
                    <ForeName>Erika</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Inst. Clinical Sciences, Dept. Ophthalmology, Lund University, Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bauer</LastName>
                    <ForeName>Patrik</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Dept. of Biology, Sec. Functional Zoology, Lund University, Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cedervall</LastName>
                    <ForeName>Tommy</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Biochemistry and Structural Biology, Lund University, Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Abdshill</LastName>
                    <ForeName>Hodan</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Inst. Clinical Sciences, Dept. Ophthalmology, Lund University, Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Fredrik</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Dept. of Biology, Sec. Functional Zoology, Lund University, Lund, Sweden.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Johansson</LastName>
                    <ForeName>Ulrica Englund</ForeName>
                    <Initials>UE</Initials>
                    <Affiliation>Inst. Clinical Sciences, Dept. Ophthalmology, Lund University, Lund, Sweden.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105359</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-04312</ArticleId>
            <ArticleId IdType="pubmed">25144684</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144681</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1949-0984</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Gut microbes</Title>
                <ISOAbbreviation>Gut Microbes</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Amelioration of DSS-induced murine colitis by VSL#3 supplementation is primarily associated with changes in ileal microbiota composition .</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Inflammatory bowel diseases encompass gastrointestinal illnesses typified by chronic inflammation, loss of epithelial integrity and gastrointestinal microbiota dysbiosis. In an effort to counteract these characteristic perturbations, we used stem cells and/or a probiotic therapy in a murine model of Dextran Sodium Sulfate induced colitis to examine both their efficacy in ameliorating disease and impact on niche-specific microbial communities of the lower GI tract. Colitis was induced in C57BL/6 mice by administering 3% DSS in drinking water for 10 days prior to administering one of three treatment plans: daily probiotic (VSL#3) supplementation for 3 days, a single tail vein injection of 1x10 (6) murine mesenchymal stem cells, or both. Ileal, cecal and colonic sections were collected for microbiota and histological analyses. Microbiota profiling revealed distinct bacterial community compositions in the ileum, cecum and colon of control untreated animals, all of which were predicted in silico to be enriched for a number of discrete KEGG pathways, indicating compositional and functional niche specificity in healthy animals. DSS-treatment perturbed community composition in all three niches with ileal communities exhibiting the greatest change relative to control animals. Each treatment group exhibited treatment-specific alterations in microbiota composition in the lower GI tract, though disease scores were only improved in VSL#3-treated animals. The ileal microbiota were most profoundly altered in composition in this group of animals and characterized by significant Enterobacteriaceae enrichment compared with colitic mice (P&lt;0.05).</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mar</LastName>
                    <ForeName>Jordan</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Nagalingam</LastName>
                    <ForeName>Nabeetha</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Yuanlin</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Onizawa</LastName>
                    <ForeName>Michio</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Jae-Woo</ForeName>
                    <Initials>JW</Initials>
                </Author>
                <Author>
                    <LastName>Lynch</LastName>
                    <ForeName>Susan</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>04</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Gut Microbes</MedlineTA>
            <NlmUniqueID>101495343</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">16S rRNA</Keyword>
            <Keyword MajorTopicYN="N">DSS</Keyword>
            <Keyword MajorTopicYN="N">Ileum</Keyword>
            <Keyword MajorTopicYN="N">Microbiome</Keyword>
            <Keyword MajorTopicYN="N">Microbiota</Keyword>
            <Keyword MajorTopicYN="N">Probiotic</Keyword>
            <Keyword MajorTopicYN="N">Stem Cells</Keyword>
            <Keyword MajorTopicYN="N">Ulcerative Colitis</Keyword>
            <Keyword MajorTopicYN="N">VSL#3</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">32147</ArticleId>
            <ArticleId IdType="pubmed">25144681</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144673</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1557-8585</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Lymphatic research and biology</Title>
                <ISOAbbreviation>Lymphat Res Biol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Decellularized Lymph Nodes as Scaffolds for Tissue Engineered Lymph Nodes.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Background: The lymphatic system is commonly injured during cancer treatment. However, despite the morbidity of these injuries, there are currently no options for replacing damaged lymphatics. The purpose of this study was to optimize methods for decellularization of murine lymph nodes (LN) and to determine if these scaffolds can be used to tissue engineer lymph node-like structures. Methods and Results: LNs were harvested from adult mice and subjected to various decellularization protocols. The degree of decellularization and removal of nuclear material was analyzed histologically and quantitatively using DNA isolation. In addition, we analyzed histological architecture by staining for matrix proteins. After the optimal method of decellularization was identified, decellularized constructs were implanted in the renal capsule of syngeneic or allogeneic recipient mice and analyzed for antigenicity. Finally, to determine if decellularized constructs could deliver lymphocytes to recipient animals, the matrices were repopulated with splenocytes, implanted in submuscular pockets, and harvested 14 days later. Decellularization was best accomplished with the detergent sodium dodecyl sulfate (SDS), resulting in negligible residual cellular material but maintenance of LN architecture. Implantation of decellularized LNs into syngeneic or allogeneic mice did not elicit a significant antigenic response. In addition, repopulation of decellularized LNs with splenocytes resulted in successful in vivo cellular delivery. Conclusions: We show, for the first time, that LNs can be successfully decellularized and that these matrices have preserved extracellular matrix architecture and the potential to deliver leukocytes in vivo. Future studies are needed to determine if tissue engineered lymph nodes maintain immunologic function.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cuzzone</LastName>
                    <ForeName>Daniel A</ForeName>
                    <Initials>DA</Initials>
                    <Affiliation>The Division of Plastic and Reconstructive Surgery, Memorial Sloan-Kettering Cancer Center , New York, New York.</Affiliation>
                </Author>
                <Author>
                    <LastName>Albano</LastName>
                    <ForeName>Nicholas J</ForeName>
                    <Initials>NJ</Initials>
                </Author>
                <Author>
                    <LastName>Aschen</LastName>
                    <ForeName>Seth Z</ForeName>
                    <Initials>SZ</Initials>
                </Author>
                <Author>
                    <LastName>Ghanta</LastName>
                    <ForeName>Swapna</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Mehrara</LastName>
                    <ForeName>Babak J</ForeName>
                    <Initials>BJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Lymphat Res Biol</MedlineTA>
            <NlmUniqueID>101163587</NlmUniqueID>
            <ISSNLinking>1539-6851</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1089/lrb.2013.0054</ArticleId>
            <ArticleId IdType="pubmed">25144673</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144647</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-1315</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Radiology</Title>
                <ISOAbbreviation>Radiology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>In Situ Monitoring of Electric Field Distribution in Mouse Tumor during Electroporation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>140311</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Purpose To investigate the feasibility of magnetic resonance (MR) electric impedance tomography (EIT) technique for in situ monitoring of electric field distribution during in vivo electroporation of mouse tumors to predict reversibly electroporated tumor areas. Materials and Methods All experiments received institutional animal care and use committee approval. Group 1 consisted of eight tumors that were used for determination of predicted area of reversibly electroporated tumor cells with MR EIT by using a 2.35-T MR imager. In addition, T1-weighted images of tumors were acquired to determine entrapment of contrast agent within the reversibly electroporated area. A correlation between predicted reversible electroporated tumor areas as determined with MR EIT and areas of entrapped MR contrast agent was evaluated to verify the accuracy of the prediction. Group 2 consisted of seven tumors that were used for validation of radiologic imaging with histopathologic staining. Histologic analysis results were then compared with predicted reversible electroporated tumor areas from group 1. Results were analyzed with Pearson correlation analysis and one-way analysis of variance. Results Mean coverage ?? standard deviation of tumors with electric field that leads to reversible electroporation of tumor cells obtained with MR EIT (38% ?? 9) and mean fraction of tumors with entrapped MR contrast agent (41% ?? 13) were correlated (Pearson analysis, r = 0.956, P = .005) and were not statistically different (analysis of variance, P = .11) from mean fraction of tumors from group 2 with entrapped fluorescent dye (39% ?? 12). Conclusion MR EIT can be used for determining electric field distribution in situ during electroporation of tissue. Implementation of MR EIT in electroporation-based applications, such as electrochemotherapy and irreversible electroporation tissue ablation, would enable corrective interventions before the end of the procedure and would additionally improve the treatment outcome. ?? RSNA, 2014.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kranjc</LastName>
                    <ForeName>Matej</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>From the Faculty of Electrical Engineering, University of Ljubljana, Tr??a??ka 25, SI-1000 Ljubljana, Slovenia (M.K., D.M.); Ljubljana Institute of Oncology, Ljubljana, Slovenia (B.M., M. ??., T.B.); Department of Condensed Matter Physics, Jozef Stefan Institute, Ljubljana, Slovenia (F.B., I.S.); Department of Biomedical Engineering, Kyung Hee University, Republic of Korea (I.S.); and Faculty of Health Sciences, University of Primorska, Izola, Slovenia (M.??.).</Affiliation>
                </Author>
                <Author>
                    <LastName>Markelc</LastName>
                    <ForeName>Bo??tjan</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Bajd</LastName>
                    <ForeName>Franci</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Cema??ar</LastName>
                    <ForeName>Maja</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Ser??a</LastName>
                    <ForeName>Igor</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Blagus</LastName>
                    <ForeName>Tanja</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Miklav??i??</LastName>
                    <ForeName>Damijan</ForeName>
                    <Initials>D</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Radiology</MedlineTA>
            <NlmUniqueID>0401260</NlmUniqueID>
            <ISSNLinking>0033-8419</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiol.14140311</ArticleId>
            <ArticleId IdType="pubmed">25144647</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144618</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>FTO Is a Relevant Factor for the Development of the Metabolic Syndrome in Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105349</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105349</ELocationID>
            <Abstract>
                <AbstractText>The metabolic syndrome is a worldwide problem mainly caused by obesity. FTO was found to be a obesity-risk gene in humans and FTO deficiency in mice led to reduction in adipose tissue. Thus, FTO is an important factor for the development of obesity. Leptin-deficient mice are a well characterized model for analysing the metabolic syndrome. To determine the relevance of FTO for the development of the metabolic syndrome we analysed different parameters in combined homozygous deficient mice (Lepob/ob;Fto-/-). Lepob/ob;Fto-/- mice showed an improvement in analysed hallmarks of the metabolic syndrome in comparison to leptin-deficient mice wild type or heterozygous for Fto. Lepob/ob;Fto-/- mice did not develop hyperglycaemia and showed an improved glucose tolerance. Furthermore, extension of beta-cell mass was prevented in Lepob/ob;Fto-/-mice and accumulation of ectopic fat in the liver was reduced. In conclusion this study demonstrates that FTO deficiency has a protective effect not only on the development of obesity but also on the metabolic syndrome. Thus, FTO plays an important role in the development of metabolic disorders and is an interesting target for therapeutic agents.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ikels</LastName>
                    <ForeName>Kathrin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Institute of Animal Developmental and Molecular Biology, Heinrich Heine University, D??sseldorf, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuschel</LastName>
                    <ForeName>Stefanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Institute of Animal Developmental and Molecular Biology, Heinrich Heine University, D??sseldorf, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fischer</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute of Animal Developmental and Molecular Biology, Heinrich Heine University, D??sseldorf, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kaisers</LastName>
                    <ForeName>Wolfgang</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Coordination Centre for Clinical Trials, Heinrich Heine University, D??sseldorf, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Eberhard</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Institute of Metabolic Physiology, Heinrich Heine University, D??sseldorf, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>R??ther</LastName>
                    <ForeName>Ulrich</ForeName>
                    <Initials>U</Initials>
                    <Affiliation>Institute of Animal Developmental and Molecular Biology, Heinrich Heine University, D??sseldorf, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105349</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-00771</ArticleId>
            <ArticleId IdType="pubmed">25144618</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144609</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1949-0984</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>5</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>5</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Gut microbes</Title>
                <ISOAbbreviation>Gut Microbes</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Commensal-pathogen interactions in the intestinal tract: Lactobacilli promote infection with, and are promoted by, helminth parasites.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The intestinal microbiota are pivotal in determining the developmental, metabolic and immunological status of the mammalian host. However, the intestinal tract may also accommodate pathogenic organisms, including helminth parasites which are highly prevalent in most tropical countries. Both microbes and helminths must evade or manipulate the host immune system to reside in the intestinal environment, yet whether they influence each other's persistence in the host remains unknown. We now show that abundance of Lactobacillus bacteria correlates positively with infection with the mouse intestinal nematode, Heligmosomoides polygyrus, as well as with heightened regulatory T cell (Treg) and Th17 responses. Moreover, H. polygyrus raises Lactobacillus species abundance in the duodenum of C57BL/6 mice, which are highly susceptible to H. polygyrus infection, but not in BALB/c mice, which are relatively resistant. Sequencing of samples at the bacterial gyrB locus identified the principal Lactobacillus species as L. taiwanensis, a previously characterized rodent commensal. Experimental administration of L. taiwanensis to BALB/c mice elevates regulatory T cell frequencies and results in greater helminth establishment, demonstrating a causal relationship in which commensal bacteria promote infection with an intestinal parasite and implicating a bacterially-induced expansion of Tregs as a mechanism of greater helminth susceptibility. The discovery of this tripartite interaction between host, bacteria and parasite has important implications for both antibiotic and anthelmintic use in endemic human populations.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Reynolds</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Smith</LastName>
                    <ForeName>Katherine</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Filbey</LastName>
                    <ForeName>Kara</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Harcus</LastName>
                    <ForeName>Yvonne</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Hewitson</LastName>
                    <ForeName>James</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Redpath</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Valdez</LastName>
                    <ForeName>Yanet</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Yebra</LastName>
                    <ForeName>Mar??a</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Finlay</LastName>
                    <ForeName>B Brett</ForeName>
                    <Initials>BB</Initials>
                </Author>
                <Author>
                    <LastName>Maizels</LastName>
                    <ForeName>Rick</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>05</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Gut Microbes</MedlineTA>
            <NlmUniqueID>101495343</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Commensal</Keyword>
            <Keyword MajorTopicYN="N">Duodenum</Keyword>
            <Keyword MajorTopicYN="N">Lactobacillus</Keyword>
            <Keyword MajorTopicYN="N">Microbiota</Keyword>
            <Keyword MajorTopicYN="N">Nematode</Keyword>
            <Keyword MajorTopicYN="N">Th17</Keyword>
            <Keyword MajorTopicYN="N">Treg</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">32155</ArticleId>
            <ArticleId IdType="pubmed">25144609</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144573</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1935-2735</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>PLoS neglected tropical diseases</Title>
                <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Panel of Trypanosoma brucei Strains Tagged with Blue and Red-Shifted Luciferases for Bioluminescent Imaging in Murine Infection Models.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e3054</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0003054</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Genetic engineering with luciferase reporter genes allows monitoring Trypanosoma brucei (T.b.) infections in mice by in vivo bioluminescence imaging (BLI). Until recently, luminescent T.b. models were based on Renilla luciferase (RLuc) activity. Our study aimed at evaluating red-shifted luciferases for in vivo BLI in a set of diverse T.b. strains of all three subspecies, including some recently isolated from human patients.</AbstractText>
                <AbstractText Label="METHODOLOGY/PRINCIPAL FINDINGS" NlmCategory="RESULTS">We transfected T.b. brucei, T.b. rhodesiense and T.b. gambiense strains with either RLuc, click beetle red (CBR) or Photinus pyralis RE9 (PpyRE9) luciferase and characterised their in vitro luciferase activity, growth profile and drug sensitivity, and their potential for in vivo BLI. Compared to RLuc, the red-shifted luciferases, CBR and PpyRE9, allow tracking of T.b. brucei AnTaR 1 trypanosomes with higher details on tissue distribution, and PpyRE9 allows detection of the parasites with a sensitivity of at least one order of magnitude higher than CBR luciferase. With CBR-tagged T.b. gambiense LiTaR1, T.b. rhodesiense RUMPHI and T.b. gambiense 348 BT in an acute, subacute and chronic infection model respectively, we observed differences in parasite tropism for murine tissues during in vivo BLI. Ex vivo BLI on the brain confirmed central nervous system infection by all luminescent strains of T.b. brucei AnTaR 1, T.b. rhodesiense RUMPHI and T.b. gambiense 348 BT.</AbstractText>
                <AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">We established a genetically and phenotypically diverse collection of bioluminescent T.b. brucei, T.b. gambiense and T.b. rhodesiense strains, including drug resistant strains. For in vivo BLI monitoring of murine infections, we recommend trypanosome strains transfected with red-shifted luciferase reporter genes, such as CBR and PpyRE9. Red-shifted luciferases can be detected with a higher sensitivity in vivo and at the same time they improve the spatial resolution of the parasites in the entire body due to the better kinetics of their substrate D-luciferin.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Van Reet</LastName>
                    <ForeName>Nick</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van de Vyver</LastName>
                    <ForeName>H??l??ne</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Institute of Medical Microbiology, University Hospital of M??nster, M??nster, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pyana</LastName>
                    <ForeName>Patient Pati</ForeName>
                    <Initials>PP</Initials>
                    <Affiliation>Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; D??partement de Parasitologie, Institut National de Recherche Biom??dicale, Kinshasa Gombe, Democratic Republic of the Congo.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van der Linden</LastName>
                    <ForeName>Anne Marie</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, Bio-Imaging Lab, Department of Biomedical Sciences, University of Antwerp, Wilrijk, Belgium.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>B??scher</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
            <NlmUniqueID>101291488</NlmUniqueID>
            <ISSNLinking>1935-2727</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month>8</Month>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pntd.0003054</ArticleId>
            <ArticleId IdType="pii">PNTD-D-14-00396</ArticleId>
            <ArticleId IdType="pubmed">25144573</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144571</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1536-4844</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Inflammatory bowel diseases</Title>
                <ISOAbbreviation>Inflamm. Bowel Dis.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Experimental Colitis Is Exacerbated by Concomitant Infection with Mycobacterium avium ssp. paratuberculosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText Label="BACKGROUND:" NlmCategory="UNASSIGNED">Crohn's disease (CD) is a chronic inflammatory disorder of the human gastrointestinal tract. Although genetic, immunological, environmental, and bacterial factors have been implicated, the pathogenesis is incompletely understood. The histopathological appearance of CD strikingly resembles Johne's disease, a ruminant inflammatory bowel disease, caused by Mycobacterium avium ssp. paratuberculosis (MAP), but a causative role of MAP in CD has not been established. In this work, we hypothesized that MAP might exacerbate an already existing intestinal disease.</AbstractText>
                <AbstractText Label="METHODS:" NlmCategory="UNASSIGNED">We combined dextran sulfate sodium (DSS)-induced colitis with MAP infection in mice and monitored the immune response and bacterial count in different organs.</AbstractText>
                <AbstractText Label="RESULTS:" NlmCategory="UNASSIGNED">An increased size of liver and spleen was observed in DSS-treated and MAP-infected animals (DSS + MAP) as compared with DSS-treated uninfected (DSS + PBS) mice. Similarly, DSS treatment increased the number and size of MAP-induced liver granulomas and enhanced the MAP counts in enteric tissue. MAP infection in turn delayed the mucosal healing of DSS-induced tissue damage. Finally, high numbers of MAP were found in mesenteric fat tissue causing large granuloma and necrotic regions.</AbstractText>
                <AbstractText Label="CONCLUSIONS:" NlmCategory="UNASSIGNED">Taken together, we present an in vivo model to study the role of MAP infection in CD. Our results confirm the hypothesis that MAP is able to exacerbate existing intestinal inflammation.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Suwandi</LastName>
                    <ForeName>Abdulhadi</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>*Molecular Immunology, Helmholtz Centre for Infection Research, Braunschweig, Germany; ???Mouse Pathology, Helmholtz Centre for Infection Research, Braunschweig, Germany; ???Institute for Microbiology, University of Veterinary Medicine Hannover, Hannover, Germany; ??Central Facility for Microscopy, Helmholtz Centre for Infection Research, Braunschweig, Germany; ???Institute of Transplant Immunology, Integrated Research and Treatment Center, Hannover, Germany; and ??Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bargen</LastName>
                    <ForeName>Imke</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Roy</LastName>
                    <ForeName>Bishnudeo</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Pils</LastName>
                    <ForeName>Marina C</ForeName>
                    <Initials>MC</Initials>
                </Author>
                <Author>
                    <LastName>Krey</LastName>
                    <ForeName>Martina</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Zur Lage</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Basler</LastName>
                    <ForeName>Tina</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Rohde</LastName>
                    <ForeName>Manfred</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Falk</LastName>
                    <ForeName>Christine S</ForeName>
                    <Initials>CS</Initials>
                </Author>
                <Author>
                    <LastName>Hornef</LastName>
                    <ForeName>Mathias W</ForeName>
                    <Initials>MW</Initials>
                </Author>
                <Author>
                    <LastName>Goethe</LastName>
                    <ForeName>Ralph</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Weiss</LastName>
                    <ForeName>Siegfried</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Inflamm Bowel Dis</MedlineTA>
            <NlmUniqueID>9508162</NlmUniqueID>
            <ISSNLinking>1078-0998</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MIB.0000000000000157</ArticleId>
            <ArticleId IdType="pubmed">25144571</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144567</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Methyl Donor-Deficient Diet during Development Can Affect Fear and Anxiety in Adulthood in C57BL/6J Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105750</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105750</ELocationID>
            <Abstract>
                <AbstractText>DNA methylation is one of the essential factors in the control of gene expression. Folic acid, methionine and choline (methyl donors)-all nutrients related to one-carbon metabolism-are known as important mediators of DNA methylation. A previous study has shown that long-term administration of a diet lacking in methyl donors caused global DNA hypermethylation in the brain (Pogribny et al., 2008). However, no study has investigated the effects of a diet lacking in methyl donors during the developmental period on emotional behaviors such as fear and anxiety-like behavior in association with gene expressions in the brain. In addition, it has not been elucidated whether a diet supplemented with methyl donors later in life can reverse these changes. Therefore, we examined the effects of methyl donor deficiency during the developmental period on fear memory acquisition/extinction and anxiety-like behavior, and the relevant gene expressions in the hippocampus in juvenile (6-wk) and adult (12-wk) mice. We found that juvenile mice fed a methyl-donor-deficient diet had impaired fear memory acquisition along with decreases in the gene expressions of Dnmt3a and Dnmt3b. In addition, reduced anxiety-like behavior with decreased gene expressions of Grin2b and Gabar2 was observed in both the methyl-donor-deficient group and the body-weight-matched food-restriction group. After being fed a diet supplemented with methyl donors ad libitum, adult mice reversed the alteration of gene expression of Dnmt3a, Dnmt3b, Grin2b and Gabar2, but anxiety-like behavior became elevated. In addition, impaired fear-memory formation was observed in the adult mice fed the methyl-donor-deficient diet during the developmental period. Our study suggested that developmental alterations in the one-carbon metabolic pathway in the brain could have effects on emotional behavior and memory formation that last into adulthood.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Ishii</LastName>
                    <ForeName>Daisuke</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsuzawa</LastName>
                    <ForeName>Daisuke</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan; Research Center for Child Mental Development, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Matsuda</LastName>
                    <ForeName>Shingo</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan; Department of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomizawa</LastName>
                    <ForeName>Haruna</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sutoh</LastName>
                    <ForeName>Chihiro</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan; Research Center for Child Mental Development, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shimizu</LastName>
                    <ForeName>Eiji</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Department of Cognitive Behavioral Physiology, Chiba University Graduate School of Medicine, Chiba, Japan; Research Center for Child Mental Development, Graduate School of Medicine, Chiba University, Chiba, Japan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105750</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-18468</ArticleId>
            <ArticleId IdType="pubmed">25144567</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144532</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1520-5118</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of agricultural and food chemistry</Title>
                <ISOAbbreviation>J. Agric. Food Chem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dietary Fermented Soybean Suppresses UVB-induced Skin Inflammation in Hairless Mice via Regulation of the MAPK Signaling Pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Soybean may be a promising ingredient for regulating UVB-induced inflammatory damage to the skin. We investigated the anti-inflammatory effects of diets supplemented with fermented soybean on UVB-induced skin photodamage and the effectiveness of soybean (S) and fermented soybean (FS) dietary supplementation. To investigate the effects of two major isoflavones-daidzein and genistein-from FS, we used co-cultures with keratinocytes and fibroblasts. Genistein treatment strongly inhibited the production of IL-6 and MAPK signaling. Forty hairless male mice divided into four groups were fed with a control diet (Group N: normal, Group C; +UVB) or diets with 2.5% S+UVB or 2.5% FS+UVB (Group S, Group FS) for 8 weeks. Macrophage infiltration to the dermis was reduced more in Groups S and FS than in Group C. The expression levels of iNOS and COX-2 were significantly decreased in Group FS (by 7.7% ?? 0.4% and 21.2% ?? 0.3%, respectively [p &lt; 0.05]).</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Taek Hwan</ForeName>
                    <Initials>TH</Initials>
                </Author>
                <Author>
                    <LastName>Do</LastName>
                    <ForeName>Moon Ho</ForeName>
                    <Initials>MH</Initials>
                </Author>
                <Author>
                    <LastName>Oh</LastName>
                    <ForeName>Young Lyun</ForeName>
                    <Initials>YL</Initials>
                </Author>
                <Author>
                    <LastName>Cho</LastName>
                    <ForeName>Dong Woon</ForeName>
                    <Initials>DW</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Seung Hyun</ForeName>
                    <Initials>SH</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Sun Yeou</ForeName>
                    <Initials>SY</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Agric Food Chem</MedlineTA>
            <NlmUniqueID>0374755</NlmUniqueID>
            <ISSNLinking>0021-8561</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf5018252</ArticleId>
            <ArticleId IdType="pubmed">25144532</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144514</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1473-5849</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>20</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Behavioural pharmacology</Title>
                <ISOAbbreviation>Behav Pharmacol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Tea component, epigallocatechin gallate, potentiates anticataleptic and locomotor-sensitizing effects of caffeine in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Tea is the most popular beverage worldwide. Caffeine, the psychoactive principle of tea, pharmacologically interacts with several drugs and bioactive molecules. Epigallocatechin gallate (EGCG) is a major component of tea and its known interactions with caffeine make it worthwhile to further study them by investigating the influence of EGCG on the anticataleptic and locomotor-sensitizing effects of caffeine. In the present investigation, we observed that (a) administration of caffeine or EGCG alone inhibited haloperidol-induced catalepsy, a widely used animal model to study parkinsonism, and (b) a combination of caffeine and EGCG produced greater inhibition of haloperidol-induced catalepsy. Furthermore, after repeated administration of caffeine and EGCG, either alone or in combination, we observed that (c) caffeine and EGCG contrasted the sensitization of catalepsy observed after repeated haloperidol administration by significantly reducing the duration of catalepsy. Furthermore, as haloperidol-induced catalepsy was also associated with increased lipid peroxidation, we observed that (d) EGCG administration reduced striatal lipid peroxide levels in a dose-dependent manner and that (e) the combination of caffeine with EGCG was most effective in reducing haloperidol-increased striatal lipid peroxide. Finally, we observed that (f) chronic caffeine and EGCG significantly elicited locomotor sensitization and that (g) their combination resulted in significantly greater effects. In conclusion, EGCG potentiated the effects of caffeine on haloperidol-induced catalepsy and of caffeine-elicited locomotor sensitization. Overall, these observations indicate critical interactions between caffeine and EGCG in an animal model of parkinsonism and locomotor activity and suggest that tea consumption might reduce antipsychotic-induced side effects.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kasture</LastName>
                    <ForeName>Sanjay B</ForeName>
                    <Initials>SB</Initials>
                    <Affiliation>aDepartment of Pharmacology, Sanjivani College of Pharmaceutical Education &amp; Research, Kopargaon bDepartment of Pharmacology, Sinhgad Institute of Pharmacy, University of Pune, Pune, India cDepartment of Life and Environmental Sciences dDepartment of Surgical Sciences eCentre of Excellence on Neurobiology of Addiction fNational Institute of Neuroscience - INN, University of Cagliari, Cagliari, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gaikar</LastName>
                    <ForeName>Mayur</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Kasture</LastName>
                    <ForeName>Veena</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author>
                    <LastName>Arote</LastName>
                    <ForeName>Sanjay</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Salve</LastName>
                    <ForeName>Balu</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Rosas</LastName>
                    <ForeName>Michela</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Cotti</LastName>
                    <ForeName>Elisabetta</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Acquas</LastName>
                    <ForeName>Elio</ForeName>
                    <Initials>E</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>20</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Behav Pharmacol</MedlineTA>
            <NlmUniqueID>9013016</NlmUniqueID>
            <ISSNLinking>0955-8810</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1097/FBP.0000000000000071</ArticleId>
            <ArticleId IdType="pubmed">25144514</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144478</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1091-7691</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>26</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Inhalation toxicology</Title>
                <ISOAbbreviation>Inhal Toxicol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Brain suppression of AP-1 by inhaled diesel exhaust and reversal by cerium oxide nanoparticles.</ArticleTitle>
            <Pagination>
                <MedlinePgn>636-41</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3109/08958378.2014.948651</ELocationID>
            <Abstract>
                <AbstractText>Abstract One of the uses of cerium oxide nanoparticles (nanoceria, CeO2) is as a diesel fuel additive to improve fuel efficiency. Gene/environment interactions are important determinants in the etiology of age-related disorders. Thus, it is possible that individuals on high-fat diet and genetic predisposition to vascular disease may be more vulnerable to the adverse health effects of particle exposure. The aim of this pilot study was to test the hypothesis that inhalation of diesel exhaust (DE) or diesel exhaust-containing cerium oxide nanoparticles (DCeE) induces stress in the brain of a susceptible animal model. Atherosclerotic prone, apolipoprotein E knockout (ApoE(-/-)) mice fed a high-fat diet, were exposed by inhalation to purified air (control), DE or DCeE. The stress-responsive transcription factor, activator protein-1 (AP-1), was significantly decreased in the cortical and subcortical fraction of the brain after DE exposure. The addition of nanoceria to the diesel fuel reversed this effect. The activation of another stress-related transcription factor (NF-??B) was not inhibited. AP-1 is composed of complexes of the Jun and/or Fos family of proteins. Exposure to DCeE caused c-Jun activation and this may be a mechanism by which addition of nanoceria to the fuel reversed the effect of DE exposure on AP-1 activation. This pilot study demonstrates that exposure to DE does impact the brain and addition of nanoceria may be protective. However, more extensive studies are necessary to determine how DE induced reduction of AP-1 activity and compensation by nanoceria impacts normal function of the brain.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lung</LastName>
                    <ForeName>Shyang</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences , Pomona, CA , USA and.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cassee</LastName>
                    <ForeName>Flemming R</ForeName>
                    <Initials>FR</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gosens</LastName>
                    <ForeName>Ilse</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Campbell</LastName>
                    <ForeName>Arezoo</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Inhal Toxicol</MedlineTA>
            <NlmUniqueID>8910739</NlmUniqueID>
            <ISSNLinking>0895-8378</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">c-Jun</Keyword>
            <Keyword MajorTopicYN="N">nanoceria</Keyword>
            <Keyword MajorTopicYN="N">stress</Keyword>
            <Keyword MajorTopicYN="N">transcription factors</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08958378.2014.948651</ArticleId>
            <ArticleId IdType="pubmed">25144478</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144474</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1091-7691</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>26</Volume>
                    <Issue>10</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Inhalation toxicology</Title>
                <ISOAbbreviation>Inhal Toxicol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The acute exposure effects of inhaled nickel nanoparticles on murine endothelial progenitor cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn>588-97</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.3109/08958378.2014.937882</ELocationID>
            <Abstract>
                <AbstractText Label="UNLABELLED">Abstract Introduction: The discovery of endothelial progenitor cells (EPCs) may help to explain observed cardiovascular effects associated with inhaled nickel nanoparticle exposures, such as increases in vascular inflammation, generation of reactive oxygen species, altered vasomotor tone and potentiated atherosclerosis in murine species.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Following an acute whole body inhalation exposure to 500?????g/m(3) of nickel nanoparticles for 5???h, bone marrow EPCs from C57BL/6 mice were isolated. EPCs were harvested for their RNA or used in a variety of assays including chemotaxis, tube formation and proliferation. Gene expression was assessed for important receptors involved in EPC mobilization and homing using RT-PCR methods. EPCs, circulating endothelial progenitor cells (CEPCs), circulating endothelial cells (CECs) and endothelial microparticles (EMPs) were quantified on a BD FACSCalibur to examine endothelial damage and repair associated with the exposure.</AbstractText>
                <AbstractText Label="RESULTS AND CONCLUSIONS" NlmCategory="CONCLUSIONS">Acute exposure to inhaled nickel nanoparticles significantly increased both bone marrow EPCs as well as their levels in circulation (CEPCs). CECs were significantly elevated indicating that endothelial damage occurred due to the exposure. There was no significant difference in EMPs between the two groups. Tube formation and chemotaxis, but not proliferation, of bone marrow EPCs was impaired in the nickel nanoparticle exposed group. These results coincided with a decrease in the mRNA of receptors involved in EPC mobilization and homing. These data provide new insight into how an acute nickel nanoparticle exposure to half of the current Occupational Safety &amp; Health Administration (OSHA) permissible exposure limit may adversely affect EPCs and exacerbate cardiovascular disease states.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Liberda</LastName>
                    <ForeName>Eric N</ForeName>
                    <Initials>EN</Initials>
                    <Affiliation>Department of Environmental Medicine, New York University School of Medicine , Tuxedo, NY , USA and.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cuevas</LastName>
                    <ForeName>Azita K</ForeName>
                    <Initials>AK</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Qu</LastName>
                    <ForeName>Qingshan</ForeName>
                    <Initials>Q</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chen</LastName>
                    <ForeName>Lung Chi</ForeName>
                    <Initials>LC</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Inhal Toxicol</MedlineTA>
            <NlmUniqueID>8910739</NlmUniqueID>
            <ISSNLinking>0895-8378</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Endothelial progenitor cells</Keyword>
            <Keyword MajorTopicYN="N">inhalation</Keyword>
            <Keyword MajorTopicYN="N">nanoparticles</Keyword>
            <Keyword MajorTopicYN="N">nickel</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08958378.2014.937882</ArticleId>
            <ArticleId IdType="pubmed">25144474</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25144457</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS ONE</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Two-point magnitude MRI for rapid mapping of brown adipose tissue and its application to the r6/2 mouse model of huntington disease.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e105556</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0105556</ELocationID>
            <Abstract>
                <AbstractText>The recent discovery of active brown fat in human adults has led to renewed interest in the role of this key metabolic tissue. This is particularly true for neurodegenerative conditions like Huntington disease (HD), an adult-onset heritable disorder with a prominent energy deficit phenotype. Current methods for imaging brown adipose tissue (BAT) are in limited use because they are equipment-wise demanding and often prohibitively expensive. This prompted us to explore how a standard MRI set-up can be modified to visualize BAT in situ by taking advantage of its characteristic fat/water content ratio to differentiate it from surrounding white fat. We present a modified MRI protocol for use on an 11.7 T small animal MRI scanner to visualize and quantify BAT in wild-type and disease model laboratory mice. In this application study using the R6/2 transgenic mouse model of HD we demonstrate a significantly reduced BAT volume in HD mice vs. matched controls (n???=???5 per group). This finding provides a plausible structural explanation for the previously described temperature phenotype of HD mice and underscores the significance of peripheral tissue pathology for the HD phenotype. On a more general level, the results demonstrate the feasibility of MR-based BAT imaging in rodents and open the path towards transferring this imaging approach to human patients. Future studies are needed to determine if this method can be used to track disease progression in HD and other disease entities associated with BAT abnormalities, including metabolic conditions such as obesity, cachexia, and diabetes.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lindenberg</LastName>
                    <ForeName>Katrin S</ForeName>
                    <Initials>KS</Initials>
                    <Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weydt</LastName>
                    <ForeName>Patrick</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>M??ller</LastName>
                    <ForeName>Hans-Peter</ForeName>
                    <Initials>HP</Initials>
                    <Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bornstedt</LastName>
                    <ForeName>Axel</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Internal Medicine II, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ludolph</LastName>
                    <ForeName>Albert C</ForeName>
                    <Initials>AC</Initials>
                    <Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Landwehrmeyer</LastName>
                    <ForeName>G Bernhard</ForeName>
                    <Initials>GB</Initials>
                    <Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rottbauer</LastName>
                    <ForeName>Wolfgang</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Department of Internal Medicine II, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kassubek</LastName>
                    <ForeName>Jan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Neurology, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rasche</LastName>
                    <ForeName>Volker</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Internal Medicine II, Ulm University, Ulm, Germany; Core Facility Small Animal Imaging, Ulm University, Ulm, Germany.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="ecollection">
                <Year>2014</Year>
                <Month/>
                <Day/>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0105556</ArticleId>
            <ArticleId IdType="pii">PONE-D-14-14705</ArticleId>
            <ArticleId IdType="pubmed">25144457</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25144434</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>21</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1439-3964</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of sports medicine</Title>
                <ISOAbbreviation>Int J Sports Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Influence of Acute Exercise on the Osmotic Stability of the Human Erythrocyte Membrane.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">This study evaluated the effects of 2 different types of acute aerobic exercise on the osmotic stability of human erythrocyte membrane and on different hematological and biochemical variables that are associated with this membrane property. The study population consisted of 20 healthy and active men. Participants performed single sessions of 2 types of exercise. The first session consisted of 60???min of moderate-intensity continuous exercise (MICE). The second session, executed a week later, consisted of high-intensity interval exercise (HIIE) until exhaustion. The osmotic stability of the erythrocyte membrane was represented by the inverse of the salt concentration (1/H50) at the midpoint of the sigmoidal curve of dependence between the absorbance of hemoglobin and the NaCl concentration. The values of 1/H50 changed from 2.29??0.1 to 2.33??0.09 after MICE and from 2.30??0.08 to 2.23??0.12 after HIIE. During MICE mean corpuscular volume increased, probably due to in vivo lysis of older erythrocytes, with preservation of cells that were larger and more resistant to in vitro lysis. The study showed that a single bout of acute exercise affected erythrocyte stability, which increased after MICE and decreased after HIIE.</AbstractText>
                <CopyrightInformation>?? Georg Thieme Verlag KG Stuttgart ?? New York.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Paraiso</LastName>
                    <ForeName>L F</ForeName>
                    <Initials>LF</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>de Freitas</LastName>
                    <ForeName>M V</ForeName>
                    <Initials>MV</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gon??alves-E-Oliveira</LastName>
                    <ForeName>A F M</ForeName>
                    <Initials>AF</Initials>
                    <Affiliation>Faculty of Medicine, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>de Almeida Neto</LastName>
                    <ForeName>O P</ForeName>
                    <Initials>OP</Initials>
                    <Affiliation>Faculty of Medicine, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pereira</LastName>
                    <ForeName>E A</ForeName>
                    <Initials>EA</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mascarenhas Netto</LastName>
                    <ForeName>R C</ForeName>
                    <Initials>RC</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cunha</LastName>
                    <ForeName>L M</ForeName>
                    <Initials>LM</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bernardino Neto</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>de Agostini</LastName>
                    <ForeName>G G</ForeName>
                    <Initials>GG</Initials>
                    <Affiliation>Faculty of Physical Education, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Resende</LastName>
                    <ForeName>E S</ForeName>
                    <Initials>ES</Initials>
                    <Affiliation>Faculty of Physical Education, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Penha-Silva</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Institute of Genetics and Biochemisty, Federal University of Uberl??ndia, Uberl??ndia, MG, Brazil.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <VernacularTitle/>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int J Sports Med</MedlineTA>
            <NlmUniqueID>8008349</NlmUniqueID>
            <ISSNLinking>0172-4622</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="epublish">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>22</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0034-1371834</ArticleId>
            <ArticleId IdType="pubmed">25144434</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
